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Abstract 
Abstract 
From 2001 to 2005, work was conducted at the Photobiology Unit at Ninewells 
Hospital in Dundee to examine the optical radiation environment and its 
implications for normal and diseased skin. Artificial sources of radiation were 
considered within the contexts of the hazards posed, measurement of the hazards, 
regulation concerning exposure and sources, and protection of abnormal skin 
from adverse effects. 
The hazards posed by both ultraviolet (UV) and visible polychromatic sources 
were examined for normal and abnormal (chronic actinic dermatitis and solar 
urticaria) skin in an effort to predict the responses to such radiation. With 
current methodologies it was shown that responses to polychromatic light cannot 
be forecast for normal and abnormal skin. 
Those hazards posed by light sources in the commercial sector are also 
considered. The sunbeds available in Perthshire and Dundee were evaluated 
spectroradiometrically and appropriate weighting functions applied. A case of 
adverse effects due to inappropriate use of an UV source is also presented and 
the implications are discussed. 
Two diode array spectroradiometers were evaluated for their potential as 
instruments to measure UV sources. It was shown that one instrument could be 
used to give measurements with acceptable errors. However, later work with a 
different instrument of the same series showed that there are manufacturing 
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Abstract 
issues to be resolved before these instruments are marketed for widespread use in 
dosimetry. 
Regulations governing exposure to and use of sources are considered where 
appropriate. Licensing of commercial sunbed parlours is suggested in order to 
enforce Health and Safety guidelines and the British Standard for such 
appliances, create a baseline for minimum standards of care within the 
commercial sector and safeguard public health. 
Lastly, it has been shown that skin sensitive to visible light can be protected with 
commercial makeup preparations. 
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Executive Summary 
Executive Summary 
This thesis considers light encountered from artificial sources and its effects on the 
skin. Normal skin is sensitive to ultraviolet (UV) radiation and exhibits an 
inflammatory response when the threshold dose is exceeded. Longer term effects 
include ageing and carcinogenesis. Photosensitive (abnormal) skin exhibits acute 
responses including swelling, excessive itching, erythema and blistering when 
thresholds for reaction are exceeded. The tolerable limits of exposure for normal and 
abnormal skin differ greatly. 
In order to quantify the risks from artificial light sources, their spectra must be 
accurately measured. Spectroradiometers are the conventional approach to these 
measurements but these bulky instruments are not suited to transportation and on-site 
measurements. Two diode array instruments were evaluated during the course of this 
research 1 and one of these instruments was found to be suitable for the measurement 
of UV. These instruments represent a powerful tool for health hazard assessment. 
There is a central paradigm in photobiology that assumes that the effects of 
polychromatic light can be predicted by using an appropriate action spectrum 2. This 
assumes that wavelengths of radiation are additive in a linear manner 3. In clinical 
photodermatology the response of skin is characterised using narrow bands of 
radiation 4. Although this is useful for diagnostic purposes, sources such as these are 
rarely encountered in the environment and therefore the applicability of these tests to 
everyday life is dubious. 
In order to test the hypothesis of additivity the results of conventional diagnostic 
techniques (phototesting) were used to construct action spectra. Tests were performed 
with polychromatic light on normal and abnormal skin. The results may indicate that 
the hypothesis is refuted for normal and abnormal skin. This result also casts doubt 
on the management of photosensitive skin conditions by avoidance of the `causal' 
wavelengths. Instead, commercial cosmetic preparations are suggested as 
photoprotective agents for photosensitive skin. A range of products were evaluated 
and some found to match or better the alternative creams for protection from visible 
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radiation 5. These products are more aesthetically pleasing than existing options and 
are readily available, some relatively cheaply. 
Assessment of the hazards of UV radiation in occupational and commercial settings is 
important for public health. Cosmetic sunbeds have been a contentious public health 
issue for some years. Of particular debate is the number of sessions that are safe to 
receive in one year. A diode array spectroradiometer was used to make spectral 
measurements of all the sunbeds in commercial and council premises in two local 
authority areas. The differences in the strength of the radiation emitted from modern 
sunbeds were found to be huge. However, the dose received depends on the length of 
the session. The actual doses that may be received has not been considered when 
guidelines for the use of sunbeds has been published 6. The dose received during 
every possible session on every bed surveyed was calculated. The results indicate that 
if the conservative approach of the precautionary principle is applied, the current 
medical guidelines of 20 sessions a year are prudent and rational. 
However, within a regulatory context it was found that the majority of the units 
surveyed do not fit into any criteria as given in the British Standard` covering these 
units. Modification of the standard should be undertaken otherwise the standard is 
farcical. 
A case study is also presented where inappropriate use of an UV source in an hotel 
kitchen led to adverse reactions amongst the staff 7. Measurement of the offending 
light source and assessment of its hazards against occupational exposure guidelines 
revealed that workers had been exceeding their 8-hour occupational exposure limit 8 
in just 14 seconds. The fact that these limits are only guidelines probably prevents 
any liable action being taken by the affected individuals. However, the fault really 
rests with the manufacturers of the UV unit as more than one type of tube could be 
fitted which inevitably leads to cases such as this 9. 
This research was conducted at the Photobiology Unit at Ninewells Hospital in 
Dundee. This is a national centre for research on light associated skin disorders 10. It 
(BS EN 60335-2-27: 1997, Safety of Household and similar electrical appliances, Part 2. Particular 
requirements, Section 2.27 Skin exposure to ultraviolet and infrared radiation) 
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has a well-recognised publication record in clinical and laboratory photodermatology 
research with excellent links with British industry, both for investigation of drug- 
induced photosensitivity and development of new light sources. This Unit is ideally 
situated for research into abnormal skin as photosensitivity is more prevalent at 
northern latitudes because of higher proportions of fair skinned individuals 11. 
Contribution to Knowledge 
" Diode array spectroradiometers (notably a Sola Scope SC-MP-A from 4D 
Controls, Redruth, UK) can be used to perform spectral UV measurements 
intended for dosimetry purposes. The errors associated with the use of these 
instruments are within acceptable limits. These instruments have the added 
advantage of providing spectral information that can then be used for hazard 
assessment and therefore provide added functionality when compared with the 
filtered radiometers traditionally used for such measurements. 
" When results from phototesting are used to construct an action spectrum for 
normal skin, it does not appear to respond as expected to polychromatic 
(ultraviolet) radiation. This may indicate that the erythemal response is not 
additive in a linear manner or that there are significant errors in the accepted 
methodology of phototesting. 
" Chronic actinic dermatitis and solar urticaria also do not appear to respond in a 
linearly additive manner to polychromatic (ultraviolet and visible) radiation. 
" Some commercial makeup preparations can be used to protect individuals 
sensitive to visible light. The protection afforded by some products betters 
that offered by the current alternative (Dundee creams 5) and may be 
considered more aesthetic. 
" Sunbeds currently available in two local authority areas in Dundee are of 
greater output than previously measured 12. 
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" The spectral distribution and strength of most sunbeds in the commercial 
sector in Perthshire and Dundee are such that they do not fit into any category 
in the existing British Standard for such units. 
" Considering the actual length of sunbed sessions available, and the dose 
subsequently received, current medical advice of no more than 20 sessions per 
year is consistent with the precautionary principle in that the total dose 
received would not exceed the recommended 15 kJm"2 erythemally weighted 
dose per year. 
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Introduction 
1. Scope of the thesis 
Chapter 1 
This thesis focuses on the exposure of skin to artificial optical radiation sources in our 
environment and the hazards posed by this radiation. In order to properly understand 
the potential harm that light can cause we must quantify the intensity of the radiation 
through measurement and then we can assess the hazards posed by sources and the 
need for protection and/or legislation to control exposure. 
Research was conducted in the University of Dundee's Photobiology Unit at 
Ninewells Hospital in Dundee. This is a national centre for the referral of patients 
with photosensitive skin and world prominent centre for research into the effects of 
light on skin. 
The link with skin cancer, effects on the immune system and biosphere are all well 
documented and huge amounts of money have been poured into researching these 
effects. Hence, this thesis focuses on the potential of artificial sources to elicit 
responses other than skin cancer, although the carcinogenic potential of sources are 
also evaluated. Normal and abnormal skin is considered throughout this thesis. 
Normal skin is at risk from overexposure to ultraviolet radiation (UVR) but 
photosensitive skin can also be at risk from visible light. 
Introduction Chapter 1 
Current legislation and guidance regarding exposure to optical radiation is considered 
in context. Means of protection from light is also considered. By extension this work 
also applies to exposure to the sun. 
This introduction discusses the optical radiation environment and the science 
underpinning the effects of light on skin. Conditions leading to abnormal 
photosensitivity are explained and light measurement techniques are considered. 
Finally the bodies involved in light safety are mentioned and the work covered in 
chapters 2 to 6 is stated to allow the reader to identify the scope of the work. 
2. Optical radiation in our environment 
Our environment features optical radiation from many sources. Visible light is the 
basis of life on this planet. Plants use visible light to photosynthesise - therefore it is 
the basis of each and every food chain. Visible radiation stimulates the 
photoreceptors in the retina, which is the basis of human vision. It is also 
fundamental to the human circadian rhythm, which controls many biochemical 
processes. UVR has an important role in the synthesis of vitamin D, which is 
required for the development of bone. 
In addition to its intrinsic importance to life, radiation at both visible and UV 
wavelengths add to our quality of life through warming effects and visual stimulation. 
During the course of a day, eyes and skin are exposed to many UV and visible 
photons from natural and artificial sources. Unfortunately, these photons are 
potentially harmful. 
1.2 
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We can split the sources of light into two groups - natural and artificial. Natural light 
comes from the sun. Artificial sources of radiation are numerous and used for a 
myriad of purposes. 
The primary use of artificial radiation is to help us see. The types of light source used 
for illumination are developing and changing as technology advances 1. New light 
sources may expose the skin to different intensities and spectral distribution of 
radiation, the effects of which may not be known. 
As well as helping us see, artificial light sources are used in equipment such as 
projectors and photocopiers. Operating theatres use strong overhead lights to assist 
surgeons. UV sources may also be encountered in our environment. Fly killers and 
welding equipment produce UVR and may represent occupational hazards. Sunbeds 
emit UVR and are used by choice to induce a suntan. There are also therapeutic uses 
of UVR. These are discussed later in this chapter. 
3. Photophysics 
Many parts of the electromagnetic spectrum (figure 1.1) are encountered in every day 
life. From gamma rays to radio waves, there are industrial, military and medical 
applications of the different regions of the spectrum. The term optical radiation 
includes visible and ultraviolet light. 
1.3 
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Figure 1.1: The electromagnetic spectrum. Courtesy of Ray Lambe, NPL. 
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Ultraviolet radiation (UVR) is the part of the electromagnetic spectrum in the 
wavelength region from 100 nm to 400 nm. For convenience this radiation is divided 
into three different bands: 
9 UVC 100 to 280 nm 
" UVB 280 to 315 nm 
9 UVA 315 to 400 nm* 
Visible radiation is characterised by the visible spectrum of colours. 
Note that the divisions WA, B and C are arbitrary divisions and certain disciplines may use slightly different 
boundaries. 
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Electromagnetic radiation may be considered to possess both wave-like and particle- 
like properties. As a wave, it may be characterised by wavelength (X), velocity (v) and 
frequency (0, related by the equation: 
v=Xf Equation 1.1 
Phenomena such as diffraction and interference may be understood according to 
classical wave theory. However, the photo-electric effect cannot be explained by this 
mechanism. Instead, emitted radiation is considered to be discreet packets of energy, 
called photons. If the energy in a photon is equal to the bond energy of an irradiated 
substance, then the chemical bonds in the substance will be broken. 
The energy of each photon (E) is proportional to the frequency of the wave: 
E= hf Equation 1.2 
where h is Planck's constant 
The wavelength of the radiation is proportional to the reciprocal of the frequency: 
C 
f 
Equation 1.3 
where c is the speed of light 
1.5 
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Thus: 
Eoc 
1 
2 
Equation 1.4 
Chapter 1 
Hence, the smaller the wavelength, the greater the photon energy of the radiation. 
Photons with sufficiently high energy are capable of having an ionising effect when 
incident on biological media. Gamma rays are known to be strongly ionising. Ultra- 
violet radiation is considered to be non-ionising and therefore generally less harmful. 
However, both ultraviolet and optical radiation can have damaging effects on the skin 
through interactions with absorbing molecules (chromophores) in the skin. 
4. The interactions of light and skin 2 
The penetration of skin by photons of different energies is related to the wavelengths 
of those photons. Figure 1.2 shows the penetration depths of UVR. The longer the 
wavelength of the radiation the deeper it can penetrate into the skin. Hence, although 
UVC photons are most energetic they are able to penetrate the least and the effects of 
this radiation are confined to the outer layers of the skin. 
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Figure 1.2 The penetration depths of wavelengths of light into human skin. 
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In order for a biological response to be seen in skin, photons must be absorbed by 
molecules in the skin. This is the Grotthus-Draper Law and is fundamental to the 
understanding of photochemistry and photobiology. Molecules in the skin that absorb 
radiation are known as chromophores and may be endogenous or exogenous. 
Exogenous chromophores are known as photosensitisers. A description of the 
chromophores in skin can be found in chapter 3. 
When a photon is absorbed an energy conversion occurs and the chromophore 
becomes electronically excited or photoionisation occurs and an electron is removed 
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completely. The absorption of photons of different energies by molecules is 
dependent upon the energy gap between the ground state and singlet state of that 
molecule. Chromophores with small energy gaps will absorb long wavelength 
radiation and vice versa. Excited singlet state molecules are unstable and only exist 
for very brief periods of time (-50 nanoseconds). They may initiate a photochemical 
reaction although this process is inefficient. The three main processes that happen to 
excited singlet state molecules are 
1) the energy is released as heat and the molecule returns to its ground state 
2) a photon of lower energy is released as fluorescence and the molecule returns 
to its ground state 
3) intersystem crossing occurs by changing the spin of one of the electrons to 
form an excited triplet state 
This state is less energetic than the excited singlet state and can persist for longer 
(microseconds) in physiological media. This state decays by phosphorescence on 
release of a photon or via the singlet state by intersystem crossing. These are 
inefficient processes and the triplet state is more likely to release its energy and 
initiate a photochemical reaction. 
5. Normal skin reactions 
Normal skin exhibits an erythemal response when the minimum erythema dose 
(MED) is exceeded. This erythema, commonly known as sunburn, is an example of 
the inflammatory wounding response of the skin and is characterised by cutaneous 
inflammation- warmth, swelling and pain. The inflammatory response, onset 2-6 
hours after exposure and at its maximum 15-24 hours after exposure, is the skin's first 
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reaction as the repair phase is delayed. Erythema fades in 72-120 hours and is usually 
followed by increased skin pigmentation and thickening of the epidermis 4. Longer 
term effects of UVR 5 include increased skin fragility 6, ageing 7 and the development 
of skin cancers 8,9. 
6. Abnormal reactions of skin to optical radiation 
Although erythema can be painful it is only UVR that is responsible for erythema in 
normal skin. These wavelengths are easily avoided if precautions are taken such as 
avoiding the midday summer sun and wearing sunscreen. There are, however, 
individuals that suffer from abnormal reactions to optical radiation, including visible 
light, which has no adverse effects on normal skin. Abnormal responses include 
excessive sunburn, oedema, itch, pain, papules and blistering. Such individuals are 
known as photosensitive. 
There are various conditions that can lead to photosensitivity. These are: 
" Idiopathic photodermatoses 
o Chronic actinic dermatitis (CAD) 
o Polymorphic light eruption (PLE 
o Actinic prurigo (AP) 
o Solar urticaria (SU) 
o Hydroa vaccineforme (HV) 
" Genophotodermatoses e. g. xeroderma pigmentosum 
" Cutaneous porphyrias 
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o Erythrocytic 
o Hepatic 
" Drug induced photosensitivity 
9 Photocontact dermatitis 
" Photoaggravated dermatoses 
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The idiopathic photodermatoses are a diverse group of conditions. CAD is manifest 
as a persistent pruritic eczematous eruption with prominent lichenification mainly 
involving photoexposed sites (see figure 1.3) although the reaction can extend to 
covered sites. This condition usually affects elderly white males but has also been 
described in Japanese and individuals of skin types 4 and 5 10. This condition 
involves UVB and UVA in 95 % of patients and, in addition, visible radiation in 50 
%. This condition can be disabling throughout the year. During acute episodes, 
patients are treated with topical steroids in specially adapted darkened rooms. 
Patients suffering from this condition often attempt suicide 11 
This condition can be associated with exposure to allergens (see chapter 3) and 
therefore patients must undergo patch testing to identify any causal agent. With 
careful management and allergen and or causal wavelength avoidance most patients 
condition will resolve 12. 
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Figure 1.3 Chronic actinic dermatitis 
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Polymorphic light eruption (PLE) is a recurrent abnormal reaction to sunlight that 
presents in a variety of forms such as papules, vesicles, plaque, erythema, and itch. 
One author describes it as "a common reaction uncommonly recognized" 13. Figure 
1.4 shows a typical PLE reaction. 
Figure 1.4 Typical polymorphic light eruption. 
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Often patients describe the onset of symptoms following 2 to 3 days' exposure on 
holiday. Thereafter, sunlight exposure as short as 10 minutes can produce an 
intensely itchy eruption. Symptoms usually resolve within a few days provided there 
is sunlight avoidance. PLE usually starts before the age of 30 and is diagnosed more 
frequently in females. It is more prevalent in northerly locations, such as Northern 
Europe, where the reported incidence is 12% compared to regions of high insolation, 
such as Australia (3% reported incidence) 14. It is believed to be a delayed type 
hypersensitivity response to a photoallergen 15 but it is not known what causes PLE. 
Further, the reason for the geographical spread is uncertain. It may be related to the 
different wavelength distribution or different skin sensitivities. 
PLE is usually elicited by sunlight, which may be direct or transmitted through 
window glass or clothing. Sunbed irradiation has also been reported as triggering a 
PLE 16. Arc welding equipment and photocopiers have also been implicated 17,18,18. 
Sun avoidance is the first line of treatment. If the condition is severe, the patient is 
obliged to holiday in places where there is limited sunlight. This has major 
repercussions on other family members. UV-absorbing film may be applied to car 
and house windows 19. Many patients also derive benefit from a course of controlled 
UV exposure in spring. Clinical opinion is that patients tend to improve after some 
years. Experience in Dundee is that a substantial proportion of those with PLE severe 
enough to require repeated annual prophylactic UV exposure do, after several years, 
experience resolution or marked improvement. 
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Actinic Prurigo (AP) is uncommon except in American Indians where it also shows a 
high familial tendency. AP patients have a perennial problem, with spring and 
summertime exacerbation. Exposed skin response to sunlight has two phases. First 
there is a delayed onset pruritic oedematous erythema. Second there is chronic 
background involvement with a widespread irritable skin eruption, termed prurigo, 
which develops within weeks. There may be secondary infection and pitted scars. 
All exposed sites, including face and hands, are usually involved. Approximately one 
third of patients exhibit normal sensitivity to wavelengths causing erythema but most 
show abnormal sensitivity to UVA and UVB. Treatment is sunlight avoidance and a 
course of desensitisation. Thalidomide, an oral hypnotic and immunosuppressive, is 
also effective. 
su 
Solar urticaria is an uncommon photodermatosis, characterized by the appearance of 
pruritic wheals after sun exposure 20. It affects more women than men 10 and may 
manifest at any age. The reaction may be triggered by direct radiation or through 
window glass and even through thin cotton clothing. Most patients are affected 
throughout the year 21. Episodes may be accompanied by systemic symptoms such as 
22 23 headache, nausea, broncospasm, faintnesss and loss of consciousness 
Wavelengths of up to 700 nm can be involved. In Dundee the probability of clinical 
resolution at 5 and 10 years after diagnosis was found to be 0.12 (95 % confidence 
interval) 21 
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Hydroa vaccineforme is a rare photodermatosis affecting an estimated 0.34 people per 
100,000 24. It affects more males than females and is usually onset in the first decade 
of life. The skin is active during spring and autumn months. Exposed sites develop 
an itchy, stinging erythema with oedema within hours of exposure. Papules and 
vesicles follow and the vesicles may be fluid filled and at risk of secondary infection 
23. These painful lesions heal with the formation of characteristic depressed pock-like 
Scars. 
Genophotodermatoses 
These photodermatoses are a rare group of autosomal recessive photosensitive 
disorders. These disorders may include exquisite photosensitivity and increased risk 
of malignancy 23. Life expectancy can be dramatically reduced by these conditions 
e. g. xeroderma pigmentosum. 
Cutaneous porphyrias 
These conditions are congenital or acquired metabolic disorders which lead to 
accumulation of porphyrins in the body. These porphyrins have strong absorption 
spectra in the UV and hence lead to damage as they generate active oxygen species 
when they absorb UVR. There are 8 steps in the haem biosynthesis pathway. An 
enzyme catalyses each step. The deficiency of an enzyme may lead to one of the 
porphyrias. Accumulated porphyrin is excited within the blood as it flows through the 
skin. This can produce painful photosensitivity. The most common conditions 
affecting the skin are erythropoietic protoporphyria (EPP) (see figure 1.5), porphyria 
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cutanea tarda (PCT), and congenital erythropoietic porphyria (CEP) also known as 
Gunther's disease. The different porphyrias may be diagnosed by spectrofluorimetric 
examination of blood, urine and stool. Many of these patients exhibit sensitivity to 
UVA and the visible part of the spectrum. Exposure to theatre lights may trigger a 
reaction. In many unfortunate patients, the condition is so severe that they must wear 
hats, gloves and dark glasses if they venture outdoors on a summer's day. Various 
treatment options are available and patients often do go into remission. 
Figure 1.5: Erythropoietic Protoporphyria 
: 
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Apart from the photoaggravated dermatoses the remaining causes of photosensitivity 
are chemically induced. There are two mechanisms for this: photoallergy and 
phototoxicity 25. Phototoxic reactions are the most common and often lead to 
persistent pigmentation. Treatment for phototoxic reactions involves the exclusion of 
the agent causing the phototoxicity from the patient's environment. 
True photocontact allergy should be distinguished from a non-allergic photocontact 
reaction. The latter occurs in all individuals exposed to a photocontact agent, such as 
dyes, tar products, fragrances, plant materials, sunscreens and animal feeding stuffs. 
True photocontact allergy is uncommon. It is the combination of UV radiation, 
usually UVA, and a particular substance that provokes an allergic response. 
Investigation of these patients is extremely problematic as it may just appear that 
there is some sort of involvement of UV or visible radiation if the radiation and 
allergen are encountered concurrently. For example, a patient may exhibit a simple 
contact allergy to one of the chemicals in a sunscreen but they may believe the 
reaction to be induced by light because they only wear the sunscreen in the sun. The 
involvement of potential allergens with light must be determined. The photopatch test 
is used to detect any photocontact allergies, and to distinguish them from simple 
contact allergies. The methodology involves 26: 
4P Application of duplicate series of allergens 
" Exposure of one set of allergens to sub-erythemal UVA after 24-48 hr 
" Assessment of results 48 hr after irradiation 
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Figure 1.6: Photopatch testing. The left hand side of the woman's back has been 
irradiated with monochromatic wavelengths of varying dose. The right hand side of her 
back is shown enlarged. The upper half has been exposed to 18 different potential 
allergens alone; the bottom area has received these same allergens plus UV at a known 
level. The reactions seen on the bottom half of her back show that this patient has a 
photocontact allergy to some sunscreen constituents. 
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Figure 1.6 shows positive photopatch testing results to several of the chemicals 
commonly used in sunscreens. Sunscreen constituents are common photoallergens, 
26, which is unfortunate as they are used in order to protect the skin. This lady's 
allergy can be diagnosed as a photocontact allergy because there is no reaction on the 
part of her back that was not irradiated. Other chemicals that are commonly tested 
because they can be photoreactive allergens are musk ambrette, coumarin and 
sandalwood oil. It is also commonplace to test with substances supplied by the 
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patient because there is sometimes an ingredient hidden amongst a vast array of 
constituents that is causing the problem. 
Phototoxicity is an immediate or delayed inflammatory reaction that looks like severe 
sunburn 10. It may be caused by topical and systemic drugs. There are a wide range 
of pharmaceuticals that are involved in photosensitisation 27. Examples include some 
antibiotics and tranquillisers, as well as common anti-inflammatory preparations such 
benoxaprofen. This photosensitisation may be a part of the modality of the treatment 
itself, as occurs during whole body psoriasis therapy using methoxypsoralen. On the 
other hand, it may be an unfortunate side effect that may severely limit the usefulness 
of the drug. The reactions may be due to phototoxic or photoallergic mechanisms 28 
and can be severe and long lasting. Figure 1.7 shows an example of drug induced 
photodermatosis. 
Figure 1.7: Drug induced photodermatosis 
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In many cases photosensitising effects can be predicted by looking for structural 
relationships to known photosensitising drugs. In recent years, regulation has 
required that new drugs that have a similar structure to a known photosensitiser are 
proven to be non photoactive before marketing 29. Double blind, randomised trials are 
required in order to determine the photosensitising potential of drugs that are 
attempting to become licensed for prescription. There is usually consistency in the 
wavelengths of radiation that will provoke a phototoxic reaction from drugs. On the 
basis of this information, the severity of reactions and the persistence of the drug, 
licensing decisions can be made. In some instances, however, photoactive 
compounds are licensed as drugs due to the importance of their therapeutic benefits. 
The classic example of this is the fluoroquinolone antibiotics. These are a family of 
effective, broad spectrum antibiotics. Some members of this group of antibiotics are 
active against MRSA, tuberculosis and other diseases, which require virulent 
antibiotics to treat. These drugs may be increasingly significant in clinical medicine 
as disease organisms gain resistance to currently used antibiotics 30. Unfortunately, 
though, many fluoroquinolones are known to cause photosensitivity. 
These antibiotics were first tested in the 1980's, when they were expected to be 
phototoxic. Since then, tests on emerging fluoroquinolones have revealed wide 
ranging photosensitising potential 31"33. In some cases, the development of these 
antibiotics has had to be abandoned due to their potent phototoxicity 34. In others, the 
drugs are only intended for use in intensive care wards, where appropriate precautions 
can be taken 34 
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Other antibiotics can lead to photosensitivity. Sulphonamides, nalidixic acid and 
tetracycline members have all been reported to be photosensitisers. In general such 
reactions are mild, although rarely some individuals have a severe response 35 
Photodynamic therapy (PDT) is an evolving cancer therapy. The technique involves 
the use of a photosensitising drug that accumulates in tumour cells, and visible light 
(usually laser light) to activate the drug and kill the cells. The mode of action is 
believed to be via the production of singlet oxygen and other reactive species. This 
technique is used, very successfully, to treat skin cancers where the photosensitiser 
may be applied topically. For the treatment of cancers where topical application is not 
possible, photosensitising drugs can be administered orally or intravenously. These 
cancers include brain tumours and lung and oesophageal cancers 36. However, 
patients can be rendered photosensitive as a side effect of systemic PDT drugs 37. 
One particular photosensitiser that induces photosensitivity that persists for up to 3 
months after injection, is porfimer sodium (Photofrin®). Overexposure to light can 
lead to severe erythema. Thus patients are advised to avoid exposure, wear close 
weave clothes, wide brimmed hats, dark glasses and gloves at all times. These 
guidelines can be very limiting for patients. Clinical experience within Dundee has 
shown that this modality is useful both as a curative and a palliative option. In the 
latter case, PDT brings symptomatic relief; for example in lung cancer, it can 
eliminate the distressing coughing up of blood (haemoptysis). In cases where PDT is 
only used palliatively, the need to avoid sunlight in the few remaining active months 
of life places a severe restriction on its use. It is also the case that some light exposure 
is necessary as there is a photobleaching effect, which accelerates breakdown of the 
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residual drug. Thus a balance must be achieved between too much and too little 
exposure. 
Plants can be responsible for chemically induced photosentitivity. Typically this 
produces a blistering reaction that often has a striated appearance arising 48 to 120 
hours after plant and light exposure. Known causes include celery, parsnips, limes and 
giant hogweed. Children who play outdoors in the summer may be affected and this 
has given rise to mistaken allegations of child abuse. A condition called strimmer's 
dermatitis is caused by pulp from cow parsley or cow parsnip being thrown by the 
strimmer onto the skin 38. Excessive consumption of celery and parsnip soup has 
resulted in photosensitivity 39. Hypericum, an extract from St John's Wort, is widely 
used as an over-the-counter treatment for mild depression. The active ingredient, 
hypericin, is a photosensitiser. 
Photoaggravated dermatoses 
Light can aggravate already existing dermatoses such as atopic eczema 40, psoriasis, 
lupus eryhtematosus and lymphocytoma. Patients experiencing a worsening of their 
condition on exposure to sunlight have to control their exposure to manage their 
condition. 
7. Psychological effects 
The psychological effects of photodermatoses can be profound. The following case 
study is produced with permission of one of the most sensitive patients that attends 
the photobiology clinic in Dundee. 
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Mr Doherty is one of the most sensitive patients regularly seen at the Photobiology 
Unit. He was diagnosed with solar urticaria in 1999. 
Frank worked as a roofer all his life. He resides in Glasgow and had enjoyed an 
active, normal life until 1993 when he suffered two minor strokes. These, coupled 
with some heart trouble led him to give up work in the same year. 
He first noticed symptoms of his urticaria in 1998. He consulted his GP about painful 
swelling and itching that he was experiencing. The swelling would subside within 
twenty or so minutes and Frank did not manage to actually demonstrate the problem 
to his doctor as the symptoms would subside during the period spent in the doctor's 
waiting room. Frank had no idea what the cause of this unpleasant sensation was as 
it appeared both when he was outside and also when he had been asleep in his bed. 
Frank slept next to the window and used to keep the blinds open a little. 
His GP tried many different combinations of drugs for his heart condition, fearing 
that these drugs were provoking an allergic skin reaction. He also tried many 
different emollient treatments for his skin. None of these attempts helped his skin and 
he grew increasingly frustrated with his tiresome condition. He reported that he 
"didn't know what to do" at the time, as no causal factor in aggravating his skin was 
apparent to him. 
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Frank was eventually referred to see a dermatologist at Glasgow Royal Infirmary. 
His condition was then diagnosed when a medical student observed his skin flare up 
as he stood next to a window in the consulting room. The consultant dermatologist 
had to ask him to move away from the window. 
Since that consultation Frank has regularly spent time as an inpatient at the 
Photobiology Unit. When he first visited the unit he was diagnosed as being severely 
sensitive in the UVA and visible regions of the electromagnetic spectrum. This visible 
sensitivity explains his skin reaction fr om behind window glass, even in early morning 
sunlight coming through his open window blind In Frank's case it is important to 
minimise his flare-ups, not simply because of the discomfort it causes him but also 
because of the risk to his heart. When his skin flares up it causes blood to rush to the 
skin and Frank experiences "very, very itchy, painful stinging and stretching 
sensation ". This rush of blood accelerates his heart rate, which he says is "quite 
frightening ". 
Frank was advised to wear protective clothing (see figure 1.11) and sunscreens but he 
finds this very limiting. If he forgets to put gloves on to take the rubbish out to the bin 
then his hands will flare up. He also finds that all his clothes end up covered in 
suncream and in the summer, when other people are wearing shorts, he feels "like a 
zombie" and says that "people look at you like you've escaped from somewhere, all 
covered up in gloves and a hat ". 
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Several means of managing his condition have been tried at the Unit. He has tried 
several antihistamine treatments with no benefit and has also tried 
immunosuppressing drugs. He reported "weird" symptoms from these drugs, 
including hallucinations. UVB and UVA desensitisation therapies have also been 
tried. Frank found some short-term benefit from UVA therapy but has also suffered 
third degree burns from the UVB therapy. 
Despite these measures, Frank has become progressively more sensitive and now 
finds it hard to enjoy any time out of doors. He reports flare-ups from lighting in 
certain shops and his symptoms now take over an hour to subside. He does not find 
any difference in winter or summer and is now, to all intents and purposes, 
housebound. 
Through all this adversity and inconvenience, Frank remains remarkably positive 
about his condition. He has found himself "special corridors and entrances" for the 
clinics he has to visit. These allow him to avoid external windows and minimise risk 
to himself. When he spends time on the dermatology ward at Ninewells he has a 
special bed where harmful rays are excluded His house is also covered in plastic 
film to protect him. He is jovial and makes jokes about his clothing but this covers up 
many psychological effects. Frank can no longer holiday with his family, so they go 
without him. He refuses to feel sorry for himself but his last comment is telling: 
"1 just cannae understand it - work outside all my life and suddenly this happens ". 
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In order to offer a patient relief from these conditions it is necessary to properly 
diagnose the condition. Phototesting is used as the objective basis for diagnosis of 
photosensitivity 41,42 The methodology and its limitations are discussed in chapter 3. 
The other tool relied upon by clinicians is a detailed history from the patient with 
suspected photosensitivity. Important factors that are considered include: 
" Skin type 
" Age of onset 
" Time of year the rash is the worst (and best) 
" Whether tolerance occurs 
" The amount of exposure required to trigger the rash 
" Whether sunlight passing through a window will cause the rash 
" Distribution of rash 
" Time course of onset after exposure 
" Appearance and symptoms of the rash 
" History of sunbed use 
" Family history 
" Drug history 
" Use of topical agents and sunscreens 
If the history is detailed and unequivocal then the clinician can often be confident of a 
diagnosis and perform further tests simply to confirm their suspicions. In more 
complicated cases monochromator phototesting and provocation testing (also 
discussed in chapter 3) may be the only tools that are useful in unravelling a patient's 
condition. These tests show the wavelengths involved in a patient's condition and the 
extent to which they are affected i. e. how sensitive they are compared with a normal 
response. 
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The need for protection from wavelengths that cause sensitivity is self-evident. This 
is conventionally achieved by avoidance of light and the use of topical sunscreens. 
Alternative means of management are discussed in chapter 4. 
10. Therapeutic uses of light 
Optical radiation is used medically for two different purposes. Controlled exposure to 
UVR can desensitise patients suffering from some photosensitive skin conditions. As 
a means of management of photodermatoses this is discussed in chapter 4. 
Exposure to UVR may also provide relief from conditions that do not directly involve 
light. Examples are the treatment of neonatal jaundice 43,44 and seasonal affective 
disorder 45,46. Green et a147 have produced an excellent review of the uses of UVR in 
the treatment of skin disease. Whatever the origin of the light we must have an 
understanding of the light that reaches our skin so that we can avoid potentially 
harmful effects. 
11. Measurement of light for quantification and understanding of our 
environment and for control of therapeutic exposure 
There are three main methods of measuring optical radiation 49 . These are: 
" Broad band measurements 
" Spectral measurement using spectroradiometry 
9 Personal dosimetry 
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Broadband measurements are achieved using radiometers usually filtered for the 
wavelengths of interest. Chapter 2 discusses the limitations of this technology. 
Spectroradiometry resolves the spectrum of any source that is measured. Absolute 
spectral irradiance measurements can be achieved at an uncertainty level of 4% 49 
However, spectroradiometers themselves are difficult to characterise and are 
"notoriously unstable and complex entities" 50. Furthermore, the underlying 
technology involved in spectroradiometry has not advanced significantly since the 
1980's 51. Nevertheless, this technology allows us to resolve the spectrum of a source 
and is therefore invaluable in health hazard assessment. 
Spectroradiometers consist of: 
" input optics 
" wavelength selection mechanism with a controlling interface 
0 detector 
Figure 1.8 Schematic layout of a spectroradiometer 
Input Optics 
Collection Optics Wavelength Selection Device Detector 
ae. IntelzratinE Sphere e. g. Scanning Monochromator e. g. vhotomukiplier 
e. g. Fibre Optic Cable 
PC, interface, controlling and recording software 
Cooler system 
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These generally consist of flat plate diffusers, either coupled to a fibre optic cable or 
directly to the wavelength selection device. The other option is an integrating sphere. 
Either way, input optics should have a response proportional to the cosine of the 
incident angle of the radiation. Deviation from this perfect response has been 
identified as one of the major sources of error in SUV spectroradiometry often 
contributing to uncertainties of up to 13% in irradiance measurements above 60° 52 
Monochromators 
Monochromators are wavelength selection devices that work on the principle of 
dispersing optical radiation and using focusing optics (i. e. spherical mirrors) to direct 
the path of dispersed radiation. There are several different models of monochromator 
but one of the most widely used and best understood is the Czerny-Turner layout. 
Figure 1.9 shows the general optical layout of a Czerny-Turner monchromator. 
Figure 1.9 Optical layout of a Czerny-Turner monchromator 
Input optics 4 
Mirrors 
Output 4 to detector 
1.29 
Diffraction Intermediate 
Grating slit 
Introduction Chapter 1 
Reflective diffraction gratings are made up of microscopic series of reflecting and non 
reflecting lines which cause incident radiation to be dispersed according to its 
wavelength and the angle of incidence. In this way, the gratings act as the wavelength 
selection device in the monochromator. Gratings are mounted on turntables which 
allow them to be moved so that incoming radiation is incident on the grating at 
different angles. Therefore, if interfaced with a computer control system, the entire 
spectrum of interest can be scanned. Typical gratings used for the selection of UV 
light, have 1200 grooves per mm and are blazed at an angle such that optimal 
diffraction occurs at 250 nm. These gratings allow measurement of a wavelength 
range from 200 to 500 nm. 
The upkeep of monochromators is very important in maintaining their accuracy 53 
Design specifications will also affect the performance and responsivity of 
monochromators. Defined slits at the input and the exit of monochromators are 
designed to exclude stray light from the system. The double grating set up of the 
Czerny-Turner monochromator is similarly designed to minimise stray light levels. 
Stray light in spectrometers is cited as one of the major sources of error in UVR 
sa spectral measurements 
Detectors 
The photomultiplier is the most sensitive type of detector. Figure 1.9 shows a 
schematic diagram of a photomultiplier tube. Incident radiation causes emission of a 
high-energy primary electron, from the photocathode, which is then accelerated 
towards the higher potential dynodes, where a cascade effect causes amplification of 
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the signal by release of more, lower energy electrons 55. This amplification chain 
makes the photomultiplier sensitive to even tiny amounts of incoming radiation and 
makes it the detector of choice when low level radiation has to be measured 56 
Figure 1.10 Photomultiplier schematic from Boyd 55. 
-H. V. 
I 
Apart from the work needed to assure measurements and maintain a 
spectroradiometer, the main drawback is that these instruments are bulky and lack 
portability. 
Unless stated, measurements presented in this thesis were made using a bench based 
double grating spectroradiometer (Bentham DM150). This is the unit's standard for 
optical radiation measurement. Flat plate diffusers are used as the input optics. A 
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Teflon diffuser is used for UVB measurements and a quartz glass diffuser for UVA 
and visible light measurements. 
The calibration of the Bentham is traceable to the National Physical Laboratory (NPL) 
and has an estimated expanded uncertainty at the 95% confidence level, of 5.72 % in 
UVB and 3.48 % in UVA. These uncertainties have been calculated in accordance 
with NPL guidelines (Bell 2001) and include consideration of the uncertainty in the 
calibration sources used, alignment errors and uncertainty in the current from the 
cooled (-20° C +/- 2° C) photomultiplier tube. The uncertainty budget has also 
received accreditation from the United Kingdom Accreditation Society (UKAS) when 
the department's UV meter calibrations were evaluated and accredited. The transfer 
standard for radiation measurements from 315 to 800 nm is a 100 W, frosted glass, 
tungsten lamp and a 30 W deuterium discharge lamp is used as a transfer standard for 
UVB (280-315 nm). 
Figure 1.11 The photolaboratory in Dundee, showing the Bentham DM150 
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Studies of personal phototherapy source dosimetry have been conducted, primarily 
using polysulphone film badges 57-59 since their introduction as personal dosemeters 
for UV radiation 60. These badges can provide useful information regarding the 
distribution of phototherapy radiation over a patient's skin. Other commercial 
personal dosemeters incorporating UV sensitivity are available. These are generally 
based on solid state detector technology e. g. the sp3 (Tunbridge Wells, Kent) 
`Sunwatch'TM which is based on a solid state gallium nitride detector. 
12. Regulation of light exposure 
In the UK there are no specific laws covering exposure to optical radiation. Two 
main bodies are involved in the production of exposure guidelines. The International 
Commission on Non-Ionizing Radiation Protection (ICNIRP) is scientific body that 
aims to disseminate information on the potential health hazards of exposure to optical 
radiation. The Health Protection Agency is aa non-departmental public body 
encompassing the old National Radiological Protection Board (NRPB). It has 
protection of exposure to optical radiation as part of its remit. Other groups such as 
the British Photodermatology Group (BPG) produce guidance on exposure to UV 
sources used therapeutically. 
There are various publications from these and other international bodies that deal with 
exposure to sources in different circumstances. These are discussed in context 
throughout this thesis. Of note is that the exposure limits published do not consider 
abnormal skin. Thus, for individuals with specific photosensitivities, symptoms may 
occur below recommended exposure limits. 
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13. Structure of thesis 
Chapter 1 
Chapter 2 presents an evaluation of new handheld spectroradiometers for 
phototherapy dosimetry. One of the instruments evaluated was found to be suitable 
for the measurement of clinical sources for hazard assessment and dosimetry. 
In chapter 3 results from a study aiming to predict the responses of normal and 
abnormal skin are discussed. It was found that it was not possible to predict responses 
using measurements made with current instruments and methodologies. This may 
mean that the conditions evaluated do not respond in a linear manner to optical 
radiation and challenges a central premise in photobiology. 
In chapter 4 results from a study to evaluate the protective efficacy of commercial 
cosmetic preparations for photosensitive skin are discussed. Based on the findings in 
this study, cosmetics are a novel tool for the management of photosensitivity. 
Chapter 5 shows results of a study conducted in all the commercial and council 
premises offering sunbeds for tanning in two local authority areas in Dundee. The 
instrument evaluated in chapter 2 was used to measure the spectral irradiance of all 
the sunbeds. The relative and absolute spectral intensities were compared with the 
British Standard for ultraviolet tanning equipment. The available lengths of sessions 
were also recorded and the dose of radiation that would be received from each bed 
was calculated and existing exposure guidelines evaluated on the basis of these 
guidelines. 
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Chapter 6 presents results from a case where an UV source was being used 
inappropriately in an hotel kitchen. The source was measured and an evaluation of 
the hazards that employees had been exposed to was made. This was achieved using 
relevant action spectra. 
In chapter 7 the main findings from the work undertaken are summarised. Areas for 
further investigation are also suggested. 
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Chapter 2 
Measurement of clinical sources 
Evaluation of new handheld spectroradiometers for phototherapy 
dosimetry 
Summary 
This chapter discusses the need for accurate dosimetry in phototherapy and the 
limitations of current technology. Results are presented from an evaluation that 
assessed the potential of two diode array spectroradiometers for use in phototherapy 
dosimetry 1. It is shown that this technology has significant scope for use in 
photodermatology provided that accuracy and calibration are carefully considered. 
1. Introduction 
Within photomedicine, the need for accurate dosimetry of therapeutic UV radiation 
has long been recognised 2,3. Clinical applications of light are discussed in chapter 1, 
section 10 and chapter 4. 
Excessive numbers of treatments can significantly increase the risk of carcino- 
genesis 4. Thus, the minimum number of treatments for maximum therapeutic benefit 
is the aim in phototherapy. Accurate dosimetry is necessary to achieve this aim. 
Furthermore, if the dosimetry is accurate, then a patient should be able to transfer 
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treatment centres without jeopardising their treatment and different treatment 
regimens can be compared between centres 5'6 
Best practice in photodermatology relies on measurement of the patient's MED or 
MPD, in order to determine a starting dose for treatment 7. If the patient then 
receives a dose that is significantly lower than 70% of their MED/MPD it will not 
have the desired therapeutic benefit for the patient 8,9. Conversely, a dose of radiation 
that is greater than the patient's MED/MPD can lead to a painful bum 10,11 Hence, 
the dosimetry of MED/MPD testing sources must be directly comparable to that of the 
treatment source and both must be accurate. 
Any instrument that is used for dosimetry should measure to within +/- 10% 12,13 
because errors in dosimetry are clinically significant and may lead to painful 
erythematous reactions. For this level of accuracy to be achievable the calibration of 
a meter for itself should be reproducible and also traceable to national standards. 
The instrument of choice is the filtered radiometer. These robust, portable, compact 
detectors are generally stable and exhibit the same response for decades 14. Different 
photodiodes exhibit different spectral responses, as can be seen in figure 2.1. Silicon 
detectors are most often used for phototherapy sources. Filters can be fitted in order 
to ensure that the detector measures only across a finite wavelength range. However, 
the use of filtered radiometers requires that the spectrum of the lamp being measured 
is known. Effective irradiance can be measured using appropriate filters but the 
similarity between a radiometer's spectral responsivity and an action spectrum can be 
poor, resulting in large errors in measurement is 
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Figure 2.1: The spectral responses of some photodiode detectors. 
Kindly supplied by Dr L Rogers, NPL. 
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Achieving traceable and consistent calibration of filtered radiometers is often an 
involved process and frequently results in one calibration specific to the measurement 
of one type of phototherapy source. This is good practice as CIE guidelines 
recommend that calibrations be performed against a source with a similar spectrum to 
the spectrum of the source to be measured 16. However, confusion and resulting 
mistakes made when picking the calibration factor, radiometer and filter combination 
could easily lead to errors in patient doses if the wrong combination were used. 
Changes in output of phototherapy sources above the 10% level should lead to change 
in patient irradiation times to avoid adverse effects 13. Errors greater than this could 
easily result from a mistake in picking the calibration factor, radiometer and filter 
combination. 
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Phototherapy sources are diffuse, wide angled (often 360°) and non directional, thus it 
is important that any instrument used in dosimetry will detect radiation from all the 
input angles over which radiation will be incident on the skin. This is approximated 
to 180° for practical reasons. 
The angular response of a detector is also known as its cosine response because the 
radiation detected should be equal to the reading at 0° multiplied by the cosine of the 
angle at which the radiation is incident 17. The poor directional responses of some 
radiometers currently in use will give errors of 20- 50% in the assessment of 
'18'19 
6,18,19 
Many cabinets come with in built radiometers but it has been shown that the 
dosimetry of these and conventional radiometry methods can vary by as much as 60% 
7. This is possibly due to the poor angular response of the in built radiometer. 
A practical evaluation of the cosine response of a detector is achieved by calculating 
the f2 value for the detector. The f2 value gives a measure of the total error that can 
be expected when using the detector to measure an 180° source. The most common 
error in angular response is underestimation of radiation input from wide angles 20. 
The accepted expectation of radiometers used in dosimetry is that they have an f2 
value of 10% or better 13'13'21 
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The f2 value is calculated such: 
RB 
1 
Ro cos 6 f2= x100 
n 
Where 0 is the angle of measurement 
Ro is the response of the instrument at 00 
RO is the response at the angle of measurement 
n is the number of measurements 
Chapter 2 
Equation 2.1 
The main limitation of a filtered radiometer is that only one number can be given for 
the output of a phototherapy source. This can be restrictive and spectral information 
gives much more scope for analysis. 
Absolute spectral irradiance measurements can be achieved at an uncertainty level of 
4% in spectroradiometry 17 but the technique involves expensive, bulky and complex 
equipment and can require a large period of time to take measurements. Within a 
busy treatment centre, transporting bulky equipment to measure outputs from 
phototherapy sources is impractical. It is also thought that with phototherapy sources, 
providing the spectrum of the source is known then it is not necessary to make 
spectral measurements as changes in the source's relative spectrum are thought to be 
insignificant 5. 
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The relatively new technology of the diode array spectroradiometer offers a potential 
solution for dosimetry in the 21St century: an answer to the trade-off between spectral 
data collected with a cumbersome instrument and the ease and speed of the filtered 
radiometer -a portable instrument that will acquire spectral data 
22. Furthermore, this 
type of technology may allow the calibration of standard lamps to be transferred 
directly to a spectroradiometer, therefore removing a step from the calibration chain 
and potentially reducing uncertainty. This would also remove the need for a different 
calibration factor for each phototherapy source and reduce potential for confusion. 
An example of the optical layout of such a spectroradiometer is shown in figure 2.2. 
After incoming radiation has been resolved into its constituent wavelengths by a 
diffraction grating, a series of fixed, solid state photodetector elements transduce the 
radiation into an electrical signal. As all the elements have fixed positions, it is 
possible to predict the wavelengths that will fall on each detector element and a 
spectrum can therefore be determined using appropriate software. 
Figure 2.2: Diagram showing the optical layout of a diode array 
spectroradiometer. (Graphic courtesy of 4D Controls) 
Diode 
detector array 
4 
U 
w0 
O 'er 
-So 
a ý. 
I0,00 
4MAMW 
Grating 
Source 
2.6 
Measurement of clinical sources for hazard assessment Chapter 2 
In order for this type of instrument to become widely used in the medical field, the 
usability, accuracy, reliability and limitations of the technology had to be assessed. If 
diode array instruments are to become the dosimetry instrument of choice in the future 
and filtered radiometers are to be usurped then the same requirements for accuracy 
should apply in both cases. 
During 2001 and 2002 two diode array instruments, from different manufacturers 
were evaluated. This work was published in 2002 1. A number of investigations were 
carried out to assess the performance parameters of these instruments. As regards 
these portable, spectral instruments, three specific areas of performance were 
identified as meriting investigation. The calibration, stray light rejection and angular 
response of the instruments were thought to present, potentially, the largest sources of 
error in using the instruments. 
2. Methods and materials 
An UV Spectroradiometer: Type SC-MP-A, from 4D Controls (Redruth, UK) 
(herefter referred to as `Sola Scope') and a USB2000-UV-VIS spectrometer from 
Ocean Optics (Duiven, NL) (hereafter referred to as `Ocean Optics') were both loaned 
by the manufacturers. 
The Sola Scope (see figure 2.3) is a self contained spectroradiometric instrument 
which consists of a hand held `sensor head' with a domed Teflon diffuser forming the 
input optics to the single grating and diode array, all contained in one compact box. 
The sensor head then connects to another hand held unit containing the software, 
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control keypad and a display panel to enable spectra of measured lamps to be 
visualised. Data from the Sola Scope can be easily uploaded to a PC spreadsheet for 
analysis via supplied (Sola-Term 2000) software. 
Figure 2.3: Sola Scope 2000 as supplied by 4D controls Ltd. (Picture courtesy of 
4D controls). 
The Ocean Optics (see figure 2.4) consists of a flat Teflon diffuser head attached to an 
optical fibre that forms the input optics to the spectrometer (a single grating and diode 
array), which is a unit no bigger than a pack of cards. The spectrometer connects to a 
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laptop PC via a USB port and the spectrometer can then be controlled using supplied 
(OOIBase32) software. 
Figure 2.4: Ocean Optics. Optical layout and instrument connected to a PC. 
(Courtesy of Ocean Optics). 
la 
The instruments differ slightly in their mode of use. The Ocean Optics was designed 
for use as a comparative radiometer, or spectrometer. The idea is to use a standard 
reference lamp to record a spectrum in the software. The standard lamp's colour 
temperature can then be input into the software and during any subsequent 
measurement the software derives the measured lamp's spectrum from the colour 
temperature profile (based on a black body emission spectrum) of the standard 
reference lamp. The Sola Scope is sold as a calibrated instrument that will give 
readings in absolute units, traceable to NPL. 
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Chapter 2 
According to best practice guidelines, the calibration of instruments for use in 
dosimetry must be traceable to national standards 12. This can be achieved by 
comparing measurements with a calibrated, double grating, bench based 
spectroradiometerand ensuring agreement. The requirement for traceability was 
tested by three different methods: (1) measurement of the error in the wavelength 
scale, (2) assessment of the spectral responses of the instruments, relative to a 
calibrated spectroradiometer and (3) measurement of clinical sources in comparison 
with a calibrated radiometer or spectroradiometer. 
Wavelength 
The Ocean Optics was not supplied with a calibration, so a low pressure mercury 
lamp was used to set the wavelength scale on the instrument. The position of eight 
known spectral lines (between 253.65 nm and 579.07 nm) and the diode array element 
that detected these lines were analysed by linear regression. The regression 
coefficients were then input into the software and the wavelength scale was 
calculated. 
The same lamp was used to test the supplied wavelength scale on the Sola Scope. 
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The relative spectral response of both instruments was assessed by measurement of a 
1 kW incandescent quartz halogen lamp (designated type FEL) calibrated at NPL. 
The lamp was allowed 30 minutes warm-up time and was run at a current of 8.33 A. 
The instrument's response at each wavelength was compared to the maximum 
response to give a spectrum of the instrument's relative response. 
This same measurement was used to form a calibration for both instruments. The 
correction (SF) at each wavelength (k) was determined such: 
SFB =Rx 
x 
where: SF;, is the sensitivity factor at a given wavelength 
Ex is the lamp irradiance at the same wavelength 
R, is the instrument response at that wavelength 
Stray light performance 
Equation 2.2 
One of the aspects most likely to limit the accuracy of these instruments is their stray 
light performance. In the case of diode array instruments, stray light is radiation that 
is detected by the `wrong' element for the wavelength of the radiation due to 
reflections inside the instrument. Commonly, longer wavelength radiation is reflected 
internally and falls on elements that are arranged to detect only short wavelengths. 
This phenomenon is common to spectroradiometric systems although in the case of 
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bench based spectroradiometers, two successive gratings may be used to improve the 
wavelength selection and prevent inappropriate wavelengths from reaching the 
detector. The trade-off from having better wavelength selection, however, is that 
signal levels are substantially reduced and thus a sensitive detector (such as a 
photomultiplier) must be employed. Diode array instruments are single grating, 
portable instruments and as such would be expected to have poor stray light levels 
which will affect the overall calculated dose for any phototherapy instrument. 
Stray light levels were assessed in theses instruments by the use of a Xenon Arc lamp, 
filtered for infrared radiation (IR) with an H2SO4"CuSO4 solution and a cut on filter 
(WG305, Schott). The lamp was allowed at least 15 minutes to stabilise before the 
spectra were measured by the diode array instruments. The advantage of using a 
source with a broad spectral output is the fact that stray light contributions from 
longer wavelengths, which may be detected as short wavelengths, can be identified 
more easily than if a monochromatic source or a source with clear emission lines is 
used. As the filter has a well known transmission profile; the stray light present in the 
recorded spectra can be expressed as a ratio of the signal level at a given 
wavelength 23. 
There is a method recommended by the manufacturer to correct for the stray light in 
the signal recorded from the Sola Scope. This method involves using an orange filter 
that only transmits radiation above 430 nm. The filter is placed over the input optics 
of the Sola Scope and the resulting irradiance profile is then subtracted from 
subsequent scans. This procedure must be repeated before each lamp measurement 
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because there will be a different stray light `profile' according to the spectral 
distribution of the lamp of interest. 
There is no method to remove stray light from the Ocean Optics instrument although 
the same procedure may be applicable. The calibration derived from the 1 kW FEL 
lamp should calibrate out the stray light levels in the signal although this will be 
subject to some error due to the differing stray light `profiles' of the calibration source 
compared to what is measured. A recording of the dark spectrum was made before 
each measurement run and the dark current or noise is therefore subtracted from each 
spectrum. 
Measurement of clinical sources 
In order to assess the reliability of these instruments in clinical practice, the 
calibration of the instrument and the influence of its angular and spectral responses 
were checked by measuring a number of phototherapy sources against calibrated 
radiometers or a spectroradiometer. The sources measured ranged from whole body 
treatment cabinets to single fluorescent tubes. These measurements were made at a 
nominal distance of 30 cm from the source and at least 5 minutes was always allowed 
for the output from the lamps to stabilise. 
Measurements were made in direct comparison with either the Unit's IL1400 
radiometer (Able Instruments, Reading, UK), which has attachments for measuring 
both UVA and UVB; or a bench based double grating spectroradiometer (Bentham 
DM150). In accordance with guidelines, the radiometer was calibrated against 
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sources with similar spectral outputs to those to be measured 16, in direct comparison 
with the Bentham spectroradiometer. The calibration of the Bentham is discussed in 
chapter 9. Its calibration is traceable to NPL and it boasts a cooled (-20° C +/- 1° C) 
photomultiplier tube and double grating monochromator. 
Angular response 
A measurement of the angular response of the instruments was made using a Xenon 
arc lamp. The lamp (as used for assessing stray light) was allowed 15 minutes to 
stabilise after ignition. The instruments were positioned with the input optics at the 
centre of rotation of a turntable. The turntable is marked at 1° intervals. The 
turntable was moved manually and a spectrum was recorded at each 5° step over the 
interval +/- 60° (see figure 2.5). 
Figure 2.5: Layout of angular response measurement 
Detector 3« turntable Xe are lamp 
The angular response of the Sola Scope was measured in the planes parallel to the 
grating and perpendicular to the grating. The response of the Ocean Optics was 
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considered in one orientation only as there is an optical fibre coupled to the diffuser so 
that all radiation is scrambled within the fibre. 
3. Results 
Assessment of calibration 
Wavelength 
Wavelength error for the Sola Scope is shown in table I and was satisfactorily small 
to be considered negligible. 
Table 1: Wavelength error of Sola Scope 
Spectral line (nm) Recorded position (nm) Error (nm) 
253.65 253.5 -0.15 
313.10 313.0 -0.10 
365.00 365.0 0.00 
404.70 404.5 -0.20 
435.80 436.0 0.20 
Spectral responsivity 
The calibrations of both instruments reveal differences in the relative responsivities 
(see figure 2.6). There was a noteworthy amount of noise in the signals from both 
instruments. 
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Figure 2.6: Graph showing the relative spectral responsivities of both the Ocean 
Optics and the Sola Scope. 
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Measurement of clinical sources 
Results from using the Sola Scope revealed wide discrepancies in measured doses 
when using the supplied calibration (figure 2.7). The error was most pronounced as 
an overestimation of the irradiance at the UVA end of the spectrum (see figure 2.8). 
Use of the calibration created from measuring the 1 kW FEL lamp reduced these 
errors significantly (figures 2.8 & 2.9). 
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Figure 2.7: Graph to show the differences in measured irradiances when 
comparing manufacturer calibrated Sola Scope with IL1400 radiometer and, in 
the case of the UVA1 lamp, the Bentham spectroradiometer. TLO1 and TL12 
values from the integrated irradiance 280-315 nm. PUVA and UVA1 from 
irradiance integrated 315-400 nm. 
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Figure 2.8: Measurement of a high dose UVA1 source, which illustrates the 
discrepancy that was seen to exist with the Sola Scope's supplied calibration. 
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Figure 2.9: Graph to show the differences in measured irradiances when 
comparing custom calibrated Sola Scope with Bentham spectroradiometer and, 
in the case of the cabinets, an IL1400 radiometer. TLO1 values from integrated 
irradiance 280-315 nm. PUVA and UVA1 from integrated irradiance 315-400 
nm. 
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Measurements of phototherapy sources using the Ocean Optics showed the instrument 
underestimated the irradiance in all but the cases of a blue light source (figure 2.10). 
The recorded spectra were very noisy at low wavelengths and this fact, combined with 
the low responsivity of the instrument at low wavelengths, produced errors of the 
magnitudes seen and illustrates that this instrument is not at present sensitive enough 
to be used for UV radiation dosimetry. 
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Figure 2.10: Graph to show the differences in measured irradiances when 
comparing calibrated Ocean Optics with Bentham spectroradiometer and, in the 
case of the PUVA bank, an IL1400 radiometer. TLO1 and TL12 values from the 
integrated irradiance 280-315 nm. PUVA from the integrated irradiance 315- 
400 nm. TLO3 from the integrated irradiance 400-500 nm. 
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Stray light performance 
The stray light levels with both instruments were significant, as was expected. The 
method of correcting for stray light with the orange filter reduced the stray light 
significantly. Table 2 shows the stray light ratios if the signal at 250 rim (no 
irradiance, 24) is compared with that at 430 run (maximum irradiance). The levels are 
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significantly reduced when the Sola Scope's stray light compensation method is used 
and when the calibration is applied to the Ocean Optics raw signal. 
Table 2: Stray light ratios from the diode array instruments. The percentage 
value expressed is the ratio of the signal at 250 nm to that at 430 nm. 
Instrument 
Without compensation or With compensation or 
calibration calibration 
Sola scope 13% 2.0% 
Ocean Optics 39% 0.4% 
Bentham DM 150 
<0.001% <0.001% Spectroradiometer 
Angular response 
The f2 values for the instruments were both found to be within acceptable limits. For 
the Sola Scope the value was 5.1% in the plane parallel to its grating and 6.7% in the 
plane perpendicular to its grating (+/-60°). This provides an overall f2 value of 5.9% 
(+/-601). For the Ocean Optics the value was 7.8% (+/-60°). The cosine responses 
can also be represented as a polar plot (figure 2.11). 
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Figure 2.11: Polar plot to represent spatially the cosine responses (as a 
percentage of the maximum) of the Ocean Optics and Sola Scope at incident 
radiation angles from 90° to -900. 
w 
4. Discussion 
, cop- optics 
:t Cosine Response 
Diode array spectroradiometers potentially represent a welcome addition to the 
instrumentation available to the medical physicist. The instruments fulfil the majority 
of the requirements of radiometers for use in dosimetry- as identified in section 2. 
The instruments are portable, easy to use and acquiring spectral data is speedy 
compared with traditional spectroradiometry. The cost of the instruments may allow 
centres to acquire spectral measuring capabilities where spectroradiometers were 
outside of their means. 
This type of instrument also allows for a shorter calibration chain than exists with 
filtered radiometers. Because radiometers do not collect any spectral information, a 
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separate calibration for each phototherapy source to be measured is needed. Diode 
array instruments negate the need for this step: 
Transfer standard > Bentham °"°`°`h" Filtered radiometer 
Transfer standard > Diode array 
However, the potential for inaccuracies in dosimetry have been shown to be 
significant. 
The most significant issue encountered when calibrating both the instruments was the 
sensitivity of the detector arrays. The transfer standards routinely used in the 
department are a 100W, frosted glass, tungsten lamp for WA radiation measurements 
(315-400 nm) and a 30 W deuterium discharge lamp for UVB (280-315 nm). Neither 
diode array instrument proved to have sufficient sensitivity to detect these transfer 
standards. 
These sources are used as transfer standards in order to comply with CIE 
guidelines 16, which recommend that detectors be calibrated against sources with a 
known spectral intensity and distribution that is similar or the same as the source to be 
measured. The 1 kW FEL lamp employed for the calibrations was not ideal for UVB 
measurements but was the only source available that had sufficient signal to be 
detected by the instruments. 
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This lack of sensitivity presented a challenge during the angular response 
measurements. The deuterium discharge lamp is also a good approximation of a point 
source, and would normally be used for measuring the cosine response of any 
radiometer 21. A xenon arc lamp was used because it had sufficient signal to be 
detected but did allow us to demonstrate that the fl values of both instruments were 
acceptable. 
The Sola Scope is supplied with a manufacturer's calibration derived from a 
deuterium source. Hence, it was very surprising that the instrument was not sensitive 
enough to detect the output from such a lamp. Consultation with the manufacturer 
revealed that the calibration is performed without the cosine diffuser attached to the 
sensor and final calibration is derived by coupling the transmittance of the diffuser 
and the responsivity of the detector array 25. It is possible that uncertainties inherent 
in this calibration method lead to the error seen in the supplied calibration and 
subsequent errors when measuring phototherapy sources (see figures 2.7 & 2.8). 
Calibration of the intact instrument using the I kW FEL lamp was sufficient to reduce 
the error in the readings from the instrument to within 12% (figure 2.9). A calibration 
method such as this, keeping the instrument intact, would certainly be necessary for 
any clinical application. Errors of the magnitude that the supplied calibration was 
producing, could certainly lead to patients receiving the wrong dose. 
The UV responsivity of the Ocean Optics meant that even using the 1 kW calibration 
source, recorded spectra were of a similar signal level to the noise inherent in the 
instrument. This meant that all the phototherapy sources measured were too low in 
intensity to give a discernable spectral output, and it was only with a largely visible 
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source that the signal was large enough to exceed noise levels (TL03). This occurred 
despite the instrument supposedly being optimised for UV and visible wavelengths. 
This instrument could have potential in the clinical environment if its quantum 
efficiency in the UV were increased substantially. The calibration method for this 
instrument should also be revised. Very few light sources, and certainly not 
phototherapy sources, match the black body emission spectral profile. Convolution of 
some calibration source to this emission spectrum, based on colour temperature 
immediately introduces error into the calibration. The method that was used with the 
1 kW FEL lamp would certainly be more satisfactory if the sensitivity issue is 
addressed. 
As expected, the stray light levels in measurements from these instruments were high. 
It has been shown, however, that it is possible to compensate for the stray light by one 
of two methods. An orange glass filter can be used to find the stray light profile for 
any source being measured and the `profile' then subtracted from any final spectrum. 
Alternatively the stray light can be calibrated out by including stray light in any 
spectrum of a calibration source and therefore including stray light in the sensitivity 
factor (SFB, ). The first method is the most favourable because it takes into account 
different spectral profiles of any source, although it requires two scans of any source 
to be made which can have potential exposure risks when measuring phototherapy 
sources. 
The Sola Scope instrument currently shows significant potential for use in a clinical 
environment. The calibration supplied by the manufacturer was unsatisfactory but 
this could be improved using a high output source and stray light correction. With 
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these modifications in place the errors in measuring phototherapy sources were 
calculated as being up to 12%, in line with errors inherent in filtered radiometer 
readings. 
The Ocean Optics device should have its sensitivity increased and its calibration 
protocol re-written before it should be considered for dosimetry. 
Although there is potential benefit associated with this type of instrument, caution 
should be advised in its use within a clinical environment. Calibration issues 
surrounding this type of instrument have not yet been adequately addressed by 
manufactures to advocate the replacement of the filtered radiometer in the 
photomedicine clinic with a device such as this. There would be particular concern 
over the use of the device like this by non-specialist staff, since errors can be 
considerable. An erroneous reading of the magnitudes shown in this evaluation could 
easily lead to a patient being burned. 
This type of technology is also beginning to have an impact on different areas of UV 
metrology. The Finnish Radiation Protection Authority (STUK) developed a method 
of correcting stray light and noise in a different Ocean Optics model for sunbed 
hazard assessment. Calibrating using a1 kW FEL lamp provided favourable 
results 26. Coupled with a Czerny-Turner monochromator, diode array systems are 
being used for SUV monitoring 27,28. It is also encouraging to see National 
Measurement Institutes (NMI's) putting effort into methods of calibrating diode array 
systems in order to correct and guarantee measurements. For instance, NIST has 
developed a method of compensating for stray light and transferring the calibration of 
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a tungsten halogen lamp to a diode array spectroradiometer 15. This is also similar to 
the method I piloted in 2002. 
5. Conclusions 
The evaluation performed shows that diode array spectroradiometers may have 
significant potential for use in dosimetry because they have most of the properties 
required for dosimetry instruments. However, the potential for errors with this type of 
instrument are also significant. 
The length of the calibration chain, from national standard to meter for dosimetry is 
shorter with spectral instruments, but the accuracy of measurements should be 
monitored carefully. There is significant potential for errors in dosimetry above the 
10% level. Such errors may be due to an inappropriate choice of detector. 
Particularly with filtered radiometers, the properties of the detector must be 
understood or doses may be under (or over) estimated. Trained staff are also 
invaluable for ensuring accurate dosimetry. This is particularly true with diode array 
spectroradiometers. The lack of sensitivity that the instruments evaluated displayed 
would lead to serious errors in dosimetry if an untrained member of staff did not 
recognise the problem. 
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Response of normal 
polychromatic light 
Summary 
Chapter 3 
and abnormal (CAD and SU) skin to 
In order to test the assumption that different wavelengths are additive in producing 
erythema, seven volunteers were recruited, during the period from 2002 to 2005, to 
undergo monochromator phototesting and then testing with polychromatic sources. 
The hypothesis of linear responses has been extrapolated to photosensitive skin and 
thus, during the same period, 19 of the most sensitive patients suffering from solar 
urticaria or chronic actinic dermatitis, and attending the clinic for routine testing, were 
tested for their response to polychromatic light in addition to their normal 
phototesting. 
In normal volunteers the MEDs at phototest wavelengths and doses at which they 
would experience erythema (based on their lowest MED) from polychromatic lights 
were calculated using the erythemal action spectrum. The actual responses are 
compared with those expected. 
For patients: individual action spectra were constructed from monochromator testing 
results, and effective irradiances for polychromatic sources were calculated from these 
action spectra. A dose at which a patient would react was predicted using the total 
effective irradiance of the source and the patient's lowest MUD and/or MED. 
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Patients were then phototested with these sources, using a geometric dose series and 
the erythemal or urticarial response was assessed and compared to the predicted 
reaction. 
Within the limits of this experiment, the results indicate that neither erythema nor 
these disorders respond in a linearly additive manner to polychromatic radiation. This 
contradicts assumptions made in many photobiological publications. 
1. Introduction 
Individuals with photosensitive skin can face a hampered lifestyle due to their 
inability to tolerate the wavelengths of light to which they are sensitive. The various 
conditions leading to photosensitivity and their impacts on the lives of sufferers are 
discussed in chapter 1. Management of these conditions (discussed in chapter 4) 
represents a clinical challenge that is further complicated by the fact that no one 
causal factor has been identified for any of the idiopathic photodermatoses. 
The Scottish Photobiology Unit at Ninewells Hospital in Dundee is a national centre 
for research on light associated skin disorders 1 and a national tertiary referral centre 
for testing, diagnosis and treatment of suspected photosensitivity. Patients referred to 
the centre have detailed histories taken, are examined and then undergo testing in 
order to rule out photosensitivity or to define the condition and then decide on 
appropriate treatment. 
Phototesting is used as the objective basis for diagnosis of photosensitivity 2°3 
Narrow band radiation, of a known intensity, is shone onto a patient's back. A range 
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of doses and wavelengths allows the tester to define the minimum amount of radiation 
necessary to provoke a response at each wavelength. The British Photodermatology 
Group has published guidance on Phototesting 4. The results of phototesting are said 
to be able to be used to construct an action spectrum for a patient's sensitivity 'ý. 
Repeated phototesting also provides useful information regarding the progress of 
disease and any changes in the involved wavelengths 8. It can also be used as an 
objective means of assessing the improvement in a condition 9. 
Some photosensitive skin disorders give normal results on phototesting (namely AP, 
PLE 10 and HV) and hence provocation testing is indicated. This type of testing 
involves irradiating a large area of skin with different light sources. The provocation 
sources may be UVA or UVB or broad spectrum, such as solar simulated radiation. 
This type of testing will reveal any multi-waveband interactions that provoke a 
reaction that is not seen with phototesting. 
In the most sensitive individuals a flare of the skin can be a serious, even life 
threatening problem 11. There are reports in the literature of severe phototoxic burns 
in patients with porphyria when they were hospitalised for surgical procedures 12°13 
While risks in situations such as this can be minimised with careful planning and use 
of appropriate filters 14, this is not always possible in the case of emergency surgery 12 
and/or lack of knowledge of a patient's sensitivity or action spectrum. Indeed, Mr 
Doherty (the case study in chapter 1) suffered a flare of his skin during a routine 
biopsy in the dermatology clinic at Ninewells (see figure 3.1). 
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Figure 3.1 Urticaria induced by theatre lights 
Chapter 3 
Clearly any such response is undesirable. The increasing use of PDT as a treatment 
modality for tumours at various body sites goes hand in hand with the problem of 
persistent photosensitivity that accompanies the use of systemic photosensitisers 15. 
These patients can spend a considerable amount of time in theatre while tumours are 
irradiated and have to be protected from exposure to sources such as theatre lights. 
Hence, a prediction of the tolerable levels of exposure would be a useful tool not only 
for those with idiopathic photodermatoses but also for those photosensitised for PDT. 
Appendix 3.1 shows measurements made of the spectra of sources encountered in an 
operating theatre and a patient being irradiated. 
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Chronic actinic dermatitis 16,17 and solar urticaria are two conditions in which 
phototesting is particularly useful. The wavelengths involved in SU can be up to 700 
nm and often more than 400 nm in CAD. In order to develop new strategies for 
managing and treating photosensitive skin disease, it is necessary to understand the 
fundamental photochemical mechanisms of the disease process. In order to do this, it 
is helpful to consider the structure of normal skin, and the photochemical reactions 
that may occur 
18 
The outer layer of the skin is the stratum corneum. This layer gives the skin its barrier 
function 19. It is made up of a metabolically active structured lamellar lipid layer and 
mature keratinocytes (termed corneocytes), which are lost in a process called 
desquamation. 
Underneath is the outer cellular epidermis. The main cell type is the keratinocyte but 
there are also melanocytes and Langerhans cells in smaller proportions. Melanocytes 
synthesise melanins that are transported as larger particles (melanosomes) to 
keratinocytes where they are degraded into smaller particles that are then discarded 
during desquamation. Langerhans cells have an antigen presenting function and are 
thus part of the systemic immune system. UVR has a direct effect on the number, 
morphology and functionality of Langerhans cells and therefore has an 
20* effect ' 
For full reviews of the immunosuppressive effects of UVR see Clydesdale et al 21 and Schwartz 22. 
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Below the outer cellular epidermis is the basal layer where keratinocytes proliferate 
by division. The basal layer sits on the basement membrane which is a largely non- 
cellular dermis containing structural proteins such as collagen and elastin. 
Normal skin exhibits an erythemal response when the minimum erythema dose 
(MED) is exceeded. This is a cutaneous inflammation characterised by the formation 
of sunburn cells that appear as early as 30 minutes after exposure and are at a 
maximum 24 hours following exposure. The sunburn cell originates from damaged 
keratinocytes. There are a number of different mediators for this damage, including 
histamine. Following erythema, which fades in 72-120 hours, there is an increase in 
skin pigmentation desquamation and thickening of the epidermis 23. 
Any biological response is actually initiated by the absorption of ultraviolet or visible 
radiation by chromophores in the skin. The term chromophores actually relates to the 
unsaturated bonds in conjugated molecules, as it is these bonds that are responsible 
for absorption properties. However, the term is commonly used to describe the whole 
molecule 18 and this trend will be followed in this chapter. There are two mechanisms 
of initiating a biological response. Firstly, in a uni-molecular reaction the 
chromophore may be directly altered by the absorption of photons. Secondly, in a bi- 
molecular process, there may be damage to bio-molecules initiated by active oxygen 
species produced when endogenous chromophores absorb radiation. 
Endogenous chromophores in human skin include keratin proteins, haemoglobin, 
pophyrins, carotene, nucleic acids, melanins, lipoprotein, peptide bonds and aromatic 
amino acids 11. The absorption spectra of individual chromophores can be determined 
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in vitro by absorption spectroscopy. Many of these chromophores have poorly 
understood absorption and scattering properties. However, the complexity of the 
structure of the skin means that even if the absorption spectra of separate 
chromophores are known, in vivo, the optical properties of tissue, the fact that 
absorption spectra overlap and interactions can occur with other bio-molecules means 
that the action spectra of human skin is not predictable on the basis of the 
chromophores contained therein 
18. 
DNA is a significant chromophore and its absorption characteristics have been well- 
defined 18. Pyrimidine bases are the most sensitive and are modified by either direct 
absorption of photons or by free radicals generated in bi-molecular reactions. These 
modifications generate photolesions, the most important being cyclobutane and 
pyrimidine dimers and pyrimidone photoproducts 
20. Normal enzymatic function will 
repair this damage unless there is excessive damage in which case mutations will 
appear in the DNA. Indeed, 80% of sun induced human skin cancers contain P53 
mutations at dipyrimidine sites 
24. DNA is thought to be the chromophore for 
erythema as pyrimidine dimer is an important causative lesion in sunburn 18. 
The absorption and scattering properties of urocanic acid (UCA) have also been well- 
defined 18. It naturally occurs as the trans isomer but UV irradiation can cause trans 
to cis photoisomerization. Cis-UCA thought to be a mediator for suppression of 
delayed-type hypersensitivity, thus effectively having an immunosuppressive effect. 
The absorption properties of the melanin group of pigments are poorly understood 18 
Melanins are known to scatter and absorb WR. Exposure of the skin to UVR 
stimulates melanogenesis, which may be associated with photosensitisation and/or the 
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development of malignant melanoma (see Diffey et al 25, Setlow et al 26 and Mackie 
27). Exposure to UVA and visible light leads to the transient effect of immediate 
pigment darkening which is believed to be due to photo-oxidation of melanins 18. 
Kollias et a128 describe the photochemistry of melanin and its photoprotective effects. 
The erythemal action spectrum is well-defined and shows that UVB is three to four 
times more effective in causing erythema than UVA 29. The functions representing 
the action spectrum are shown in equations 4.1 to 4.3. 
E(k) =1.0 
£(i) = 100.094(298-ý) 
ew = 100.015(139-%) 
250: 5 ),: 5 298 nm Equation 3.1 
298 < ?,: 5 328 nm Equation 3.2 
328 < X<_ 400 nm Equation 3.3 
The action spectrum is shown in figure 3.2 and has been confirmed with laser-based 
studies 30. This action spectrum can be used to calculate an erythemal effective dose 
of any source (e. g. 14), using the spectral irradiance of the source: 
ED=2]IA6A'&', 
Where: 
ED is effective dose 
Et is the action spectrum value at wavelength A 
IA is the spectral irradiance of the source at wavelength A 
Equation 3.4 
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Figure 3.2: Erythemal action spectrum 29 
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If a person's minimum erythema dose (MED)* is known then the time to erythema 
from any source can be calculated once the erythemal action spectrum has been 
applied to the source's spectral irradiance. This technique also allows the relative 
effectiveness in eliciting erythema to be compared for different sources. Inherent in 
the use of this equation is the assumption that different wavelengths are linearly 
additive. That is that there are no synergistic or protective interactions between 
different wavelengths and the incorporation of a multiplication factor (action 
spectrum) allows the effective irradiance of a source to be calculated. This has been 
said to be true for erythema in normal skin, derived from tests with phototest 
equipment 31,32. This equipment irradiates with narrow band radiation and therefore 
does not test the integrity of the action spectrum for polychromatic radiation. 
The dose required to produce just perceptible erythema (redness) 
3.9 
303 308 313 318 323 328 
Wavelength (nm) 
Measurement of skin response for hazard assessment Chapter 3 
Chronic actinic dermatitis was proposed in 1979 33 and widely accepted in 1990 as a 
unifying concept for the previously separate syndromes of persistent light reactivity, 
photosensitive eczema, photosensitivity dermatitis and actinic reticuloid 34. By 
definition CAD must encompass abnormal sensitivity to UVB wavelengths but may 
also feature increased UVA and visible light sensitivity. However, the 
pathomechanism for CAD is unknown. Action spectra have been created for CAD 
sufferers using phototesting results 16, which recently have been said to be similar to 
that for erythema 35. This suggests that the same chromophore is involved in 
erythema and the abnormal response in CAD, possibly DNA 18. 
In the 1960's there was a mini epidemic of photoallergic reactions to halogenated 
salicylanilides used in soaps and hair toiletries 11.23 Photoallergic contact dermatitis 
reactions are rare because the individuals that suffer must have a specifically altered 
immunologic background 23. These reactions are mediated by lymphocyes and 
characterized as delayed hypersensitivity reactions. Photoallergic reactions need 
radiation to form a complete antigen, in contrast to allergic contact dermatitis where 
the antigen is present already. The events that form a complete antigen are not well- 
understood 11. 
Many of the patients that suffered from photoallergic contact dermatitis to 
halogenated salicylanilides went on to develop persistent light reaction 23_ eczematous 
dermatitis when exposed to radiation, even if the photosensitiser is no longer 
present' 1. Hence one early theory of CAD pathogenesis was that photoallergic 
chemicals persist in the skin 17. The action spectrum of any such photosensitiser 
would have to include UVB, A and visible radiation and as yet no such compound has 
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been found 36. A more complex hypothesis is that the development of CAD occurs 
after an episode of photoallergy. This then causes alteration and transformation of a 
skin chromopore that consequently develops into an endogenous antigen that can 
perpetually react with specific wavelengths to induce a chronic inflammatory process 
1 1. However, only up to 75% patients have associated contact and/or photocontact 
allergy " and hence these theories do not account for the whole story. 
Certainly the pathophysiology of CAD is only partially understood. Cellular 
hypersensitivity to UVA has also been shown in cultured fibroblasts from CAD 
patients 37. It is suggested that there is deficiency in the cellular mechanisms dealing 
with oxygen radicals leading to excessive cell damage on exposure to UVA 37. This, 
however, does not explain the increased sensitivity to UVB and/or visible 
wavelengths. 
The histologic findings in CAD bear a resemblance to persistent allergic contact 
dermatitis and are compatible with delayed type hypersensitivity response 23,36 There 
have been several evidence based suggestions made that CAD is aT cell mediated 
response compatible with type 4 immune response 1736. The prospective 
chromophore involved in this process remains unidentified 36 
It may be many years before the causal factor(s) for CAD is known and the 
mechanisms involved are elucidated. It seems likely that this condition represents a 
spectrum of disorders 38 resulting from heightened immune reactivity 17 whereby a 
weak, endogenous photoallergen that is present at all times in all people, is recognised 
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as a photoallergen in patients with CAD 36. The type 4 response to UV light and 
associated contact allergies would therefore represent immune dysregulation 17. 
More research into the etiology of this disabling condition is needed to help clinicians 
manage and treat sufferers. This is an uncommon condition, affecting 1: 6000 people 
in Tayside with men accounting for 78 to 90 % of sufferers 36. Patch and photopatch 
testing should always be performed in cases of suspected CAD in order to exclude or 
39 reveal any associated contact dermatitis and/or photoallergic contact dermatitis 
Solar urticaria is a rare disorder, affecting 3.1 per 100,000 people in Tayside 1 7. The 
wavelengths involved in the condition include UVA, B and visible radiation 40 and 
occasionally infrared radiation 41. The action spectra as derived from monochromator 
testing are often broad 17 and can change in individual patients over a period of years 
42. The interactions of wavelengths in solar urticaria are known to be complex and in 
some subjects feature augmentation and inhibition effects 4344. The mechanisms 
involved in these interactions are not understood 41. Knowledge regarding these 
effects in patients is often based on pre or post-irradiation and not on the simultaneous 
effects of polychromatic light in comparison to irradiation monochromator 
phototesting results. 
Solar urticaria is an IgE mediated immediate type hypersensitivity reaction 11. The 
histological features of the disease are the same as acute urticaria: dermal odema, 
vasodilation and variable perivascular infiltrate consisting of lymphocyes and 
eosinophils 11. The chromophore responsible for this immune response is not known 
3.12 
Measurement of skin response for hazard assessment Chapter 3 
but may be a normal serum factor in some patients and an abnormal endogenous 
substance generated in others 41 
It has been proposed that a photoallergen is formed after irradiation in SU 45. The 
urticarial response is then triggered when IgE antibodies specific to the photoallergen 
are generated and bind to mast cells. Further interaction between the IgE mast cell 
complex and the photoallergen leads to mast cell degranulation and release of 
inflammatory mediators, including histamine 41 
In precis: phototesting is used for diagnosis, and thought to be useful for constructing 
an action spectrum in photosensitive skin disease. However, no studies have been 
published to date that test the assumption that the results of phototesting can be used 
to construct an action spectrum and an effective irradiance for any light source as is 
routinely done for erythema. 
The use of the erythemal action spectrum to compare erythemal effectiveness of 
sources is ubiquitous and represents a widely accepted paradigm in photobiology. Its 
use with polychromatic radiation is accepted although, to my knowledge, there are no 
publications that test this assumption. Sutherland 46 presents a theoretical 
interpretation of the effects of polychromatic light and suggests that the linear 
hypothesis of the erythemal action spectrum can be tested by predicted erythema 
doses and then testing them with polychromatic sources. He calls the prediction of 
the effects of polychromatic light a `central goal' of environmental photobiology. 
The ability to predict safe exposure limits for diseased or photosensitised skin would 
assist in hazard assessment. The safe limits of exposure to theatre lights for patients 
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having PDT in an operating theatre and the amount of sunlight tolerable by a CAD 
patient could all be assessed. Furthermore, the hazards posed to patients when 
photosensitising broad-spectrum antibiotics 47 are a therapeutic necessity could be 
determined. 
In order to test this assumption for erythema and diseased skin, patients and 
volunteers were recruited to take part in the presented study. Volunteers with normal 
skin were recruited to be phototested and then tested with polychromatic sources. 
Also, CAD and SU patients attending the Photobiology Unit for routine testing for 
photosensitivity were recruited to have some extra provocation testing with broadband 
sources in order to test the hypothesis that phototesting results can be used to 
construct an action spectrum in these disorders. This hypothesis assumes that the 
wavelengths of light provoking reaction in these patients are linearly additive. In SU 
patients it was expected that this would not be the case due to the likelihood of the 
existence of inhibition and augmentation spectra. However, this testing may help to 
understand the interactions of wavelengths of light when irradiating with 
polychromatic sources. 
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2. Methods and materials 
Phototesting 
Chapter 3 
At the Unit, Phototesting is carried out according to BPG guidelines 4 and accepted 
best practice. The back is used as the phototest site as it is usually the most sensitive 
area, unlikely to be tanned and gives a uniform response 48. If there is too much 
active skin on the back then either another area is chosen, namely the buttocks 49, or 
the patient is hospitalised until their reaction has been suppressed with topical 
corticosteroids. 
A xenon arc lamp and single grating irradiation monochromator are used (see figure 
3.3) with the wavebands and filters listed in table 3.1. The monochromators are 
aligned with a medium pressure mercury arc lamp and dosimetry is performed prior to 
each irradiation using thermopiles with calibration traceable to NPL. Thermopiles are 
wavelength independent detectors 50 and therefore have a flat response across the 
wavelength range used for phototesting. 
Table 3.1 Routinely used phototest wavelengths, wavebands and filters. Lowest 
normal MED values against which comparisons are made. 
Wavelength FWHM Filter Lowest normal MED mJcm" 
305 5 - 27 
335 30 WG305 1800 
365 30 WG305 8200 
400 30 WG345 47000 
430 30 GG375 82000 
460 30 GG420 82000 
500 30 GG420 82000 
600 30 GG420 82000 
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I 
The dose increments used are shown in figure 3.4. The series is geometrical- 
exposures are increased by a ratio of 3. On the first day of testing, crude dose 
increments are used. The blue bars in figure 3.4 indicate those doses given at 305 nm 
(+1-5 nm). These steps include the lowest normal MED at the test wavelengths (see 
table 3.1) and are designed to `catch' a patient's MED. Appropriate multiples of the 
test doses are used e. g. for 335 nm (+/-30 nm) the doses are multiplied by 100. The 
patient returns 24 hours later for reading of the grades of erythema seen and then fine 
dose increments (pink on the graph) from the step above where no reaction was seen 
to the dose below where a reaction was seen are used to define the MED at each 
phototest wavelength. Barely perceptible erythema is the most reliable threshold for 
measurement of sensitivity 51 and this is the level taken as the MED. 
3.16 
Figure 3.3: Irradiation monochromator testing. The irradiation 
monochromator (left) and a subject's back, where erythema can clearly be seen 
from testing at different doses and wavelengths. 
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Figure 3.4 Dose series used for monochromator phototesting. See text for 
explanation. 
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If a patient had an urticarial reaction to the radiation then a MUD (minimum urticarial 
dose) is defined as well as the MED at each test wavelength. Urticarial responses are 
shown in figure 3.5. 
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Figure 3.5 Patient with an urticarial response to radiation at 460 and 500 nm 
Polychromatic light testing 
A variety of sources were used to test the sensitivity of the volunteers. These 
included a xenon arc solar simulator, blue and UVA light provocation source, TLO1 
source, PUVA source, a portable theatre light and an UVA1 source. The spectra of 
these sources were measured using the department's bench based spectroradiometer 
(Bentham DM150, see chapter 1). 
Normal subjects 
From November 2002 to April 2005, seven healthy volunteers were recruited from 
among staff and family at the Photobiology Unit to be phototested as per the method 
described above. 
The erythemal action spectrum was extrapolated to 500 nm 31 and then normalised to 
305 nm as this is the first phototest wavelength. Each light source was weighted, in I 
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run steps, according to this spectrum and the total erythemal effective dose (ED) 
between 305 and 500 nm was calculated according to equation 3.7. 
The predicted time to erythema (ti) for each light source and each volunteer was 
calculated based on the volunteer's MED at 305 nm (MED305). 
_ 
MED305 
t" 
ED 
A series of exposure times were then calculated thus: 
dose 1: 
2x 
tX 
dose 2: 
1x 
tx 
dose 3: tx 
dose 4: -12- x tx 
dose 5: 2x tx 
Equation 3.5 
Hence the maximum exposure was twice the predicted reaction time. In practice 
many of the exposure time series calculated were rather long and in consultation with 
experienced staff and in order not to bum volunteers, the same dose series as used in 
phototesting (with appropriate multiplication factor) was used in order to `catch' the 
MED with each source. Sources were chosen according to the time that the volunteer 
had available and their willingness to tolerate persistent pigmentation. During 
irradiations appropriate protective sheeting and goggles were used. 
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The volunteer's responses were assessed at 24 hours after irradiation. As the 
perception of MED has been argued to be subjective 52, an attempt was made to 
exclude this with the use of an erythema meter 53 and a chromameter sass However, 
the readings were inconsistent because excess pressure causes the skin to blanche. 
Thus, slight differences in the pressure applied to the skin with either meter leads to 
unreliable results and hence these results are not presented. An experienced 
technician's assessment, made by eye, was found to give a more accurate assessment 
of the MED. Hence the study was `blinded' as the technicians had not been made 
aware of the expected reaction times. 
Theoretical MED's were also calculated from the erythemal action spectrum. These 
results were compared with the actual MED's given from phototesting results. 
Abnormal subjects 
Patients were deemed to be suitable for the study if they 
1. Were return patients- so that a diagnosis already existed 
2. Attended the clinic as in patients- as they were kept longer than normal and so 
that inconvenience to the patient was minimised 
3. Were suffering from solar urticaria or chronic actinic dermatitis 
4. Were happy to volunteer for some extra testing 
5. Had enough space on their back for extra testing 
6. Were not taking any antihistamines on the day of testing (for this study) that 
they had not been taking during their phototesting. This effectively ruled out a 
lot of potential volunteers as antihistamines were often given and repeat 
testing undertaken on the following days in order to assess the efficacy of 
antihistamines for that patient. 
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19 patients were recruited during the period from November 2002 to April 2005. 
Results from their phototesting were used to construct an action spectrum for each 
patient. This was achieved by linear interpolation between the phototest points giving 
a value for the expected MED at each wavelength (see equation 3.6). 
MED2 =m2+c 
where MED is the MED at wavelength X 
m is the gradient of the line 
c is the intercept on the y axis 
Equation 3.6 
This data was tabulated and divided by the patients' minimum measured MED to give 
a weighting function (aa) (equivalent to s) at each wavelength (A). The spectral 
irradiances of the light sources were then used to calculate an effective irradiance (Ix) 
for each source (equivalent to ED), thus: 
600 
Ix =1Ix6,0A 
305 
Where: 
Equation 3.7 
I,, is the spectral irradiance of the lamp of interest at wavelength A 
Q-(, tdis a weighting function calculated from the patient's specific action spectrum at 
wavelength A 
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The predicted time to erythema was calculated and revised as for the normal subjects. 
Irradiation times > 40 minutes were regarded as impractical. Sources were chosen 
according to the time that the patient was willing to sit for and the space available on 
the back. Suitable protective shielding and goggles were used during irradiations as 
with the normal subjects. 
The action spectra of the patients with solar urticaria were treated separately. Two 
spectra were created for these patients: one from their MED's from the monchromator 
results and one from their MUD's from the monchromator testing. The erythemal 
effective irradiance of the test sources was calculated as detailed above and then the 
same process was repeated for the urticarial effective irradiance of the test sources. 
Hence there are two sets of data, the expected time to erythema and the expected time 
to urticaria. If urticaria was seen within the doses given then the dose series was 
discontinued. 
Readings were made by experienced technicians at 24 hours for erythemal responses 
and within 20 minutes for urticarial responses as per the normal subjects. 
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3. Results 
Spectra of light sources used 
Figure 3.6: Solar simulator spectrum: xenon arc lamp filtered for IR radiation 
with a circulating HZSO4"CuSO4 solution filter. Schott glass filters are used with 
this source. With filter WG305 is referred to as SS + UVB and with filter 
WG345 is referred to as SS - UVB. 
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Figure 3.7: Provocation source: Dr Honle UVA blue light source (metal halide) 
with hll filter 
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Figure 3.8: Ninewells custom-built TLO1 MED unit 
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Figure 3.9: Ninewells custom-built UVA MED unit 
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Figure 3.10: UVA1 source: Dr Honle Dermalight Ultra 1 
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Figure 3.11: Theatre light: Daray portable theatre light 
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Normal subjects 
The calculated and actual MEDs as shown by phototesting revealed sizeable 
differences. The use of the erythemal action spectrum led to an overestimation of the 
MED in all but one case (volunteer 5, MED at 365 +/- 30 nm). This data is tabulated 
in table 3.2, and figures 3.12 and 3.13 showing the maximum and minimum 
differences respectively between theoretical and actual MEDs. Of interest is the fact 
that the volunteer (5) with the responses that approximate closest to the erythemal 
action spectrum was the fairest of all the volunteers. He had very fair hair and skin 
that showed no evidence of sun damage. The predicted and seen response times with 
polychromatic light were also closest in this volunteer, with one response being 
underestimated. 
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A total of 20 tests were performed with polychromatic light, on 7 volunteers, using 4 
light sources. Table 3.3 shows the results from the testing with the polychromatic 
light sources. The solar simulator actually generates a substantial amount of heat, 
despite its copper sulphate filter and most volunteers asked to stop this test at around 
the 2 minute mark due to the discomfort felt. Hence, there are inconclusive results 
from the 6 tests using the solar simulator minus WB radiation. 
The differences in the predicted and actual reaction times are substantial. The use of 
the erythemal action spectrum led to an overestimation of the time to erythema in 9 
cases and an underestimation in only 3 cases. The differences in the calculated and 
observed MEDs at 365 +/- 30 nm nm are less than those at 335 +/- 30 nm. 
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Table 3.2: Calculated and observed MEDs for normal subjects from irradiation 
monochromator testing 
Phototest Wavelengths 
Volunteer 
number 
Skin 
type Sex 
305 +l- 5 
nm 
335 +l- 30 nm 365 +l- 30 nm 
Actual 
MED 
mJcm 2 
Calculated 
MED 
mJcm 2 
Actual 
MED 
mJcm'2 
Difference 
Calculated 
MED 
mJcm"Z 
Actual 
MED 
mJcm 2 
Difference 
1 3 F 56 10356 3900 165% 29186 27000 8% 
2 3 M 47 8692 2200 295% 24496 15000 63% 
3 3 F 47 8692 1800 383% 24496 12000 104% 
4 3 F 47 8692 2700 222% 24496 18000 36% 
5 2 M 22 4068 1000 307% 11466 12000 -4% 
6 3 F 39 7212 3900 85% 20327 15000 36% 
7 2 F 39 7212 3300 119% 20327 18000 13% 
Maximum' 383% 104% 
Minimum 85% 4% 
Mean 225% 38% 
Maximum, minimum and mean values calculated from root, mean squared percentage values. 
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Figure 3.12 : Maximum difference between theoretical and actual MED's, volunteer 3 
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Table 3.3: Predicted and actual responses to polychromatic radiation for normal 
subjects 
Volunteer 
number 
Skin 
type Source 
Predicted 
time to time 
erythema 
(mm: ss) 
Actual 
time to 
erythema 
(mm: ss) 
Difference 
(mm: ss) 
Difference 
(%) 
SS + UVB 00: 41 00: 07 00: 34 486% 
1 3 F 
SS - UVB 16: 42 >02: 45 
Provocation 27: 43 26: 00 01: 43 7% 
UVA1 15: 28 17: 25 -01: 57 -11% 
2 3 M 
SS + UVB 00: 34 00: 07 00: 27 386% 
Provocation 23: 16 08: 29 14: 47 174% 
SS + UVB 00: 36 00: 08 00: 28 350% 
3 3 F SS - UVB 13: 55 >02: 03 
Provocation 23: 18 13: 30 9: 48 73% 
4 3 F 
SS + UVB 00: 34 00: 13 00: 21 162% 
SS - UVB 14: 01 >04: 03 
SS + UVB 00: 15 00: 08 00: 07 88% 
5 2 M SS - UVB 06: 33 >02: 12 
Provocation 10: 53 15: 00 -04: 07 -27% 
SS + UVB 00: 28 00: 05 00: 23 460% 
6 3 F SS - UVB 11: 38 >01: 55 
Provocation 19: 18 19: 30 -00: 12 -1% 
SS + UVB 00: 28 00: 06 00: 22 367% 
7 2 F SS - UVB 11: 38 >02: 15 
Provocation 19: 18 18: 44 00: 34 3% 
Maximum* 14: 47 486% 
Minimum 00: 07 1% 
Mean 02: 34 185% 
* Maximum, minimum and mean values calculated from root, mean squared percentage values. 
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Abnormal patients 
Action Spectra 
The action spectra of those patients with CAD revealed that as expected the MEDs 
were much lower than those of normal skinned individuals (see figure 3.14). Figure 
3.15 shows the action spectrum for patient 1 and the erythemal action spectrum. The 
patient's spectrum is flatter than the erythemal action spectrum, contradicting the 
results of Menage et a13s 
Figure 3.16 shows the interpolation equations as calculated from Equation 3.6 for 
patient 5's erythemal responses. 
Figure 3.14: MED results of a CAD patient (1) 
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Figure 3.15: Log plot of the action spectrum of patient 1's sensitivity spectrum 
and the erythemal action spectrum (normalised to 305 nm) 
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Figure 3.16: MED's, interpolations and equations for a patient with chronic 
actinic dermatitis. 
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As expected the urticarial action spectra for the SU patients was found to be very 
different from the erythema action spectrum. Urticaria was found to be caused by 
narrow wavebands in the monchromator testing. Figure 3.17 shows the MUD's, 
MED's and urticarial sensitivity spectrum calculated from patient 4's phototesting. 
The distinct peak in the urticarial sensitivity spectrum represents the patient's very 
low MUD at this dose (100 mJcm 2). An urticarial reponse was not provoked at 305, 
360 or 430 nm in this patient and hence a MUD of 82000 mJcm-2 has been assumed in 
order to construct the action spectrum. This gives a6 value of 1.2 x 10'5 at these 
wavelengths. Assumptions such as this were necessary in order to construct action 
spectra. In reality the MUD at 305 nm could not be elucidated without drastically 
exceeding the patient's MED and possible leading to a blistering response. 82000 
mJcni 2 was used consistently throughout this work to estimate a response that was 
unlikely as it represents the lowest normal MED at 430 run upwards. 
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Figure 3.17: MUD's, MED's and urticarial sensitivity spectrum for patient 4 
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Polychromatic testing results 
Figure 3.18 shows the effective irradiance for a TLOI source as calculated for patient 
15, a CAD patient. The sensitivity spectrum and the unweighted irradiance of the 
lamp are also shown. The effective irradiance and spectral irradiance of the lamp are 
plotted on the same axis to show the effect of the application of the sensitivity 
spectrum to the lamp's spectrum. 
Figure 3.19 shows the effect of the application of a calculated CAD sensitivity 
spectrum to the solar simulator. The effective and actual irradiances are shown on 
different axis to show the relative shape of the spectra. 
Figure 3.20 shows the urticarial sensitivity spectrum of patient 6, as applied to the 
portable theatre light. This patient's urticarial sensitivity peaks at 460 nm. 
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Figure 3.18: Patient 15 relative sensitivity and the effective irradiance of a TLO1 
source. 
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Figure 3.19: The relative sensitivity of patient 9, and as applied to the solar 
simulator - UVB radiation 
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Figure 3.20: The relative sensitivity of patient 6, and as applied to the portable 
theatre light 
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The results from the testing of abnormal patients with polychromatic sources is shown 
in table 3.4. The sources chosen for testing were dependent on the amount of space 
available on the patient's back. As with the normal volunteers, the solar simulator 
with UVB radiation excluded often proved too painful for volunteers to tolerate due to 
the heat generated. So, testing was stopped on request. 
A total of 52 tests to define MEDs were performed (17 of these on SU patients). Six 
of these tests (11%) were stopped before a reaction was seen and thus do not provide 
any useful information. 
4.5E-02 
4.0E-02 
3.5E-02 
3.0E-02 
E 
2.5E-02 
E 
2.0E-02 
1.5E-02 ego 
1.0E-02 
5.0E-03 
0.0E+00 
Among the tests on CAD patients, 65% of the calculations were overestimates of the 
time to erythema, 29% were underestimations. The remaining 6% accounts for the I 
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test that gave no results (testing was stopped before a reaction was seen) and the 1 
perfect test result. 
The tests giving results on the time to erythema on SU patients showed that 39% of 
the time the model overestimated the time to erythema, 28% of the tests yielded no 
results and 33% of the results were underestimates of the time to erythema. The large 
proportion of the tests that yielded no results are accounted for because the tests were 
stopped due to the MUD being reached or exceeded. 
In total there were 16 underestimates of the time to erythema, 39 overestimates and 1 
perfect prediction. 61% of the tests allowed the difference between the predicted time 
to erythema and the actual time to erythema to be calculated. Of these the erythemal 
responses were predicted to within a mean time of 3 minutes and 52 seconds (? 0 
mins 0 secs, <_ 51 minutes 54 seconds). The remaining 28% that did provide results 
only showed whether the reaction was an overestimate or an underestimate. For 
example, patient 1 reacted to the solar simulator with UVB radiation in under 4 
seconds, although the actual MED was not determined. The model predicted 6 
seconds so the result was an overestimated time to erythema. 
The 17 urticarial response tests conducted revealed that in 53% of the cases the time 
to urticaria was overestimated, 12% of the calculations underestimated the time to 
urticaria and 35% of the tests yielded no results as testing was stopped before urticaria 
was seen. It was necessary to limit the exposures in order to prevent the patients 
experiencing severe erythema. This illustrates the difficulty in trying to model the 
erythemal and urticarial responses in solar urticaria. Figure 3.21 shows the urticarial 
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responses of patient 4 to the provocation source. Of the tests that did give results, it 
was possible to predict the time to urticaria in 2 minutes and 57 seconds (>_ 0 mins 5 
secs, <_ 15 minutes 19 seconds). 
Figure 3.21: The urticarial responses of patient 4 to the provocation source. The 
first exposure, seen in the top left square (1 minute) would later develop into 
erythema. The MUD is seen in the 2"d dose (top right). 
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4. Discussion 
Normal Subjects 
The results from this study were surprising. The fact that the erythemal action 
spectrum led to an overestimation of the MEDs in all cases points to the conclusion 
that the erythemal action spectrum should not be used to estimate the time to 
erythema for polychromatic sources. Of note is the fact that the calculations and 
actual MEDs at 365 +/- 30 nm were closer than those at 335 +/- 30 nm. This may 
indicate the involvement of more than one chromophore at - 335 nm. The 
disagreement in observed and predicted results is possibly due to the erythemal 
response being non linear, as suggested by Sutherland 46 but the fact that other 
investigators have shown the erythemal action spectrum to be plausible 30,31 indicates 
that the reasons for this finding may be due to errors inherent in the phototesting 
method. 
The determination of the MED is never exact, as the actual MED may lie anywhere 
between just above the dose where a response is not seen and the dose where it is 
visible. This constitutes a systematic uncertainty in the phototest system 32. Using 
finer dose increments could reduce these uncertainties but this would increase the 
time necessary for testing and was not practical while using unpaid volunteers. 
Furthermore, there are errors inherent in the determination of the MEDs. Visual 
detection of erythema is subjective and dependent on the illumination 52. These errors 
were minimised as far as practical by using experienced staff and a tungsten halogen 
source to illuminate the subjects' backs. It was disappointing that the use of an 
erythema meter could not help to provide an objective measure of the erythema, but 
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the results were so variable that the decision to abandon these measurements and rely 
on the human eye led to consistent results. 
The bandwidth of the radiation is also important. Young & Diffey 32 showed that 
providing the monochromator bandwidth is kept constant in phototesting, the 
theoretical effectiveness of radiation at UVB wavelengths can be related to that at 300 
nm. They assessed this by testing the MED at 300 nm and then predicting the MED 
at another wavelength using the erythemal action spectrum and testing to check their 
assumptions. Thus they did not use broad-spectrum polychromatic radiation. 
In this study the MEDs at wavelengths across the UVB and UVA spectrum were 
related to that at 305 +/- 5 nm. The bandwidths used vary due to the output of the 
monochromators. Narrower bands could be used at 335 nm upwards but this would 
increase the dosage times considerably and is therefore not practical. It is recognised, 
therefore, that the MED measured at 365 nm in this study is due to radiation with a 
full width at half maximum of 30 nm. With constant bandwidths these errors cancel 
out (for UVB wavelengths) 32 but the difference in observed and expected MEDs 
found in this study may be due to these differences in bandwidths. 
The fact that the erythemal action spectrum model did not transfer to polychromatic 
radiation is surprising. The erythemal effectiveness of the sources was calculated 
using the erythemal action spectrum and related to the MED at 305 +/- 5 nm. It is 
possible that the erythemal response to polychromatic radiation is not additive across 
the UVB and UVA wavebands due to the optical properties of the skin and 
chromophores therein, hence rendering the erythemal action spectrum redundant for 
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the assessment of the erythemal potential of broadband sources. However, the 
differences in observed and expected reactions may also be due to experimental error. 
As well as the errors inherent in the phototesting method (as already discussed), the 
differences in observed and expected reaction times may be accounted for by the 
dosimetry methods used. The doses of the radiation used in phototesting are achieved 
using thermopiles and the dosimetry of the polychromatic sources is accomplished 
with a spectroradiometer. These two methods of dosimetry are related to different 
calibration chains at NPL and thus there may be differences in doses accounted for by 
uncertainties in the standards as well as by uncertainties inherent in the dosimetry 
methods. Consideration of the uncertainties in the spectroradiometer measurements is 
given in chapter 1. There is no uncertainty budget available for the thermopile 
measurements. This gap in knowledge should be addressed in order to provide proper 
quality assurance for these measurements. 
During the course of this research, United Kingdom Accreditation Society (UKAS) 
accreditation was given to the unit's UV meter calibration procedures, and thus an 
uncertainty budget for spectral measurements was constructed. A similar assessment 
for thermopile measurements is indicated. Appendix 3.2 contains results of 
measurements made of the spectral distribution and beam uniformity of the 
monochromators used in phototesting. There is considerable non-uniformity of the 
beams, particularly at 305 +/- 5 nm. As can be seen from these results, a complex 
uncertainty budget for dosimetry of these instruments would be somewhat futile given 
the problems inherent in instruments. Attempts have been made to find more reliable 
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and uniform equipment for phototesting, but to date no instrument is available with 
suitably high output of visible light as well as UV radiation. 
No concrete conclusions can be drawn from this study due to the small sample 
number. There are many pointers to a better experimental design, including 
phototesting at more wavelengths and an assurance of the dosimetry based on 
thermopiles. A study recruiting a large number of paid volunteers is suggested seeing 
as this action spectrum is so widely used and relied upon in photobiology. 
Abnormal subjects 
The testing of abnormal subjects also showed that the responses to polychromatic 
radiation could not be predicted based on results from monchromator phototesting. 
The spacing of the phototest points prevented more complex modelling of the action 
spectrum, such as curve fitting. The action spectra are certainly not comprised of 
straight lines but in the absence of more data points this is the only model that is 
mathematically robust. 
With CAD patients the results are surprising, as the action spectrum for CAD has 
been said to be similar to that for erythema 35. The identification of the chromophore 
involved in CAD would assist in modelling the action spectrum. Within the limits of 
this study, the response of patients with CAD to polychromatic light can be said to be 
non-linear but the inconclusive nature of the findings in erythema prevent more 
inferences being drawn regarding the nature of the chromophore involved in CAD. If 
phototesting of all patients was to be conducted at more wavelengths then a large 
amount of data could be collected and a more feasible model of the action spectrum 
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could be developed. The response to polychromatic light could then be matched to 
one of the integral equations suggested by Sutherland 
46 
With urticaria patients the differences in predicted and observed responses an 
interrelation of the erythemal and urticarial responses is indicated and the simple 
model used in this study is not applicable to this condition. However, the errors in the 
MED/MUD determination and phototesting also apply as discussed above. The 
determination of a MUD is perhaps easier than an MED as urticaria can be felt. There 
is a characteristic raising of the skin that happens and perhaps leads to a more reliable 
determination of a MUD. 
The overlap of the erythema and urticaria sensitivity in SU patients presents 
difficulties in the measurement of an action spectrum in these patients. SU and CAD 
have been found to co-exist in some patients 56 and it is possible that the same 
unidentified antigen is responsible for mediating both these conditions. The fact that 
CAD represents a spectrum of disorders 38 could mean that the primary stages of CAD 
are present in some (or all) SU sufferers although clinical manifestations of CAD are 
not seen due to the stage of the progression of the disease. An animal model for solar 
urticaria would allow for the construction of a complete action spectrum. The 
urticarial responses to polychromatic sources would then be easier to rationalise. 
These results challenge the assumption that the potential hazards of sources can be 
predicted using a linear model of response and suggest that more work is needed to 
find the chromophores involved in disease processes and photosensitive skin. Even if 
this was achieved the feasible models for response to polychromatic light suggested 
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by Sutherland 46 may not be found to hold true for human skin. It must be 
remembered that the skin is a complex and multifaceted organ with many endogenous 
chromophores even in normal skin. 
We may never be able to construct a mathematical equation to predict reactions to 
polychromatic light. Irradiation monochromator phototesting has been called 
`pseudoscience' and criticised as a reductionist approach to clinical medicine 57. This 
testing clearly has its place in the diagnosis of photosensitive skin conditions but it 
may be that it has been relied upon too much in helping patients manage their 
conditions by avoiding certain wavelengths. The extrapolation of these results to 
estimating the hazards of sources encountered in everyday life should be halted until 
more research is carried out and the interactions of wavelengths are better understood. 
S. Conclusions 
" The results are inconclusive due to uncertainties in the measurements. 
However, they point to the responses of normal, CAD and SU skin being non- 
linear. 
" For erythema this challenges a central paradigm in photobiology. 
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Appendix 3.1 
Chapter 3 
In order to gauge the magnitude of the risks of an operating theatre to photosensitive 
or photosensitised individuals, an operation to give PDT to a brain tumour was 
observed. The surgical team used all possible precautions to minimise the patient's 
exposure to light, which meant that the anaesthetist was working in sub optimal 
conditions in the anaesthetic room. The theatre was then visited when it was not in 
use and measurements were made of all the light sources that the patient had been 
exposed to. The department's bench based spectroradiometer was used for these 
measurements. The distances used were those that the patient would experience e. g. 
for the main theatre lights the input optics was placed level with the operating table. 
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Figure 3A1.1: Patient with a brain tumour receiving PDT. The laser fibre can 
be seen (red) and the light source illuminating the patients head is the 
microscope used by the surgeon to identify the demarcations of the tumour. 
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Figure 3A1.2: Irradiance from lights used in the neurology theatre at Ninewells 
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Appendix 3.2 
Chapter 3 
There are 3 monochromators in the photobiology unit. Monos 2 and 3 are routinely 
used for phototesting and mono 1 is used if necessary due to its output being lower. 
Figures 3A2.1 and 3A2.2 show the spectral distribution of all three monochromators 
when set at 335 and 365 nm as measured with the Sola Scope (see chapter 2). 
Figure 3A2.1 Spectral distribution of radiation from department 
monochromators. The FWHM is indicated for monochromator 1 and the actual 
peaks are also indicated. 
1.0 
0.9 
0.8 
0.7 
0.6 
j 0.5 
V) 0.4i 
0.3 
0.2 
0.1 
00 
0.0 1- 
306 
333 nm 342 nm 
3.52 
316 326 336 346 356 366 376 
Wavelength (nm) 
Measurement of skin response for hazard assessment Chapter 3 
Figure 3A2.2 Spectral distribution of radiation from department 
monochromators. The FWHM is indicated for monochromator 1 and the actual 
peaks are also indicated 
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Figure 3A2.3 show the uniformity of the beam for monochromator 3 at all the 
phototest wavelengths. These measurements were made using a radiometer with 
a1 mm2 aperture. The axis were defined such: 
X 
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Figure 3A2.3 Beam uniformity of monchromator 3 
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Chapter 4 
Protection of photosensitive skin from optical radiation 
hazards 
Management of photosensitive skin disorders with commercial 
cosmetic products 
Summary 
In this chapter the management of photosensitive skin conditions is discussed. 
Sunscreens are often used in conjunction with other therapies but conventional 
sunscreens provide little or no protection for patients sensitive to visible 
wavelengths 1"2. Sunscreens developed in Dundee are available which afford 
protection into longer wavelengths 3. However, these creams are not readily available 
and are thick and difficult to apply and wear and thus are not aesthetically acceptable. 
Results from an investigation of commercial makeup products for topical 
photoprotection are presented. 
1. Introduction 
The photosensitive patient can face a severely restricted quality of life if their adverse 
response to light is not suppressed. Photosensitive skin disorders can have a major 
impact on the lives of sufferers. Patients that suffer pain, itch and potentially life 
threatening allergic reaction to light 2 must avoid being exposed to the wavelengths of 
light that cause their skin to flare. Furthermore, the psychological impact of 
reddened, scaly skin, particularly on the face, is often severe, in some cases leading to 
suicide. 
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Without the correct diagnosis and treatment, patients may be limited to only being 
able to venture outside on dull, cloudy days. The most sensitive patients can, 
effectively, be left housebound by their condition. 
Thus, the first step in treating a patient with a suspected photosensitivity skin disorder 
is for the patient to be referred to a specialist centre for diagnostic phototesting 4 (see 
chapter 5). This testing assists in diagnosis by defining the wavelengths that are 
involved in the reaction so that appropriate means of management can then be 
considered 5"8. There are several strategies that are used to manage symptoms and 
allow photosensitive patients to lead as close to a normal life as possible. 
ment Means of manage 
The management of photosensitive skin is a clinical challenge that often necessitates 
the use of a variety of approaches simultaneously. Light avoidance is unparalleled as 
a means of control of photosensitivity and is often the first line of defence 9,10 
However, complete avoidance is often not possible due to the wavelengths involved 
in the sensitivity and the patient's lifestyle. Nevertheless, some changes in lifestyle 
can be sufficient to prevent an adverse response from occurring in some patients. 
For example, a patient with mild UVB sensitivity only will have no problems in the 
winter months but will have to avoid exposure to summer sun between the hours of 11 
am and 3 pm. A patient such as this would most likely be able to cope by using high 
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factor conventional sunscreen and/or staying in doors on bright days, or covering up 
as much exposed skin as possible with clothing 5,9 
The protection afforded by clothing is affected by several factors: fabric porosity, 
type, colour, wear, wetness, weight and thickness 11. Dark coloured, close weave 
fabrics are best for UV protection 5. Clothing labelled with an ultraviolet protection 
factor (UPF) are available from shops, particularly those specialising in outdoor 
pursuit equipment. Adding UV absorbers to the fabric can also further enhance the 
UPF 11. There is a standardised in vitro method of testing textiles for their UPF 
protection and independent testing laboratories have been shown to give good 
agreement in their results 12. However, one study found that the in vivo UPF is 
significantly different to the in vitro UPF provided by clothes 13. Thus, patients 
sensitive to UVB should choose clothes with a high UPF or dark coloured, close 
weave clothes in order to maximise the protection offered by their garments. 
UVA sensitivity is more complicated to manage by means of avoidance. UVA is 
transmitted through glass where UVB is not 914, including car windscreens which 
transmit from 380 nm 15 so patients may have to protect themselves when indoors. 
5 UV attenuating museum film can be applied to car, house and office windows 1.16 
Clothing and avoidance are also important for these patients although they will have 
to be more fastidious than those sensitive solely to UVB. 
Sunscreens formulated to include UVA protection may have a role to play for these 
patients as well. Sunscreen products have two modes of action: chemical and 
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physical 2. Chemical sunscreens absorb specific absorption bands, and hence a 
combination of chemical filters are often used in commercial preparations u" 
Physical sunscreens (sometimes marketed as `sunbiocks') are opaque formulations 
that contain inorganic powders that scatter or reflect UVR 2. Titanium dioxide is a 
white pigment that is used in cosmetics, paint, textiles and ceramics and is commonly 
used in physical sunscreens, as is zinc oxide 17 and iron oxide 18 The protection 
afforded by these particles depends on the size of the particles and the thickness of the 
layer applied to the skin 2,19,20 Both these powders are white and a thick coating is 
required for adequate protection 17. This can lead to patients rejecting these 
preparations on aesthetic grounds 1. A study has shown that patients apply more 
chemical sunscreen than physical sunscreen (Z/3rds of the amount of chemical 
sunscreen) due to cosmetic unacceptability of physical blocks 21. Reducing the size of 
the particles can enhance the cosmetic acceptability of physical sunscreens; microfine 
particles are now commonplace 2.17,22 in broad-spectrum sunscreens. 
Over the counter sunscreens are generally formulated to protect against the erythemal 
effects of UVB and the ageing effects of UVA. In order to give consumers a guide as 
to the level of protection provided by a sunscreen, the sun protection factor (SPF) 
exists. SPF testing is stringent, with standards requiring in vivo testing 23,24. However 
the SPF of a product gives no indication of the UVA protection afforded 25-28 because 
the SPF is calculated using the erythemal action spectrum and is therefore an 
indication of bum protection only. As UVB has the greatest potential for causing 
erythema, sunscreen users are able to spend a much longer period of time in the sun 
without experiencing discomfort, and hence receive a large dose of UVA 29 
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Concerns regarding chronic exposure to UVA 25,30,31 have meant that during the past 
decade many sunscreens that include UVA filters have become available 27 but there 
is no standardised method of defining the amount of UVA protection afforded by a 
sunscreen product 
2'25'27,32 
Furthermore, some sunscreens that claim UVA protection can have transmittances 
that vary from 6% to 52% 33. In particular, one product that claimed a UVA 
protection factor of 15 was found in practice to be only factor 4 34. Instead of 
claiming an UVA protection factor, Boots the Chemist, the UK's largest producer of 
sunscreens, have developed their own star rating system for UVA protection, based on 
the ratio of the total absorption of a product in the UVA to that in the UVB 35. A five 
star product has a UVA ratio 0.8 >_ 0.8 and would therefore be suitable for most UVA 
sensitive patients. 
Of further concern for the UVA sensitive patient seeking to identify a suitable product 
is the fact that chemical sunscreens have been reported to cause allergic contact and 
photoallergic contact dermatitis 2.36. There is one reported case of a CAD patient 
being hospitalised after severe exacerbation of his condition by exposure to a 
sunscreen 10. This is a rare case and there are several reports in the literature of the 
scale of this problem. Two of the most comprehensive studies analyse 15 years' of 
data. Darvay et al analysed the patch test results of 2715 patients with suspected 
photosensitivity. 49 patients had a total of 75 positive allergic contact reactions, 51 of 
which were due to UV filters. 80 photoallergy reactions in 62 patients (34 with 
underlying photodermatosis) were recorded, of which UV filters accounted for 52 
positives. Darvay et al conclude that allergic contact and photoallergic contact 
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reactions to UV filters are rare but patients with photodermatoses are at increased risk 
of developing photoallergy 37. The other comprehensive study analysed the patch and 
photopatch test results of 402 patients with suspected photosensitivity. 80 (47 with 
underlying photodermatosis) patients had allergic contact and/or photoallergic contact 
dermatitis to one or more UV absorbers 38. It is notable that the Darvay et al study 
report lower rates of skin sensitisation to UV filters but this may be due to the fact 
that they included a larger sample in their survey and also may reflect different 
criteria for patch and photopatch testing patients. Other studies confirm that 
sunscreens may be problematic for photosensitive patients 39,40 
Chemical sunscreens were thought to be absorbed into the stratum corneum where 
there are no viable cells, however, the fact that sunscreens can cause phototoxic and 
photoallergic reactions indicates that some sunscreen must be absorbed into viable 
skin where UV filters may react with endogenous proteins and lead to 
photosensitisation 2. Hence, physical sunscreens are considered a better option for 
photosensitive patients 36 but titanium dioxide and zinc oxide both have absorption 
bands in the UV (up to 400 nm) and may therefore act like chemical sunscreens. 
However, there are no reports in the literature of sensitisation to physical sunscreens . 
2 
Of further concern are problems of photodegradation of UV filters. Irradiation of UV 
filters with UVA in lab conditions has been shown to lead to break down of such 
filters 41 and thus becoming unstable 42. This can lead to reduction of protection by 
50-60%3 1 and emphasises the need for sunscreens to be reapplied frequently 9. 
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Thus, the problems encountered by those photosensitive to UVA are in identifying a 
suitably protective product and one that will not lead to sensitisation of the skin. 
Photosensitive patients with defined UVA sensitivity should choose a sunscreen 
recommended by their treatment centre or a broad spectrum physical sunscreen, 
taking care to avoid any ingredients to which they know they are sensitised 10. 
Visible light sensitivity is the most complicated to manage because exposure to 
visible wavelengths is practically unavoidable. Clothes and wide brimmed hats are 
commonly used. Figure 4.1 shows a solar urticaria patient who attends the 
photobiology unit regularly. His typical dress for leaving the house even on a 
winter's day includes the hat and gloves pictured. 
Figure 4.1: A severely sensitive solar urticaria patient in typical photoprotective 
clothing. Picture used with permission. 
t1 ý. 
t: ý 
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There are numerous publications suggesting topical photoprotection as a management 
strategy for photosensitive skin 1.2.5,9,18,30,43,44® Chemical sunscreens are of limited 
therapeutic benefit for the photosensitive patient whose action spectrum extends into 
the visible spectrum 2. Zinc oxide and titanium dioxide are used in conjunction with 
UV filters to enhance protective effect above 370 nm 17. Certainly these powders 
reflect mainly the longer WA wavelengths 30 and the addition of pigments to 
sunscreens improves the protection in the visible region 22. There are few products 
except opaque, physical sunscreens that offer sufficient protection into the visible 
spectrum for visible sensitive patients 18 
Moseley et al developed a range of creams, known as the Dundee creams that offer 
significant protection against visible light 3. These creams contain titanium dioxide as 
well as other, coloured pigments. Using an action spectrum of a patient with PCT, a 
protection factor was defined for these creams for photosensitive patients, and they 
are routinely prescribed for management of photodermatoses as 
Dundee creams are available in three colours: beige, coral and coffee colours. In 
order to achieve an acceptable skin match for a person with skin type 1-2, some coral 
must be mixed with beige. This elaborate process is time consuming and awkward 
for patients and it is difficult to achieve the desired colour. Patients describe these 
creams as being uncomfortable to wear as a thick layer must be applied, which means 
that the skin can become very hot as pores are blocked and the creams often rub off 
onto and stain clothes. 
0 Suggest SPF factor 20 
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Chemical means of protection 
In severe cases of photosensitivity, the protective measures detailed above may not be 
sufficient or suitable to reduce a patient's reaction to a tolerable level. In these cases 
more drastic measures are necessary. Perhaps the least extreme medical intervention 
is the use of oral beta-carotene as a photoprotective agent in EPP 5,46 Apart from 
giving the skin a slightly orange colouration, there are no other known side effects 
from this therapy and it is therefore the treatment of choice in EPP 47. Beta-carotene 
does not work by absorbing UVR as it does not reach sufficient concentration in the 
skin, therefore it must work by an alternative mechanism in EPP patients 
48. This 
therapy has been tried for other photosensitive skin disorders but often no clinical 
improvement is seen 45,49, probably due to the fact that it., does not work as a 
photoprotective agent 48. As a last resort EPP patients can be given allogenic bone 
marrow transplants but this carries with it a high associated mortality 
45 
Topical corticosteroids can reduce redness and inflammation of the skin. They can 
also be given orally if symptoms require greater control 
50. However, systemic 
corticosteroids if taken over a long period of time, have associated side effects, such 
as osteoporosis and increased susceptibility to opportunistic infections 
51 so short 
courses of treatment are often preferred. 
UV treatment is common for managing solar urticaria 52 and PLE 2.5, either used on its 
own or in combination with oral steroids 
53. There are two modalities to this 
treatment: desensitisation and immunosuppression. Patients sensitive to summer sun 
can have a course of UVB phototherapy in spring to desensitise the skin through what 
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is thought to be a combination of immune suppression, tanning and thickening of the 
stratum corneum 54. PLE has been successfully treated with TLOI or PUVA in the 
springtime ss. Those with a well-defined, limited action spectrum can be treated with 
wavelengths that do not provoke their adverse skin response as an 
immunosuppressive treatment. UV phototherapy does carry with it an increased risk 
of skin cancer and so treatments should be limited to therapeutic necessity -s9 
Clinical experience has provided evidence of further chemical ways to manage 
photosensitivity. Low doses of anti malarial drugs can also be used to control PLE 2'36 
and antihistamines are effective in suppressing the urticarial response in many patients 
2 with solar urticaria , a3 
An even more rigorous means of management is immunosuppressive therapy. This is 
reserved for patients whose conditions are severely restrictive. Cyclosporine 49,60 and 
azathioprine are used as immunosuppressive agents in dermatology 51. The latter has 
been available since the 1960's and is used for a variety of dermatologic conditions 61 
Immunosuppressive therapy is commonly used to manage debilitating CAD 2,10,50,62,63 
and PLE when the symptoms are disabling 2,36. However, this type of therapy carries 
with it the risk of potentially serious long and short-term side effects, including renal 
toxicity, gastrointestinal disturbances causing nausea and vomiting, increased 
susceptibility to opportunistic infection, neurological disturbances, reproductive 
toxicity and, most worryingly an increased risk of malignancy 51. 
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It is clear that medical interventions (except beta-carotene) carry with them side 
effects that should be avoided. One of the cheapest, most effective, and certainly the 
least intrusive means of management is topical photoprotection S. 
Cosmetics forphotoprotection 
The success of the Dundee creams but their limitations in aesthetic terms prompted 
this investigation to evaluate other products that could potentially be used for 
photoprotection into the visible spectrum. It has been proposed that coloured 
compounds are good at absorbing long wavelengths 
9. Commercial, cosmetic 
preparations (foundations) are used by many women to cover blemishes and 
imperfections of their skin. These products are pigmented so could afford 
photoprotection. 
Foundations are widely available, vary in price and there are also a wide range of 
colours and consistencies available. Thus, if these products afford protection in the 
visible part of the spectrum, patients would have a much wider choice of products to 
protect themselves. The availability of many different colours means that patients 
could match their skin tone with relative ease and without any requirement for 
blending colours. Many foundations are hypoallergenic and also contain sunscreens. 
Of particular interest is the possibility of using makeup products for photoprotection 
of patients photosensitised due to PDT drugs. PDT is a treatment modality that is 
growing in popularity and patients that take systemic photosensitising drugs can be 
rendered photosensitive for up to 3 months, which, in cases where the treatment is 
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only palliative can be a factor that prevents the patient from consenting to the 
treatment. If patients were required to wear makeup after their treatment but could 
otherwise lead a normal life then more people may consent to the treatment. 
To my knowledge there are no published studies of the transmission spectra of 
commercial makeup products into the visible part of the spectrum. Hawk et al 
included Covermark` in their study and found it to have low transmittance up to 650 
nm (13% maximum for all shades tested and wavelengths stated) in 1982 but 
suggested that men would not tolerate wearing this makeup 1. Cosmetic science has 
advanced during the years since that study and the fashion is now for makeups to 
cover imperfections but look natural. It is likely that men would be more comfortable 
using these modem products than Hawk et al suggested they were using Covermark. 
Testing photoprotective efficacy 
There are two ways to test the protection offered by a product 
(1) in vivo testing whereby the protection is defined as the ratio of the dose 
required to cause minimal erythema on protected skin to the dose required to 
cause minimal erythema on unprotected skin 
and 
(2) in vitro analysis of the transmittance of the product. 
A commercial preparation 
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From in vitro measurements, the SPF is defined as 
400 
ZE, S2LJ% 
SPF = 4290 00 
E2S, TýO2 
290 
Equation 4.1 
Where E,, is the CIE erythemal effectiveness for radiation at wavelength X 64 
S, % is the solar spectral irradiance at wavelength ? 
Tx is the transmission of the sample at wavelength ?. 
This expression was used by Moseley et a! 
3 to create a photosensitivity protection 
factor from in vitro tests by replacing E,. with the action spectrum of a patient with 
PCT. This action spectrum was calculated from the results of this patient's 
phototesting at 305 ±5 nm and seven other wavelengths f 30 nm. This calculation 
assumes that monochromator phototesting can be used to derive an action spectrum 
for a photosensitive patient. This, however, is not necessarily the case, as shown by 
work carried out in relation to the current investigation and discussed in chapter 5. 
SPFs quoted on commercially available sunscreens are based on in vivo tests. 
There have been many studies conducted looking at the correlation between in vivo 
and in vitro protection factors derived from sunscreens 65. Although it is generally 
accepted that in vivo testing is the most reliable way to determine the protection that a 
sunscreen will give, it is not always possible. Normal skin is not sensitive to visible 
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light so irradiation times would be impractically long for evaluating the protection 
available at these wavelengths. A similar problem has been encountered when testing 
products for their UVA protection 
34 and explains why there is no standardised test for 
UVA protection. Several studies suggest alternative means of deriving protection 
factors for UVA and broad-spectrum sunscreens. Volunteers have been given 
psoralen in order to test the protection factor of UVA sunscreens, however, this 
method produces a false action spectrum in the patient and the results are therefore 
biased towards UVA 22. Photosensitive patients have been suggested as models for in 
vivo testing 22,28 but these results would depend on the action spectrum of the 
individual. This varies between and within diseases. 
Thus in vitro testing is the best available option and also removes the need to expose 
volunteers to acute exposures of high dose UV 32 and any uncertainty due to errors 
associated with MED determination 66. A substrate then has to be chosen for the 
product. Previous groups have used human epidermis from recently deceased 
cadavers 19, or excess tissue removed during breast reduction surgery 26. Results have 
been shown to be reliable when comparing in vivo and in vitro SPF results from 
human skin 26. However, this substrate was not available to the department and would 
have proved costly to acquire. 
Artificial substrates are available. Diffey 67 first used Transpore tape as a substrate. 
This is a surgical tape and has dimples in the surface, thought to mimic the 
topography of human skin. This tape is cheap and readily available and good 
agreement can be gained when comparing in vivo and in vitro results 35. Some studies 
criticise the use of Transpore tape due to differences between in vivo and in vitro 
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results, for example, Kelley et al were unable to match in vitro SPF's with those 
quoted (from in vivo testing) on some sunscreen products 65. They were, however, 
using an UVB radiometer to measure the transmittance of the samples. This can give 
large errors due to the specific wavelength sensitivity of the the radiometer 68. 
Labsphere have developed a glycerine based substrate known as `Vitro Skin' that 
mimics the surface tension, pH and topography of human skin. Studies suggest that 
the correlation between in vivo tested SPF's and in vitro tested SPF's are `excellent' 
when testing is done with Vitro Skin 
35. This substrate, however is expensive and 
complicated to use as it requires hydration prior to use and can only be kept for a 
limited amount of time once hydrated. 
2. Methods and Materials 
During April 2004, twenty-five makeup samples were collected from high street 
stores in Dundee. Different colours were collected in order to evaluate the difference 
that pigmentation would make to the protection offered. High end (expensive) 
samples were chosen, as well as cheaper products. Table 1 lists the manufacturers, 
names and prices of the products per 100 ml. Dundee creams supplied by Tayside 
Pharmaceuticals were also included as they are the only products currently available 
for photosensitive patients. 
The method used was first described by Diffey and Robson in 1989 67. Samples were 
spread onto the non-adhesive side of Transpore surgical tape at a concentration of 2 
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µlcm"2 *using a gloved finger. The samples were then allowed 20 minutes to dry 
69 
and used within 2 hours of preparation. 
Eight measurements were made per 48 cm2 (one spread) of sample by attaching jigs 
consisting of 8 circular apertures of 1 cm diameter to the adhesive side of the tape. 
Blank controls were made similarly but with no sample spread on the tape. The eight 
samples from each spread were irradiated in turn with xenon are lamp, filtered for 
infrared radiation (IR) with an HZSO4 CuSO, solution and a cut on filter (GG375, 
Schott). The GG375 filter was used to exclude any possible photodegredation effects 
due to the large amount of UVR present in an unfiltered Xe lamp. This is similar to 
the approach used by Gröf et al 70. 
The lamp was allowed at least 15 minutes to stabilise prior to commencing 
measurements. The transmission through the samples was recorded with a Bentham 
DM150 double grating spectroradiometer. A flat plate quartz diffuser made up the 
input optics for the monochromator. The detector is a cooled (-20°C +/- 1 °) 
photomultiplier tube. The transmission of the sample at X nm is the ratio of the 
photocurrent at wavelength ? on blank tape to the equivalent photocurrent with a 
product applied to the tape. The photocurrent was recorded at 5 nm intervals from 
400 to 800 nm. Two independent measurements were carried out for each product 
tested. 
' The volume of sunscreen needed to fill all the grooves responsible for primary epidermal surface lines 
on l cm2 of skin surface, to produce a featureless surface, is 1-2 µl "6. 
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3. Results 
Table 4.1 shows the makeup names, maker, cost per 100 ml and transmission at 100 
nm steps across the range shown. The transmissions at 630 and 652 nm are also 
shown, as these are wavelengths routinely used in PDT. Patients are sensitised to 
these wavelengths using either systemic or topical preparations before treatment with 
the appropriate source in PDT. 
The mean coefficient of variance (CoV) of each sample is also shown to indicate the 
errors inherent in the measurement technique. The CoV is the ratio of the standard 
deviation of the measurements to the mean measurement at each wavelength interval 
and can be regarded as the uncertainty in each measurement. The mean variances for 
all samples range from 6.9% to 22.6%, mean 12.9%, median 11.7%. These errors 
represent the problems inherent in this method of in vitro testing. Spreading the 
samples on the tape has been shown to be tester specific 65 and also non-uniform 71, 
hence accounting for the variances in the samples. Two independent spreads and 8 
measurements of each spread were done in order to reduce the error but at the 
prescribed concentration it was difficult to achieve an even spread with some samples. 
Hence, in practice, greater amounts of the makeup samples may be used in order to 
achieve even coverage on the skin. This would result in greater protection being 
afforded to the user. 
Figures 4.2 to 4.8 show the makeups from the different manufacturers represented in 
graphical form. Error bars are shown on selected samples at 20 nm intervals in order 
to preserve the clarity of the information represented on the graphs. It is clear that 
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within one brand and type of makeup, the darker colours do offer more protection, but 
colour is not a good indicator of the protection offered. Table 2 lists all the products 
average transmission over the 400nm range tested, in ascending order. Max Factor 
Seamless Makeup in sand is the best protector across the wavelength range and would 
be the best choice for protection of photosensitive individuals who require protection 
over the full range of wavelengths. It is notable that this makeup and Clinique Dewy 
smooth anti ageing makeup in neutral and Max Factor Seamless makeup in porcelain 
offer more protection than Dundee coffee, which is the most protective Dundee 
cream. 
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Table 4.2: Average transmittances of makeups 400-800 nm, in ascending order 
Average 
Transmittance 
Manufacturer/Brand Makeup name Colour 
13% Max Factor Seamless makeup Sand 
16% Clini ue 
Dewy smooth anti ageing 
makeup Neutral 
17% Max Factor Seamless makeup Porcelain 
17% Tayside Pharmaceuticals Dundee cream Coffee 
18% Max Factor Lasting Performance Natural bronze 
18% Marks and Spencer 
Autograph flawless finish 
foundation Coffee 
18% Clini ue Superbalanced makeup Ivory 03 
18% Marks and Spencer 
Enhance line minimising 
foundation Honey 
19% Clarins Extra-Firming Foundation Shell 05 
19% Max Factor Hyper smooth makeup Natural 
20% Max Factor Lasting Performance 102 Pastelle 
22% Clarins Hydrating liquid foundation Soft Ivory 03 
23% Clinique Superbalanced makeup Toffee 
24% Marks and Spencer Flawless finish foundation Ivory 
25% Clini ue Superfit makeup Beige 
25% Clini ue Superfit makeu Petal 
25% NO Radiant glow foundation Beige 07 
26% Elizabeth Arden 
Flawless Finish Bare Perfection 
Makeup Mocha 1141 
28% Elizabeth Arden 
Flawless finish radiant moisture 
makeup Cameo 24 
28% NO Radiant low foundation Almond 10 
28% Tayside Pharmaceuticals Dundee cream Pink 
32% Clarins True Radiance Foundation Tender gold 10 
32% Marks and Spencer Flawless complex foundation Honey 
32% Marks and Spencer Sheer finish foundation Ivory 
33% Clarins Multi-Matte Foundation 
Tender ivory 
07 
34% Tayside Pharmaceuticals Dundee cream Bei e 
35% Marks and Spencer Flawless complex foundation Sand 
35% Marks and Spencer Sheer finish foundation Coffee 
5. Discussion 
These results suggest that commercial makeup products would be appropriate for the 
protection of photosensitive or photosensitised individuals from light in the 
wavelength range 400 to 800 nm. Other studies looking at products other than 
sunscreens for photoprotection of photosensitive individuals, have focussed on 
camouflage creams used to disguise birthmarks and scars etc. Schwartz et al found 
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that in vivo testing of dark cover creams showed that they were 3.4 times better than 
sunscreens and therefore suitable for photosensitive skin 72. Kaye et al assessed in 
vitro and in vivo (using an animal model) sunscreens as well as `Covermark' from 
350-800 nm and found that products containing absorbing pigment outperform 
sunscreens in the visible range 18. In another similar study in 1982, Hawk et al found 
that Covermark and reflectant titanium dioxide creams provided good protection up to 
600nm. However they criticised such products suggesting they were `unpopular' with 
patients and indicated that men would not tolerate wearing makeup 1. Such 
camouflage creams are complicated to apply, as they have to be set with a powder and 
removed with special cleansers. Many women use commercial makeups and the 
range of products available increases their aesthetic appeal. When given a choice, it is 
highly likely that these commercial makeups would be favoured over camouflage 
creams and may also be marketed as suitable for both sexes. Furthermore, the amount 
of protection offered is significant and may have implications for the 
photodermatology industry. 
Attempts were made to contact the manufacturers of the products tested in order to 
invite them to participate in the research. These attempts were in the form of phone 
calls to try and speak to research and development teams and failing this (in all cases), 
letters were written to each of the UK offices of the companies. Unfortunately there 
was no response from any of the companies. Although the market would be small, 
some of these products could be marketed to photosensitive patients. It is not 
suggested, however, that makeup should replace sunscreen for protection of UV 
sensitive and normal individuals from summer sun. 
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As a method of topical photoprotection, sunscreens are problematic. It has been 
shown that people use too little sunscreen to provide the protection suggested by an 
SPF 9,73 and do not apply products thickly enough 74. Commonly people apply only '/4 
to '/3 rd of the amount of product used in SPF testing, which results in only '/3 rd of the 
stated SPF being afforded, hence the `rule of nines' as used to assess bum injuries has 
been suggested as a dosing method for sunscreens 75 but this has not been accepted or 
publicised by the sunscreen industry. 
Sunscreens have also been shown to be potential photosenisisers but furthermore, 
concerns have been raised regarding the absorption of sunscreen constituents into the 
body. The safety of any new sunscreen is important and penetration should be low to 
negligible 76. However, conflicting work showed that substantial amounts of 
oxybenzone are absorbed into systemic circulation whilst little is known of its chronic 
toxicity 44. Benzophenone-3 also passes through the skin in significant amounts 77 . In 
individuals that are photosensitive, and while the causes of conditions such as CAD, 
PLE and SU are unknown (see chapter 3), exposure to potentially photolabile 
chemicals should be avoided. Physical barriers are therefore a much safer method of 
protecting sensitive individuals, as has already been suggested by Wolf and Oumeish 
36, and also provide a barrier to reduce exposure to allergens 5. 
This work could be criticised due to the choice of substrate for testing. Given the 
close agreement between Vitro Skin tests and in vivo SPF's 35, Vitro Skin would have 
been the preferred substrate for this work. However, the method used to test 
transmittance, using the spectroradiometer, meant that the exposure time was 
considerably longer than the short, pulsed exposure that vitro skin was designed for 
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(using commercial transmittance analyser) and the Vitro Skin desiccated when 
exposed to the duration and intensity of radiation that the xenon arc lamp provided. 
Therefore we could not use Vitro Skin and chose Transpore as a next best option and 
also to keep the testing across the spectrum and range consistent. 
Further investigation of the effect of these makeups in vivo is indicated. Testing could 
be carried out on photosensitive volunteers. This kind of study would be a huge 
undertaking and could be facilitated by investment from interested cosmetic 
companies. 
6. Conclusions 
This is the first work that has analysed the protective efficacy of cosmetic products for 
the protection of photosensitive or photosensitised individuals. The results 
demonstrate that some commercial products offer substantial protection against light 
in the wavelength range 400 to 800 nm and rival the Dundee creams which, to date, 
have been the only products recommended for photosensitive individuals. Colour is 
not a good indicator of the protection offered and only products that have been tested 
in work such as this should be recommended. 
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Chapter 5 
Measurement of cosmetic tanning sources and evaluation of 
hazards and existing regulations 
Spectral irradiance of sunbeds, associated hazards and 
assessment against existing legislation 
Summary 
During a one-year period from April 2004 to April 2005 all the premises that offer 
sunbeds in Dundee and Perthshire were visited. Spectral measurements were made of 
all the sunbeds and the lengths of sessions available were noted. The results reveal 
that many sunbeds are stronger than previous studies have suggested, and can have a 
carcinogenic potential of up to 2.7 times that of southern European sun. Accounting 
for all the lengths of sessions, the maximum recommended dose for one year (15 kJm' 
2 erythemally effective radiation) could be exceeded in less than 20 sessions on some 
sunbeds. Most of the units surveyed do not fit into any criteria as given in the British 
Standard (BS EN 60335-2-27: 1997, Safety of. Household and similar electrical 
appliances, Part 2. Particular requirements, Section 2.27 Skin exposure to ultraviolet 
and infrared radiation). A Health and Safety questionnaire was also completed and 
revealed that there are many shortcomings in the way that tanning salons are operated. 
Questionnaires left for users to fill and return anonymously also indicated that many 
people are not well informed as to the risks of using sunbeds. 
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1. Introduction 
Throughout the 20`x' century there has been a fashion for tanned skin. This is a 
considerable change from the penchant for a `pale and interesting' appearance, which 
was vogue in the 19th century. The industrial revolution, the discovery of the 
therapeutic effects of light, the move of the working classes into indoor jobs, and the 
suntans which provided evidence of foreign travel have all contributed to the change 
in trend of preferred skin colours. An excellent review of the history of the suntan is 
contained in a paper by Randle, written in 1997, including the famous comment by 
Coco Chanel: 'the 1929 girl must be tanned' 2. 
Hand in hand with this fashion has been the increased incidence of skin cancer 
noticed by epidemiologists since the 1970's. Specifically, melanoma incidences have 
increased 3-7% in fair skinned populations in recent decades, with a mortality rate of 
20%3 . Rates of non-melanoma skin cancer are also on the 
increase 4. Fears over a 
skin cancer epidemic are further compounded by reports on the thinning of the ozone 
layer and the potential for increased solar radiation fluences 5-8. The current cost of 
care of patients with skin cancer in the UK is estimated at £34 million per year 9. 
High profile sun awareness campaigns, such as the Australian `slip, slop, slap' 
campaign, launched in the last 25 years, have attempted to change attitudes towards 
UV exposure 2'10. In the southern hemisphere, changes in attitudes have been reported 
11,12 but for many people the suntan is still desirable 13 as it represents a positive 
stereotype 14 Furthermore, increased knowledge of risks does not necessarily 
12 correspond to a change in behaviour . 13.15 In the UK the picture is similar. Health 
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promotion campaigns have increased awareness, but the proportion of people 
developing sunburn has not reduced 16 
It is not surprising that along with a desire for tanned skin would go ways to achieve a 
tan. Hence the ubiquitous presence of the sunbed*- a way to get and keep a tan even 
in winter at northerly latitudes. The use of artificial tanning devices has been 
increasing since the 1960's, 17 when broad spectrum lamps were used to irradiate skin 
for short periods of time. The last twenty years has seen the advent of the fluorescent 
UVA lamp, the rise and rise of the tanning salon 18 and the development of high 
intensity lamps to make sunbed use more viable for the busy professional. 
Exposure to UVA radiation used in cosmetic sunbeds to tan the skin is, however, not 
without its inherent dangers. The acute risks are erythema and photokeratitis if 
suitable goggles are not worn. There are also reports of phototoxic skin reactions 
initiated by the use of WA sunbeds 19. Ingestion of a large amount of celery led to 
severe phototoxic burn and hospitalisation in one woman 20 and three tanners 
choosing to use psoralen to speed up the tanning process were reported to have 
developed extensive skin burns 21. Pseudoporphyria is another phenomenon caused 
by sunbed use 22, where patients develop PCT like symptoms but have normal red 
blood cell, urine and stool porphyrin levels 23. While phototoxic reactions are rare, 
operators and users of tanning beds should be aware of the potential for such reactions 
and guard against them. Of particular importance is the potential of many prescribed 
19 drugs to be photoactive 
' Please note that unless stated, `sunbed' refers generically to both lie down and stand and tan booths 
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Chronic effects of sunbed use are premature skin ageing, increased skin fragility 19, 
cataract and skin cancer 4. For many years there has been confusion surrounding the 
issue of whether or not exposure to UVA radiation causes the potentially fatal form of 
skin cancer, malignant melanoma. 
In the 1980's and 90's there were studies published in reputable journals that cited 
sunbed use as a risk factor for melanoma. Swerdlow et al reported a significantly 
increased risk (2.9) of melanoma in Scottish sunbed users 24. One Canadian 25 and 
one Swedish 26 study also found sunbed use to be a risk factor for melanoma although 
they quote lower risk factors than the Scottish study. 
Conversely, studies were also published citing no meaningful association between 
melanoma risk and exposure to sunbeds 27,28 There are several reasons for the 
confusion evident in the literature. 
Poor experimental design is one reason. In 1998, De Guire and Rhiands 17 analysed 
the findings of fifteen case-controlled studies of malignant melanoma during the 
period 1979 to 1996. They found only four of these studies to be methodologically 
sound. Any occurrence of melanoma is always confounded by sun exposure 4, thus 
any epidemiological evaluation of melanoma occurrence due to sunbed use must be 
rigorous. 
Of those studies that are credible there are further issues to consider. Most 
importantly is the long latent period for the development of melanoma 29", so that 
Study published in 2004 but conducted between 1991 and 1999 
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subjects may go on to develop melanoma in the future. Hence there have been 
inconclusive studies published 30. Many melanoma patients do not admit to having 
used sunbeds when giving their medical history 31, so complicating the picture. Also, 
users of older devices may have used devices that emitted UVC radiation 32 and thus 
their melanoma may not be attributable to exposure to UVA radiation. Thus the 
qualified medical opinion has been that it is reasonable to assume that exposure to 
high doses of UVA radiation are dangerous but this was not a firmly established fact 
at the end of the millennium 33 
More recent publications are less equivocal regarding the potential for UVA to cause 
skin cancer. Bataille et al 34 assess the risk of melanoma for fair skinned individuals 
in the UK using sunbeds as increased by a factor of 2.66 but state that due to the lag 
time between exposure and development of melanoma, they may have underestimated 
the risk. Diffey 35 estimates that 100 melanoma deaths in the UK each year are 
attributable to sunbed use. 
There is a widely held belief, perpetuated by the tanning industry, that tanning on a 
sunbed is safer than tanning in the sun 19,29,36,37 In fact, it has been found that 
sunbeds produce similar levels of radiation to that produced by the midday 
Mediterranean sun so that sunbeds are in fact no safer than the sun but can increase 
yearly doses dramatically if used regularly 38. Furthermore, there is biological 
evidence to support the hypothesis 39 of the carcinogenic potential of UVA radiation 
40-46 
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Within the context of environmental technology, this chapter would not be complete 
without a sociological consideration of why people feel compelled to use sunbeds 
despite warnings from the medical profession that their use is inadvisable for cosmetic 
tanning 47,48. A review of the psychological literature reveals that the main 
motivations are to look and feel better 15. Boldeman et al report that the sunbed use is 
twice as common in young females as males 49 and young, professional women are 
50 thought to be the most likely to use sunbeds ,5 
Although motivations for using sunbeds are complex and multiple, commonly cited 
reasons for the use of sunbeds are to promote feelings of well-being and attractiveness 
and can be correlated with physical activity in many cases, possibly due to the 
placement of many sunbeds in gymnasiums 
36. In a survey of adolescents, it was 
found that boys achieving the highest scores for self worth are most likely to use 
sunbeds and girls with the lowest scores for self worth are also most likely to use 
sunbeds 52,53 Adolescents are also more likely to use sunbeds if their friends or 
parents do and access is rarely regulated 54. Use among school children in Scotland 
has also been reported; a Lanarkshire survey of 1405 children aged 8-11 revealed that 
7% had used sunbed 55. This worrying finding suggests that parents believe UVR to 
be beneficial. 
There is also a reported link between sunbed use and smoking behaviour 36,56,57 
possibly due to a similar cognitive dissonance between UVR effects and tanning as 
there is between smoking and lung cancer 58.59. There is a reported `unrealistic 
optimism' among sunbed users 13 and one American study found that 10% of users 
so would still choose to use sunbeds even if they were proven to cause skin cancer 
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The consequence of the high level of demand for sunbed use is an increase in the 
possibility of negative physiological effects from exposure to UVA radiation. This 
idea was backed up by a study in which frequent sunbed users were offered a blind 
choice between identical sunbeds, one of which had only visible light tubes in and the 
other that was UVA. 95% of the elected exposures were on the UVA bed therefore 
suggesting that there is some reinforcing stimulus from UV exposure 60. Some 
research groups have investigated the presence of beta-endorphins after UV exposure 
as a possible mechanism for the sense of well being reported after sunbed use. This 
particular mechanism has been rejected 61,62 Further work to elucidate the 
mechanism of the positive psychological benefit would be useful in developing our 
understanding of the popularity of the use of sunbeds and the `addiction' that some 
users seem to develop 22. Armed with this knowledge the medical profession could 
then suggest alternative and less risky ways of creating this benefit. 
Legislation 
Given the potential risks of sunbed use it would be reasonable to assume that the use 
of these units was legislated. However, there is no specific legislation covering the 
provision of artificial tanning units. Premises offering sunbeds fall under the 
legislative capability of the Health and Safety at Work etc Act 1974 63. The Health 
and Safety Executive has produced a set of guidelines for users and operators of 
" sunbeds . 
Within these guidelines operators are told that, according to the relevant legislation, 
they need to: 
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" assess the health and safety risks caused by work activity; including 
o risks to employees and customers from exposure to UV radiation; and 
o take measures to reduce these risks as far as reasonable practicable. 
Hence, a risk assessment for employee exposure to radiation from sunbeds is required 
under the Health and Safety at Work etc Act 1974. 
The rest of the HSE document is only guidance. It suggests that operators should 
  Be able to say what the nature and extent of UV hazards are 
  Know the health risks associated with use of UV tanning equipment 
" Know the extent to which exposure to UV can vary according to the lamps 
that are in the equipment 
  Have information from supplier on extent and magnitude of the UV hazard 
  Advise customers on duration of and periods between each session 
  Limit total sessions per year (recommend 20) 
a Screen beds to prevent accidental exposure 
  Record the date and length of each customer's session 
Sunbed operators may choose to ignore the HSE guidelines but following them 
certainly ensures compliance with the law 64 
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Survey of premises offering cosmetic tanning in East Scotland 
During the period from April 2004 to April 2005,50 premises that offer sunbeds for 
cosmetic tanning in the local authority areas of Dundee City Council and Perth and 
Kinross Council were visited. 
In Dundee, council health and safety officers compiled a list of those premises with 
sunbeds from local knowledge and records. There were 24 premises in total, 3 of 
which are operated by the local authority. Authorisation was given to enter the 
premises with an inspector under section 20(2)(C)(i) of the Health and Safety at Work 
Act, 1974. Hence, these visits were accompanied by one of the environmental health 
officers from Dundee City Council. All but one of the commercial premises were 
successfully visited, this final one being closed on each occasion a visit was made. At 
the same time as the measurements were made, the officers inspected each business to 
check that Health and Safety guidelines were being followed. 
In Perthshire, all local authority facilities have removed their sunbeds so only 
commercial premises were visited. In the first place an environmental health officer 
wrote to the 11 businesses that were known to offer sunbeds. The letter alerted the 
owners to the survey and informed them that they would be visited and also offered to 
discuss any worries prior to the visit. A further 10 premises were identified because 
they formed part of the survey undertaken by Moseley et al in 1997 65. A further 7 
businesses offering sunbed use were identified by telephoning all the hairdressers, 
beauty salons, sports centres and gyms listed in the Yellow Pages. One tanning 
parlour of which the council were aware, had closed down between the letter being 
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written and the proposed visit. Hence a total of 27 businesses were contacted and 
visited; all co-operated fully by making the units available, switching them on and 
answering questions asked. 
Aims of the surv ey 
  Find out exactly how many sunbeds were available and in what type of 
premises. 
  Undertake on site spectral measurements at all premises to determine strength 
of radiation from beds. 
  Determine whether sunbeds used commercially operate within parameters in 
existing British Standard (BS EN 60335-2-27: 1997, Safety of Household and 
similar electrical appliances, Part 2. Particular requirements, Section 2.27 Skin 
exposure to ultraviolet and infrared radiation) classifications, hereafter referred 
to as BS. 
  Find out whether the premises were compliant with the relevant legislation. 
  Compare the results from with the similar survey (of Perthshire) undertaken in 
1997. 
  Determine the number of sessions in each premises, on each bed, that would 
be within recommended safe limits for one year. 
  Estimate carcinogenic risk from the sunbeds. 
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2. Methods and Materials 
Instrument and calibration 
On site measurements were made using a Sola-Scope handheld UV 
spectroradiometer, Type SC-MP-A, from 4D Controls (Redruth, UK). This model of 
instrument was evaluated for measurements of phototherapy units (see chapter 2), 
however, the instrument purchased and used for this survey had a response that did 
not match the instrument evaluated (the purchased instrument was less sensitive), 
hence the calibration method with the 1 kW FEL lamp could not be used. Instead, the 
instrument was calibrated at the Photobiology's United Kingdom Accreditation 
Society's (UKAS) accredited laboratory, using a recognised protocol. This method 
employs fluorescent UVA tubes with a similar spectral distribution to those that are 
found in cosmetic sunbeds. Simultaneous measurements were made at 20 cm from 
the UVA tubes with the Sola Scope and a bench based double grating 
spectroradiometer (Bentham DM150). The spectroradiometer has a calibration factor 
derived from measurement of a tungsten halogen lamp calibrated at NPL. A 
calibration factor at each half nanometre was derived for the Sola Scope thus: 
Eý, A CFý = Esst 
where 
CF is the correction factor at wavelength ? 
ion 5.1 
EB is the irradiance as measured by the Bentham spectroradiometer at wavelength ?, 
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Egg is the irradiance as measured by the Sola Scope at wavelength X 
Hence multiplication of any measurement taken by the Sola Scope by the correction 
factor gives the irradiance as would have been measured by the Bentham. 
A second calibration was made in a similar fashion using a metal halide source for use 
with those sunbeds that have metal halide lamps either as their main tanning source or 
as facial lamps. This is also a UKAS accredited measurement. 
The calibration of the Bentham is traceable to the National Physical Laboratory 
(Teddington, UK) and has an expanded uncertainty at the 95% confidence level, of 
5.89 % in UVA. The transfer standard for UVA radiation measurements is a 100W, 
frosted glass, tungsten lamp. Thus an estimated uncertainty of +/_ 15% can be 
attributed to the Sola Scope measurements. This is in agreement with similar studies 
of similar measurements 66 . 
Figure 5.1: Sola Scope SC-MP-A 
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Measurement of sunbeds 
All sunbeds were allowed 3 minutes to warm up prior to commencing measurements. 
Lie down units 
Lie down units are those traditionally thought of as `sunbeds' where the user lies flat 
on the bottom of the bed and lowers a canopy down over the their body (see figure 
5.2). There were also beds that feature irradiation just from above the user, so that 
they have to turn over half way through their session. In each case measurements 
were made using the positions shown in figure 5.3. These positions represent the 
theoretical maximum spread of a person on the bed. For the base of the bed (where 
the customer lies) the Sola Scope was placed in a stand (built by request by Medical 
Physics research and development), pointing downwards (see figure 5.4). This was 
designed to exclude reflected light originating from the canopy. Spectra were then 
recorded at positions 1-9 across the base of the bed. For measurements of the canopy, 
the bottom of the bed was covered with black cloth and the meter was placed in its 
stand at a fixed height of 20 cm from the base of the bed (see figure 5.5). If the bed 
had separate metal halide facial tanning lamps then spectra were recorded for 
positions 1-9 and IF-3F. If there were not separate metal halide facial tanning lamps, 
then positions 1-9 were adjusted accordingly to gather average readings for the whole 
bed. 
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Figure 5.2: A lie down tanning unit 
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Figure 5.3: Measurement positions 
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Figure 5.4: Measurement of the bottom of a lie down unit 
Figure 5.5: Measurement of the top of a lie down unit 
R 
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Stand up booths 
In order to account for the absorbance and reflection of a customer in a stand up unit 
such as those depicted in figure 5.6, these measurements were made in an occupied 
booth. A white coat was worn during each measurement in order to negate any 
effects of different clothes altering the absorbance and reflection of the UV light. 
Four spectra were recorded at knee, waist and shoulder height, (front, left, right and 
back) with the detector as flush as possible to the surface of the skin, see figure 5.7. 
Thus the average output of these units was determined from 12 measurements. 
Figure 5.6: Stand up units 
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Figure 5.7: Measurement positions 67 
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Treatment of data 
An average irradiance was determined for each bed by taking the mean of the spectral 
measurements. In order to assess whether or not each of the booths falls within the 
limits in the BS, the erythemal action spectrum, see figure 5.8 was then applied to the 
mean spectral data. This weighting function takes account of the relative 
effectiveness of different wavelengths to induce erythema. The UVB (280-320 nm) 
and UVA (320-400 nm) effective irradiances were calculated in order to classify the 
sunbeds (see table 5.1). 
Figure 5.8: Erythemal action spectrum 68 
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Table 5.1: BS classification of sunbeds, based on erythemal effective irradiance 
UV Type Effective Irradiance (WM- 2) 
Use 
appliance 250 < X_< 320 nm 320 <), S 400 nm 
1 <0.0005 >_ 0.15 Supervised` 
2 0.0005 to 0.15 >_ 0.15 Supervised 
3 < 0.15 < 0.15 Unskilled 
4 >_ 0.15 < 0.15 Following medical advice 
Effective irradiances were also used to calculate the dose received during each session 
offered in each salon visited. For example, if tanning parlour X offered 5 and 10 
minute sessions on sunbeds that had a total effective irradiance of 0.5 Wm 2, the dose 
that would be received in a5 minute session would be: 
5 mins x 60 seconds = 300 seconds 
0.5 Wm 2x 300 secs = 150 Jm 2 
and a 10 minute session would give 300 Jm'2 
The BS recommends that the first tanning session should not exceed 100 Jm'2 
effective dose, which is equal to I standard erythema dose (SED) 69. Thus salon X 
Supervised by `appropriately trained persons' in `tanning salons, beauty parlours and similar 
premises'. 
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offers 2 sessions, 1.5 SED's and 3 SED's, both greater than the recommended first 
session time. 
The BS also recommends that not more than 15 kJm 2 effective dose is received in one 
year. By calculating each dose during each session and calculating the total number 
of sessions required to reach this top dose, this can be compared to the British 
Photodermatology Group recommendation of 20 sessions per year 70, and the sunbed 
association's 60 sessions per year can be tested. Whether or not blanket advice such 
as this is sensible, given that the dose received in one `session' can vary hugely 
according to the strength of the lamp and the length of the session, will be shown 
from this data. 
In order to compare the results from this survey with a similar one done in 1997, the 
SCUP-h action spectrum 71 was also applied to the data. This action spectrum is an 
approximation of the human carcinogenesis action spectrum. It is derived from data 
recorded from hairless mice and corrected for differences in epidermal transmission. 
It provides a relative measure of the cancer risk from different sources. 
This action spectrum is quite different to the erythemal action spectrum as it peaks at 
299.5 nm and not 280 nm. However, as the sources under consideration are primarily 
UVA, the effective irradiances as calculated with these two action spectra are likely to 
be similar. 
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Figure 5.9: SCUP-h action spectrum '1 
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Health and Safety assessment of premises 
A checklist was drawn up (table 5.2) in order to assess how the businesses operated in 
terms of their compliance with health and safety legislation. The list also covered 
how non-legislated aspects such as customer record keeping and enforcement of 
guidelines on total number of sessions in a year were approached. 
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Table 5.2: Inspection points 
Inspection area Assessment point 
bed safety 
stop buttons Equipment 
adequate screening 
hygiene 
i k cleaning ng eep House fire precautions 
tanning lotions offered 
i ili eye protection provided t es Fac washing facilities 
ventilation 
B i no clients per week ness us member of sunbed association 
staff training 
knowledge of hazards 
Safety 1st aid kit 
risk assessment for employees 
equipment maintenance and records 
medical 
skin type 
Customer advice eye protection 
display advice 
take away advice 
records kept 
length of session 
Records and controls time between sessions 
total sessions per year 
recording of accidents 
User survey 
A number of questionnaires were left at each premises together with pre paid 
envelopes for their return. Table 5.3 shows the questions in the questionnaire. 
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Table 5.3: User questionnaire 
Age : Sex: male / female Date: 
How many years have you been using sunbeds? 
How old were you when you first used a sunbed? 
During the last 12 months have you only used one premises for sunbeds? 
If no, how many other premises do you visit? 
How many sunbed sessions have you had in the last twelve months? (e. g. 20 
half-hour sessions, approximately 4 hours a week every week etc. ) 
How often have you used a sunbed in previous years? 
Which type of bed(s) do you use (upright, tan fast, etc)? 
Why do you use sunbeds? 
Do you think there are health risks from sunbed use, if so what are they? 
What information were you given prior to using the sunbed? 
Do you wear goggles when using the sunbed? 
3. Results 
Premises types and numbers 
There were a total of 50 premises in Dundee and Perthshire, with 133 sunbeds. 
The premises were classified according to the main type of business they were 
involved in (figure 5.10) and then each given an unique identifying number. Many of 
the gyms were part of a hotel leisure complex, but they have been classified as gyms 
because most of the sunbed users were people living locally who had become gym 
members. Hence, those premises classified as holiday resorts were those where the 
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use of the sunbed was restricted solely to use by holidaymakers and not by regular 
users. Perthshire and Dundee had similar businesses in each area except there were 
holiday resorts and beauty salons in Perthshire, and the supermarket with a tanning 
area located at the back of the shop in Dundee (see figure 5.11). 
Figure 5.10: Types and numbers of premises 
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Figure 5.11: Supermarket in Dundee with a sunbed area in the back. The area 
had not had a ventilation system installed and was partitioned with room 
dividers that did not reach the ceiling 
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The numbers of beds in each premises varied from a maximum of 12 in one video 
shop to the median of 1 unit in 58 % of places (figure 7.12). 73% of the tanning units 
were lie-down units (beds) and the remaining 27% were stand-up units (booths). 
Stand up units are generally marketed as being `fast-tan' units and were found in 1997 
to be the strongest units of the two types 65 
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Figure 5.12: Numbers of beds in each premises 
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Perthshire 
In Perthshire there were 27 premises, with 47 tanning units (22 beds and 25 booths). 
This is a decrease in the number of premises, but an increase in the number of sunbeds 
since the survey was done in 1997 
65 when there were 32 premises and 41 sunbeds. In 
fact, the rise in the number of sunbeds is due to the opening of two new tanning salons 
and a video shop in Perth City centre offering multiple units. 
There were 16 premises that had not changed numbers or availability of beds since 
1997. The 5 local authority leisure centres had removed their units and 6 businesses 
video 
shops 
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had either closed or dispensed with their sunbeds. Hence, 11 premises were visited 
for the first time, only 4 of which were known to the council and a further 7 that were 
identified by telephone enquiry. 
Dundee 
There are 23 premises in Dundee with 86 beds (43 beds and 43 booths). Three of 
these are local authority sports centres (gyms), one of which has 6 sunbeds and the 
others which offer just one. 
Spectral Measurements 
Calibration of the instrument 
Separate calibrations were made for fluorescent UVA tubes and for metal halide 
lamps, see figure 5.13. The mean calibration factor for UVA fluorescent tubes was 
1.11, indicating an underestimation of the irradiance from the instrument if its in built 
calibration were used. In particular, the peak at 312 nm had to be corrected by a 
factor of 3. 
Conversely, with the metal halide lamp, the average correction factor was 0.4 
indicating that the Sola Scope overestimated the irradiance from this lamp using its in 
built calibration factor. The relative differences in these calibration factors are likely 
to be due to the different spectral distributions of these lamps, creating different stray 
light profiles, which are then calibrated out. 
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Figure 5.13: Sola Scope calibration factors 
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Measurements of the sunbeds 
The erythemal effective UVB, UVA and total irradiances from each sunbed were 
calculated. Total values ranged between 0.02 Wm -2 and 0.93 Wm-2 , with a mean 
value of 0.41 Wm-2 . 
Comparing the magnitude of the UVB portion with the UVA 
portion allows the beds to be classified with the BS system. Figure 5.14a and 5.14b 
shows the total effective irradiances of each bed. Only 22 (17%) of the units were 
type 3 and therefore suitable for unskilled use. Two of these were stand up booths, 
the rest were lie down units including the 8 local authority run beds. 
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One lie down sunbed was classifiable as a type 3 as the UVB irradiance was below 
0.15 Wm'2 effective and the UVA was greater than 0.15 WM -2 effective irradiance. 
This bed, however, was in the unmanned salon and therefore there was no supervision 
available. 
All the other beds and booths contained more than 0.15 Wm'2 effective UVB 
irradiance, and more than 0.15 WM -2 effective UVA irradiance. Therefore 83% of 
sunbeds in Dundee and Perthshire do not fit into a category under the existing BS i. e. 
their strength is greater than that recommended for medical use only. 
Figure 5.14a: Total erythemal effective irradiance of each sunbed surveyed 
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Figure 5.14b: Total erythemal effective irradiance of each sunbed surveyed 
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Midday Southern European summer sun, by contrast, has an erythemal effective 
irradiance of 0.27 Wm -2 65. With a mean value of 0.41 Wm 2, the average sunbed is 
now significantly stronger than the midday southern European sun. This presents a 
different picture to the one found by Moseley et al in 1997 65, when the median 
exposure from the highest output sunbeds were comparable with Mediterranean sun. 
This shows that new-style sunbeds are in use with higher UVB output and greater 
carcinogenic potential. 
Figures 5.15a to 5.15d show the does in SEDs that would be received during each 
available session length in each premises, on each sunbed. For example, premises 16 
(see figure 5.15a) has 6 beds on which one can have a 20 minute session only. The 
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numbers of SEDs received during this time are between 1 and 1.27 SEDs. Premises 
40 (see figure 5.15a) offers one bed and sessions of 4,6,9,12,15 and 20 minutes. If 
a4 minute session were chosen the SEDs received would be 0.46 and if a 20 minute 
session were chosen then the total dose received would be 2.29. Please note that for 
clarity these figures have different scales and legends. 
The BS states that the first exposure should not exceed 1 SED. Only 47 % of the beds 
had sessions available that were less than 1 SED. 
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The number of sessions that it would take to reach the maximum recommended dose 
of 15 Um 2 was calculated for each available session on each bed. The number of 
SEDs received in one session ranged from 0.2 to 8.7 SEDs, with a median value of 
2.1 SEDs. Hence, it would take only 17 sessions at 8.7 SED per session, to reach 15 
kJni-2 and 651 sessions at 0.2 SED per session. The median value was 71 sessions to 
reach the maximum recommended exposure. 
The carcinogenic potential assessed of the sunbeds was assessed using the SCUP-h 
action spectrum. The SCUP-h effective irradiance for the beds varied between 0.02 
and 1.58 Wm 2, with a median value of 0.69 Wm 2. Southern European sun has 
previously been quoted as having a SCUP-h effective irradiance of 0.595 WM-2 65 
Hence, using the median value, sunbeds can be said to be 1.15 times as carcinogenic 
as southern European sun. This value is similar to that calculated in 1997 65 
The maximum SCUP-h weighted irradiance came from a stand up tanning unit and is 
substantially higher than that found by Moseley et al. In that study the maximum 
SCUP-h weighted irradiance from a stand up unit was 0.682 WM -2 which led Moseley 
to the conclusion that stand up units had equivalent irradiance (a factor of 1.1) to 
southern European sun. Using the strongest unit as measured in the current work, the 
factor for comparison was 2.7 times as carcinogenic as southern European sun. This 
unit was a standard stand up unit with 160 W tubes in place and plastic diffusers in 
place. This is a significant and worrying rise in the SCUP-h weighted irradiance and 
suggests that the sunbeds in common use today have the potential to significantly 
increase the cancer risk for users. 
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Health and Safety assessment 
In Dundee council health and safety officers carried out the assessments. Thus, 
through their authority, they were able to request proof of equipment and customer 
records etc. During the visits to Perth, there was no council health and safety officer 
attendance. Therefore it was only possible to ask questions during visits rather than 
requesting supporting information. Thus, the results from Perth may be biased in the 
business' favour. 
One sunbed was found to be unsafe as the plastic covers to the tubes had large gaps in 
them and also had sharp edges. The screening of the units was found to be adequate 
in all but two commercial premises. In one case the bed was in the changing room of 
a gym and was not screened at all. In the other case a stand up unit was not screened 
and there was no circuit break to turn off the tubes if the door were opened. In two of 
the Dundee City Council premises there was inadequate screening of the sunbeds. In 
one these cases the sunbed booths were curtained but the curtaining did not reach the 
floor therefore providing questionable levels of privacy as well as protection (see 
figure 5.16). 
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Figure 5.16: Inadequate screening in one of Dundee City Council's premises 
Most of the beds were clean and fluid was provided for cleaning of the units prior to 
use. Concerns were raised regarding the type of cleaning fluid provided and whether 
it should be the customer's responsibility to clean the beds. Although there is no legal 
requirement for ventilation, those premises that are said to have inadequate ventilation 
are those where the cubicle/room became very hot while taking measurements. These 
were judged to be a risk for people fainting. Of concern were the premises that kept 
no records of their customers' exposure. Of those that did keep a record the majority 
reported that they would not enforce the yearly limit by turning clients away but 
would only advise on safe limits. 
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Table 5.4: Health and safety assessment results 
Inspection 
area 
Assessment point 
Number of premises where no 
evidence/inadequate/not offered 
bed safe I 
stop buttons 0 Equipment 
adequate screenin 4 
hygiene 4 
i cleaning 
6 
ng Housekeep fire precautions 0 
tanning lotions offered 31 
eye protection provided 3 Facilities 
washing facilities 17' 
ventilation 21 
Business 
no clients per week 
Minimum 2 
Mean 100 
Maximum 700 
member of sunbed 
association 
40 
staff training 15 
knowledge of hazards 43 
1st aid kit 9 
Safety risk assessment for 
employees 
46 
equipment maintenance and 
records 
33 relied on contractors 
medical 17 
skin type 24 Customer 
d i eye protection 13 a v ce display advice 18 
take away advice 46 
records kept 29 
lengtli of session 35 
Records and 
l 
time between sessions 
6 recommend 48h 
21 recommend 24h contro s 
total sessions per year 
6 enforce no more than 20 
10 enforce not more than 60 
recording of accidents 7 
User Survey 
There were 87 respondents to the survey, 14 of which were male and 73 female. It is 
likely that these respondents were the more concerned users, as completion of the 
questionnaires was voluntary. The majority of users were in the 25-34 years age 
* The provision of a hand basin was not counted as washing facilities; only a full shower unit was 
regarded as adequate. 
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bracket (see figure 5.17). 51 % of the respondents started using sunbeds when aged 
between 16 and 24. Four people admitted to having first used a sunbed at age 15. 
45% of the respondents had used sunbeds for between 0 and 3 years. 22% reported 
using sunbeds for more than 10 years. 
Figure 5.17: Ages of users 
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31 % of respondents admitted to visiting more than one tanning salon. Of these 41 % 
used only two other salons and 28 % used more than 2 salons. 39% of users admitted 
to between 0 and 19 sessions in the last year, 35% said they had had 20-49 sessions, 
and 26% had had 50 plus sessions in the last year. One user admitted to 3 hours of 
use per week on one particular bed in one particular salon. Her effective exposure 
amounts to 3 UM -2 in one week! 
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Figure 5.18: Reasons for using sunbeds 
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Among the 15 people who cited medical reasons for using sunbeds, the specific 
conditions quoted were acne, eczema, psoriasis, avoidance of prickly heat and relief 
from general and arthritis pain. One respondent said that she had completed a course 
of UV treatment in the photobiology unit and was continuing to use sunbeds as a self 
prescribed follow on from that treatment. 
13 people stated that they thought there were no risks from using sunbeds. The rest 
stated that there were risks. The main risks cited are indicated in figure 5.19. In the 
category of damaged eyes, one person mentioned blindness and two mentioned 
eyesores. Basal cell carcinoma and melanoma were each mentioned by one person in 
the `skin cancer' group. Sunburn was mentioned by two people in the `bad for your 
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skin' category and changing moles by three people. The comment about moles was 
not, however, linked to a statement about skin cancer in any of the three respondents. 
Figure 5.19: Perceived risks from using sunbeds 
age eyes 
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These figures indicate that the messages about the potential risks of sunbeds are not 
filtering through to the end users. Even where respondents recalled having received a 
fill consultation before using the beds, they had only noted the risks linking sunbed 
use with ageing of the skin. Furthermore, 13 people said that they believe there to be 
no risks from sunbeds and 23 people admitted that they never wear goggles when 
using sunbeds. Seven said they only sometimes use goggles. 
A worrying 7% of the users reported that they had had no advice at all before using 
the sunbed and only 7% had actually been advised to wear goggles. 12 people had 
only had literature to read regarding recommended usage and potential risks, seven of 
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who reported only posters to look at. Only one person reported a full consultation and 
only one had been recommended the correct 48 hours between sessions. Of the skin 
care advice, two people were recommended to use tanning accelerators, such as those 
sold in 62% of the businesses and one was advised to moisturise afterwards. 
Figure 5.20: Advice given to users 
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4. Discussion 
This survey represented an opportunity to put the instrumentation tested (see chapter 
2) to the test. It was disappointing to discover that the instrument purchased for this 
work did not perform as expected. Thus the calibration performed was the same type 
as that used for radiometers. A separate calibration is required for each source 
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measured, which defeats the purpose and the benefit of this instrument to some extent. 
However, the instrument did allow spectral measurements to be made which is not 
always practical with a traditional spectroradiometer. 
This work has revealed that a large number of the commercial properties offering 
cosmetic suntanning are not adhering to the guidelines stipulated by the HSE. This is 
similar to the picture that has been reported previously for Scotland 38. This finding 
also agrees with those of other surveys assessing the competence of operators to run 
tanning salons. One Canadian study pronounced only 19% fit to run a tanning salon 
72 and a Polish survey reported staff knowledge to be poor 73. 
Many of the premises visited in this survey simply asked clients to sign a disclaimer 
in the thought that this would prevent the clients from taking legal action in the event 
of any adverse effects. This is a risky strategy in today's litigious climate. Operators 
would be on safer ground if they were to subscribe to current medical opinion and 
published guidelines. Indeed, those properties that did not have a risk assessment for 
employee exposure are in direct contravention of the Health and Safety at Work Act. 
Of interest during this survey were the different approaches used by the two local 
authorities. Dundee City Council were much more proactive in their regulation of the 
premises and a number of findings of concern were followed up in the proceeding 
months. These included poor ventilation in a number of premises, the screening 
issues in the Council's premises and the ventilation and exposure control issues in the 
Supermarket. Perthshire Council were not able to dedicate as many man-hours to the 
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survey, and indeed they were unaware of the presence of sunbeds in a number of the 
properties visited. 
This lack of standardised approach is surely replicated across the UK. Perth has one 
unmanned salon where users pay a machine for a token to use the sunbeds. This 
premises was effectively unregulated. There was a questionnaire on the machine 
selling tokens that asked for skin type and then would sell an exposure time 
appropriately but without the presence of someone, there is nothing to stop minors 
using the facilities. Conversation with the owner of the salon revealed that he had 
encountered many different levels of intervention and demands from local authorities 
all over the UK in which he had established sunbed centres. 
The positive benefit that many users experience from using sunbeds 14,51, and the self 
treatment of skin conditions such as psoriasis 74 reveals a perceived need in our 
society for sunbeds. Although the epidemiological literature reveals that sunbeds are 
a risk factor for the development of melanoma, the prohibition of sunbeds is not 
justified given the societal impacts of other risky activities, which are not banned, i. e. 
smoking and drinking alcohol 35 
The question of licensing of sunbeds had recently been proposed in the Scottish 
Parliament. This idea should be encouraged and the current survey adds weight to the 
argument that these centres should be more closely regulated. 
In 1996 Norris suggested that due to the risk of cancer from sunbeds, councils should 
remove them from their facilities 75. This step has certainly pushed users from 
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regulated centres to the commercial sector 65 where the risks may be greater 76. Thus 
the wisdom of this decision may be questioned. However, Dundee City Council were 
still operating sunbeds that did comply with the BS but the facilities were found to be 
lacking in terms of their screening, ventilation and by not providing sessions that were 
less than 1 SED. Hence, the removal of sunbeds from council premises and licensing 
of the commercial sector would ensure that all facilities operated in the safest possible 
manner. 
Licensing would further protect children. During the course of this study there was an 
incident in Stirling, reported in the media 77, where two eleven year old boys had 
visited an unmanned salon in the city centre and had a total of half an hour each. The 
boys were later hospitalised when they developed severe bums. A Lanarkshire survey 
revealed that 21 children aged 8-11 (survey total 1405) had used a sunbed in a 
commercial premises 55. In fact a number of respondents to this current user survey 
reported using sunbeds in commercial premises before they were 16. It is believed 
that risks of exposure are greater in children 78 and suggestions have been made, by 
researchers, that legislation should be introduced to protect children 79. None of the 
facilities visited admitted to allowing children to use their sunbeds, but during the 
course of this research, operators were observed allowing young girls access to the 
units without checking identification. 
Hand in hand with a more closely regulated approach should be better education. A 
suntan is often perceived as healthy 51 and attractive 52,80 where in fact any suntan is a 
sign of skin damage 19. This message is not disseminating to the population that are 
regular users of sunbeds and their use is still regarded as safer than exposure to the 
5.47 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
sun 36. What is required is a more effective form of education 51°81 The UV index 
was introduced to the UK in April 1999 37 but there is little understanding among the 
general population of what this actually means. Although there are campaigns run to 
educate the public, the complexities of the situation regarding the effects of UVB 
compared to UVA, the use of sunscreens and the safety of sunbeds should be taught in 
schools in order to allow people to make informed choices. Intensive intervention 
programmes have been shown to reduce children's exposure in Australia 82. 
There is widespread use of sunbeds to create a tan prior to going on holiday, as was 
reported in this study. Users often believe that this `base tan' will protect them from 
erythema, however, a UVA induced tan actually provides little protection 18,83 and in 
fact this strategy can significantly increase the total UV dose received as less sun 
protection is then used 78,84. The mean carcinogenic potential of modern sunbeds in 
Eastern Scotland has been shown by this study to be similar to that of southern 
European Sun and in some cases, much greater. 
The majority of sunbeds do not comply with the British and European standard for 
cosmetic tanning units, hence the standard should be reviewed and updated in order to 
account for the strength of sunbeds that are now available. The BS stipulates that 
there should be sessions available that do not provide more that 1 SED for first time 
users. Less than half of the sunbeds surveyed had sessions available that were below 
this limit. In 1991 the International Non-Ionizing Radiation Committee of the 
International Radiation Protection Association suggested that manufacturers should 
`supply a schedule of exposure and recommended maximum exposure durations 
based on the emission characteristics of the sunbed' 49 . Given that two thirds of 
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premises offering sunbeds already have their beds maintained under contract, it would 
make sense to enforce this guideline, thereby placing the onus on the manufacturer to 
appreciate and understand the spectral profile, ageing characteristics and strength of 
the sunbeds they supply. Advice could then be given on the length of sessions that 
constitutes 1 SED and operators could then comply. 
Considering that a `weak' bed can give as large a dose as a strong one, if the tanning 
session is long enough, it is clear that the magnitude of the spectral irradiance is 
somewhat irrelevant as what is important is the dose received during one session. 
Thus it is the length of the session offered that affects the total number of sessions that 
should be taken in one year. In this study all the available lengths of sessions on all 
the sunbeds in two local authority areas have been calculated. 
The exposure limit of 15 kJm'2 erythemally weighted radiation per year suggested in 
the BS is based on the comparative risk of cancer for indoor and outdoor workers. 
This dose is half of the estimated difference between these two groups and is said to 
be a reasonable contribution for an indoor worker 85. However, it is known that 
people who use sunbeds are also likely to engage in sun seeking behavior 52; therefore 
they may exceed the dose for indoor workers by choosing holidays in equatorial 
regions etc. Once again, education is indicated in order to continue to inform 
individuals of their individual risk. The alternative approach would be to revise the 
exposure limit data on the basis of a person's likelihood to expose themselves to 
excessive natural sunlight, and reduce the yearly dose limit from sunbeds accordingly. 
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However, this approach is futile where there are no real controls over the number of 
sessions that people engage in during the course of one year. If manufacturers 
provided schedules then the cumulative dose could be monitored but this would be a 
complicated system to enforce particularly where sunbed operators appear to be 
unskilled. The fact that people use more than one salon would also allow them to 
greatly increase the total yearly dose received. 
At present the best estimate that exists of the total safe yearly dose is the 15 UM -2 
erythemally weighted dose and according to the precautionary principle, given that 
the strongest sunbeds will allow a user to reach this dose in under 20 sessions, the 
BPG guidelines are justified. The Sunbed Association should also be pressurised into 
changing its advice from 60 sessions in one year to 20. 
5. Conclusions 
" The aims of this study were fulfilled. In Perthshire it was found that there 
were more premises offering sunbeds than those that the council were aware 
of. If local authorities are not aware of the existence of the sunbeds then they 
are unable to inspect the premises in order to fulfil their regulatory duties. 
" Most modem sunbeds are stronger than they were reported to be in 1997 and 
they also have spectral distributions and strengths such that they do not fit into 
any category in the existing British Standard. 
" Most premises do not fulfil the criteria set out by the HSE in terms of 
recommended operator guidelines. 
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9 In order to safeguard the public, the existing recommended maximum number 
of sessions in one year (20) is concurrent with the precautionary principle. 
5.51 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
References 
1. Holubar, K. & Schmidt, C. Sun and Skin: An Individual Risk., pp. 32-38 (Verlag der 
Österreichischen Arztekammer, Vienna, 1994). 
2. Randle, H. W. Suntanning: Differences in perceptions throughout history. Mayo 
Clinic Proceedings 72,461-466 (1997). 
3. Marks, R. Epidemiology of melanoma. Clin. Exp. Dermatol. 25,459-463 (2000). 
4. Swerdlow, A. J. Epidemiology of chronic disease risks in relation to ultraviolet 
radiation exposure. Radial. Prot. Dosim. 91,19-23 (2000). 
5. Molina M& Rowland, F. Stratospheric sink for chlorofluoromethanes: chlorine atom- 
catalysed destruction of ozone. Nature 249,810-812 (1974). 
6. Coldiron, B. M. Thinning of the Ozone-Layer - Facts and Consequences. J. Am. 
Acad. Dermatol. 27,653-662 (1992). 
7. Kerr, J. B. & McElroy, C. T. Evidence for large upward trends of ultraviolet-B 
radiation linked to ozone depletion. Science 262,1032-1034 (1993). 
8. Moseley, H. & MacKie, R. M. Ultraviolet B radiation was increased at ground level 
in Scotland during a period of ozone depletion. Br. J Dermatol. 137,101-102 (1997). 
9. NHS Executive. Burdens of Disease. 1996. London, HMSO. 
10. Ferrini, R. L., Perlman, M. & Hill, L. American College of Preventive Medicine 
practice policy statement: Skin protection from ultraviolet light exposure. Am. J. 
Prev. Med. 14,83-86 (1998). 
11. Livingston, P. M., White, V. M., Ugoni, A. M. & Borland, R. Knowledge, attitudes 
and self-care practices related to sun protection among secondary students in 
Australia. Health Ed. Res. 16,269-278 (2001). 
12. Richards, R., Mcgee, R. & Knight, R. G. Sun protection practices, knowledge and 
attitudes to tans among New Zealand adolescents, 1991-1997. New Zealand Medical 
Journal 114,229-231 (2001). 
13. Lowe, J. B. et al. Sun-safe behaviour among secondary school students in Australia. 
Health Ed. Res. 15,271-281 (2000). 
14. Hanley, J. M., Pierce, J. L. & Gayton, W. F. Positive attitudes towards suntanning and 
reported tendency to engage in lifestyle behaviors that increase risk of skin cancer. 
Psychological Reports 79,417-418 (1996). 
15. Arthey, S. & Clarke, V. A. Suntanning and Sun Protection -A Review of the 
Psychological Literature. Social Science & Medicine 40,265-274 (1995). 
16. Stott, M. A. Tanning and sunburn: knowledge, attitudes and behaviour of people in 
Great Britain. Journal of Public Health Medicine 21,377-384 (1999). 
17. De Guire, L. & Rhainds, M. Are sunbeds and sunlamps associated with the 
development of skin cancer? A review of the epidemiologic evidence. J. Invest. 
Dermatol. 110,11 (1998). 
5.52 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
18. Diffey, B. L. & Farr, P. M. Tanning with UVB or UVA - An appraisal of risks. J. 
Photoch. Photobio. B. 8,219-223 (1991). 
19. Hawk, J. L. M. Sunbeds. Radiat. Prot. Dosim. 91,143-145 (2000). 
20. Ljunggren, B. Severe phototoxic bum following celery ingestion. Arch. Dermatol. 
126,1334-1336 (1990). 
21. Nettelblad, H., Vahlqvist, C., Krysander, L. & Sjoberg, F. Psoralens used for 
cosmetic sun tanning: An unusual cause of extensive bum injury. Burns 22,633-635 
(1996). 
22. Thomsen, K. Solarium pseudoporphyria. Photodermatology 6,61-62 (1989). 
23. Pohfitzpatrick, M. B. & Ellis, D. L. Porphyrialike bullous dermatosis after chronic 
intense tanning bed and or sunlight exposure. Arch. Dermatol. 125,1236-1238 
(1989). 
24. Swerdlow, A. J. et al. Fluorescent lights, ultraviolet lamps and risk of cutaneous 
melanoma. Brit. Med J. 297,647-650 (1988). 
25. Walter, S. D. et al. The association of cutaneous malignant melanoma with the use of 
sunbeds and sunlamps. Am. J Epidemiol. 131,232-243 (1990). 
26. Westerdahl, J. et al. Use of sunbeds or sunlamps and malignant melanoma in southern 
Sweden. Am. J. Epidemiol. 140,691-699 (1994). 
27. Osterlind, A., Tucker, M. A., Stone, B. J. & Jensen, O. M. The Danish case-control 
study of cutaneous malignant melanoma. 11. Importance of UV-light exposure. Int. J. 
Cancer. 42,319-324 (1988). 
28. MacKie, R. M., Freudenberger, T. & Aitchison, T. C. Personal risk-factor chart for 
cutaneous melanoma. Lancet 2,487-490 (1989). 
29. Autier, P. Perspectives in melanoma prevention: the case of sunbeds. Eur. J. Cancer 
Care 40,2367-2376 (2004). 
30. de Vries, E. & Coebergh, J. W. Cutaneous malignant melanoma in Europe. Eur. J. 
Cancer Care 40,2355-2366 (2004). 
31. Gallagher, R. P., Spinelli, J. J. & Lee, T. K. Tanning beds, sunlamps, and risk of 
cutaneous malignant melanoma. Cancer Epidemiology Biomarkers & Prevention 14, 
562-566 (2005). 
32. Chen, Y. T. et al. Sunlamp use and the risk of cutaneous malignant melanoma: a 
population-based case-control study in Connecticut, USA. Int. J. Epidemiol. 27,758- 
765 (1998). 
33. Autier, P. et al. Cutaneous malignant melanoma and exposure to sunlamps or 
sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. 
EORTC Melanoma Cooperative Group. Int. J. Cancer. 58,809-813 (1994). 
34. Bataille, V., Winnett, A., Sasieni, P., Bishop, J. A. N. & Cuzick, J. Exposure to the 
sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. 
Eur. J. Cancer Care 40,429-435 (2004). 
5.53 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
35. Diffey, B. L. A quantitative estimate of melanoma mortality from ultraviolet A 
sunbed use in the UK. Br. J. Dermatol. 149,578-581 (2003). 
36. Amir, Z., Wright, A., Kernohan, E. E. & Hart, G. Attitudes, beliefs and behaviour 
regarding the use of sunbeds amongst healthcare workers in Bradford. Eur. J. Cancer 
Care (Engl. ) 9,76-79 (2000). 
37. Coldiron, B. M. The UV index: A weather report for skin. Clin. Dermatol. 16,441- 
446 (1998). 
38. Moseley, H., Davidson, M. & Ferguson, J. Sunbeds and the need to know. Br. J. 
Dermatol. 141,589-590 (1999). 
39. Moan, J., Dahlback, A. & Setlow, R. B. Epidemiological support for an hypothesis 
for melanoma induction indicating a role for UVA radiation. Photochem. Photobiol. 
70,243-247 (1999). 
40. Setlow, R. B., Grist, E., Thompson, K. & Woodhead, A. D. Wavelengths effective in 
the induction of malignant melanoma. P. Natl. Acad. Sci. USA 90,6666-6667 (1993). 
41. Gallagher, R. P. & Elwood, J. M. Epidemiological Aspects of Cutaneous Malignant 
Melanoma. Gallagher, R. P. & Elwood, J. M. (eds. ), pp. 15-66 (Kluwer Academic 
Publishers, Boston, 1994). 
42. Diffey, B. L., Healy, E., Thody, A. J. & Rees, J. L. Melanin, melanocytes, and 
melanoma. Lancet 346,1713 (1995). 
43. Autier, P. et al. Melanoma and use of sunscreens- An EORTC case-control study in 
Germany, Belgium and France. Int. J. Cancer. 61,749-755 (1995). 
44. Westerdahl, J., Olsson, H., Mäsbäck, A., Ingvar, C. & Jonsson, N. Is the use of 
sunscreens a risk factor for malignant melanoma? Melanoma Res. 5,59-65 (1995). 
45. McGregor, J. M. & Young, A. R. Sunscreens, suntans, and skin cancer - Sunscreens 
should not be seen as a safe way to prolong sun exposure. Brit. Med. J. 312,1621- 
1622 (1996). 
46. Young, A. R. Does UVA exposure cause human malignant melanoma? Eur. J. 
Dermatol. 6,225-226 (1996). 
47. Diffey, B. L. et al. Tanning with ultraviolet A sunbeds. Brit. Med. J. 301,773-774 
(1990). 
48. Repacholi, M. H. et al. Health issues of ultraviolet A sunbeds used for cosmetic 
purposes- A statement by the International Non-Ionizing Radiation Committee of the 
International Radiation Protection Association. Health Phys. 61,285-288 (1991). 
49. Boldeman, C. et al. Tanning habits and sunburn in a Swedish population age 13-50 
years. Eur. J. Cancer Care 37,2441-2448 (2001). 
50. Mawn, V. B. & Fleischer, A. B. A survey of attitudes, beliefs, and behaviour 
regarding tanning bed use, sunbathing and sunscreen use. J. Am. Acad. Dermatol. 29, 
959-962 (1993). 
5.54 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
51. Fiala, B., Kopp, M. & Gunther, V. Why do young women use sunbeds? A 
comparative psychological study. Br. J. Dermatol. 137,950-954 (1997). 
52. Boldeman, C., Jansson, B., Nilsson, B. & Ullen, H. Sunbed use in Swedish urban 
adolescents related to behavioral characteristics. Prev. Med. 26,114-119 (1997). 
53. Brandberg, Y., Ullen, H., Sjoberg, L. & Holm, L. E. Sunbathing and sunbed use 
related to self-image in a randomized sample of Swedish adolescents. Eur. J. Cancer 
Prev. 7,321-329 (1998). 
54. Lazovich, D. A. & Forster, J. Indoor tanning by adolescents: prevalence, practices 
and policies. Eur. J. Cancer Care 41,20-27 (2005). 
55. Hamlet, N. & Kennedy, K. Reconnaissance study of sunbed use by primary school 
children in Lanarkshire. Journal of Public Health 26,31-33 (2004). 
56. Boldeman, C., Jansson, B., Dal, H. & Ullen, H. Sunbed use among Swedish 
adolescents in the 1990s: a decline with an unchanged relationship to health risk 
behaviors. Scandinavian Journal of Public Health 31,233-237 (2003). 
57. Boldeman, C., Beitner, H., Jansson, B., Nilsson, B. & Ullen, H. Sunbed use in 
relation to phenotype, erythema, sunscreen use and skin diseases. A questionnaire 
survey among Swedish adolescents. Br. J. Dermatol. 135,712-716 (1996). 
58. Slovic, P. What does it mean to know a cumulative risk? Adolescents' perceptions of 
short-term and long-term consequences of smoking. Journal of Behavioral Decision 
Making 13,259-266 (2000). 
59. Gibbons, F. X., Eggleston, T. J. & Benthin, A. C. Cognitive reactions to smoking 
relapse: The reciprocal relation between dissonance and self-esteem. Journal of 
Personality and Social Psychology 72,184-195 (1997). 
60. Feldman, S. R. et al. Ultraviolet exposure is a reinforcing stimulus in frequent indoor 
tanners. J. Am. Acad. Dermatol. 51,45-51 (2004). 
61. Gambichler, T. et al. Plasma levels of opioid peptides after sunbed exposures. Br. J. 
Dermatol. 147,1207-1211 (2002). 
62. Wintzen, M. et al. Total body exposure to ultraviolet radiation does not influence 
plasma levels of immunoreactive beta-endorphin in man. Photodermatol. 
Photoimmunol. Photomed. 17,256-260 (2001). 
63. Health and Safety at Work etc Act. Chapter 37.1974. 
64. [Anon]. Controlling health risks from the use of UV tanning equipment. INDG209 
C75.1995. Health and Safety Executive. 
65. Moseley, H., Davidson, M. & Ferguson, J. A hazard assessment of artificial tanning 
units. Photodermatol. Photoimmun!. Photomed. 14,79-87 (1998). 
66. Ylianttila, L., Visuri, R., Huurto, L. & Jokela, K. Evaluation of a single- 
monochromator diode array spectroradiorneter for sunbed UV-radiation 
measurements. Photochem. Photobiol. 81,333-341 (2005). 
5.55 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
67. Moseley, H. Scottish UV dosimetry guidelines, "ScUViDo". Photodermatol. 
Photoimmunol. Photomed. 17,230-233 (2001). 
68. McKinlay A& Diffey, B. L. Human Exposure to Ultraviolet Radiation: Risks and 
Regulations. Passchier, W. F. & Boznjakovic, B. F. M. (eds. ), pp. 83-87 (Elsevier 
Science Publishers, London, 1987). 
69. Diffey, B. L., Jansen, C. T., Urbach, F. & Wulf, H. C. The standard erythema dose: a 
new photobiological concept. Photodermatol. Photoimmunol. Photomed. 13,64-66 
(1997). 
70. Diffey, B. L. et al. Tanning with Ultraviolet-A Sunbeds. Brit. Med. J. 301,773-774 
(1990). 
71. deGruijl, F. R. & van der Leun, J. C. Estimate of the Wavelength Dependency of 
Ultraviolet Carcinogenesis in Humans and Its Relevance to the Risk Assessment of A 
Stratospheric Ozone Depletion. Health Phys. 67,319-325 (1994). 
72. Ross, R. & Phillips, B. 20 questions for tanning facility operators- a survey of 
operator knowledge. C. J. Public Health 85,393-396 (1994). 
73. Szepietowski, J. C. et al. Tanning salons in southwest Poland: a survey of safety 
standards and professional knowledge of the staff. Photodermatol. Photoimmunol. 
Photomed. 18,179-182 (2002). 
74. Turner, R. J., Farr, P. M. & Walshaw, D. Many patients with psoriasis use sunbeds. 
Brit. Med. J. 317,412 (1998). 
75. Norris, J. F. B. Sunscreens, suntans, and skin cancer - Local councils should remove 
sunbeds from leisure centres. Brit. Med. J. 313,941-942 (1996). 
76. Wright, A., Hart, G. & Kernohan, L. Dangers of sunbeds are greater in the 
commercial sector. Brit. Med. J. 314,1280-1281 (1997). 
77. Boys burned on unmanned sunbeds. 2004. 
Internet Communication http: //news. bbc. co. uk/2/hi/uk news/scotland/3605064 stm 
78. Swerdlow, A. J. & Weinstock, M. A. Do tanning lamps cause melanoma? An 
epidemiologic assessment. J. Am. Acad. Dermatol. 38,89-98 (1998). 
79. Demierre, M. F. Time for the national legislation of indoor tanning to protect minors. 
Arch. Dermatol. 139,520-524 (2003). 
80. Broadstock, M., Borland, R. & Gason, R. Effects of Suntan on Judgments of 
Healthiness and Attractiveness by Adolescents. Journal ofApplied Social Psychology 
22,157-172 (1992). 
81. Gibson, G. E., Codd, M. B. & Murphy, G. M. Skin type distribution and skin disease 
in Ireland. Irish J. Med. Sci. 166,72-74 (1997). 
82. Milne, E. et al. Reduced sun exposure and tanning in children after 2 years of a 
school-based intervention (Australia). Cancer Causes & Control 12,387-393 (2001). 
83. Gange, R. W., Blackett, A. D., Matzinger, E. A., Sutherland, B. M. & Kochevar, I. E. 
Comparative Protection Efficiency of Uva-Induced and Uvb- Induced Tans Against 
5.56 
Measurement of cosmetic tanning sources and evaluation of hazards and existing regulations Chapter 5 
Erythema and Formation of Endonuclease- Sensitive Sites in Dna by Uvb in Human- 
Skin. J. Invest. Dermatol. 85,362-3 64 (1985). 
84. Moseley, H., Davidson, M. & Ferguson, J. Quantifying the risks from sunbeds. J. 
Invest. Dermatol. 110,698 (1998). 
85. Kivisäkk, E. Human exposure to ultraviolet radiation- risks and regulations. 
Passchier, W. F. & Boznjakovic, B. F. M. (eds. ), pp. 443-454 (Elsevier Science 
Publishers, Amsterdam, 1987). 
5.57 
Measurement of occupational UV sources and evaluation of hazards against existing regulations Chapter 6 
Chapter 6 
Measurement of occupational UV sources and evaluation of 
hazards against existing regulations 
Hazards associated with inappropriate use of UV sources 
Summary 
This chapter discusses some of the potential hazards of exposure to ultraviolet 
radiation sources in the workplace. The main focus of the chapter is the case of a 
hotel in central Scotland where inappropriate use of an UVC source caused an 
outbreak of skin and eye complaints among staff 1. Results from spectroradiometric 
assessment of the light source concerned are presented with evaluation against 
existing exposure criteria. 
As a result of this case, recommendations are made: 
There should be greater safeguards in place to ensure that the correct UV tubes are 
fitted to flykillers and companies supplying UVC tubes should check the intended use 
more carefully. The fittings on UVC tubes should be altered in order to prevent the 
tubes being fitted to a unit intended for UVA tubes 
1. Introduction 
Ultraviolet radiation in the workplace 
Ultraviolet radiation has several specific uses in non clinical environments e. g. arc 
welding, water and air sterilisation, in electric fly killers and for curing processes in 
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manufacturing, dentistry and for cosmetic tanning. In addition to these specific UV 
sources used in the workplace, inadvertent exposure to UV may also occur when 
visible light sources are used that contain some UV in their spectrum. Whatever the 
purpose of the UVR, the potential hazards posed to unprotected skin should be 
considered in order to avoid adverse effects to both photosensitive and normal skin. 
As mentioned in chapter 5, this is particularly important within the workplace, given 
the increasingly litigious nature of British culture. 
Uses and effects of UVC radiation 
UVC radiation is widely used for water, air and surface sterilisation 2.3 UVC radiation 
is germicidal because it can disable the DNA of microorganisms 4°5. This property 
has been harnessed for water sterilisation in developing countries where clean water is 
not readily available. UVC can also be useful for sterilisation in operating theatres 6 
and in air conditioning ducts to avoid health problems associated with `office air' 7. 
UVC can cause transient erythema and photokeratitis if skin and eyes are not suitably 
protected 8. In all cases where UVC radiation is used at work, exposure should be 
avoided or protective masks worn, for example with arc welding. Photokeratitis is 
temporary photochemical injury of the cornea. It is a very painful condition where 
epithelial cells are destroyed due to exposure to UVC or UVB radiation 9. The pain 
experienced is due to the fact that nerve endings are exposed. The short wavelengths 
of UVC penetrate only as far as the sclera and cornea of the eye and are therefore not 
implicated in the development of cataract to 
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Photosensitive skin can be susceptible to damage from UVC radiation. Atopic skin 
can flare on exposure to welding torches and has been reported to lead to 
hospitalisation 11. There is also a report of polymorphic light eruption being revealed 
upon exposure to the UVC radiation in an arc-welding torch 12. The emission of UVC 
13 during welding has been extensively studied 
Uses and effects of UVB radiation 
Photodermatologists and phototherapy nurses could be exposed to UVB radiation 
during the course of treating patients. As already discussed, eyes are susceptible to 
UVB and exposure can lead to photokeratitis. Sunburn and carcinogenesis 14 are 
other adverse effects of UVB radiation. Except in the case of welders 10, exposure to 
UVB radiation is rare in the workplace unless such sources are used in error. A case 
was reported in the literature where UVB tubes were fitted to a flycatcher and caused 
photokeratitis among employees 15 
Uses and effects of UVA radiation 
Cosmetic sunbeds (see chapter 5) contain mainly UVA radiation, which can present 
problems for tanning parlour workers if there is insufficient screening. The Health 
and Safety at Work Act requires that tanning parlour operators have undertaken a risk 
assessment for their employees in order to guard against occupational exposure 16. It 
was discovered that most operators had not considered an employees' risk 
assessment". There is no literature to the author's knowledge that discusses problems 
associated with occupational exposure to sunbeds. However, the literature detailing 
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the carcinogenic potential of sunbeds is comprehensive and suggests that excessive 
exposure could be hazardous 18,19 This idea can be extrapolated to excessive UVA 
exposure in any workplace. 
UVA radiation is used in electric fly killers: devices that are common in kitchens as 
they provide a hygienic and efficient way of trapping and killing insects and flies. 
Standard fly catching units use UVA radiation from fluorescent tubes to attracts insect 
onto an electrified mesh where they are killed and their bodies drop into a collecting 
tray 20. This kind of trap removes the need for chemical deterrents or killers and thus 
also removes the possibility of cross-contamination of foodstuffs. These devices do 
not normally present hazardous levels of UVA radiation, however, there was a case 
reported in 1991 where staff in a meat processing factory suffered from erythema due 
to UVC tubes being fitted to their fly killer in error 21. 
UVA penetrates further into the eye than shorter wavelength UVB and UVC and is 
linked to the development of cataract 22,23. The lens absorbs virtually all UVA and 
therefore individuals that have had a lens removed due to a cataract (aphakes) are 
susceptible to retinal damage from WA 24. In severe cases this can lead to blindness 
lo Furthermore there is reported to be a two to four fold increased risk of intraocular 
melanoma with sunbed use 25. 
Inadvertent exposure to UVR 
As well as the potential problems caused by exposure to these clearly identified UV 
sources, hazards are also presented by sources with a UV component in their spectrum 
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that is not widely recognised. There are reported cases of the UVA component of 
photocopiers causing skin problems. One such report was of the aggravation of skin 
lesions caused by lupus erythematosus 26 and the other was of the exacerbation of 
polymorphic light eruption 
27. In both these cases the exposure to the UVA radiation 
could have been avoided with sensible precautions such as closing the lid of the 
photocopier, but the users were unaware that the machine emitted UVA. 
In recent years there have been many new developments in lighting technology. The 
aim for engineers is to develop light sources that provide high quality, energy efficient 
lighting at low cost 28" In 1990 70% of tungsten halogen lamps were shown to 
provide excessive UV 29 if workers used them for desk illumination for 4 hours per 
day, 5 days per week, at a distance of -30 cm 30 and significant numbers of workers 
did so 31. This hazard is eliminated if the sources are filtered against UVR 32. Further 
concern has been raised about the UV emissions from fluorescent lamps 33.34 although 
this was refuted in a publication by the National Radiological Protection Board 
(NRPB) which concluded that these sources `present neither an acute nor a significant 
chronic hazard' 35. These concerns and findings emphasize the idea that as there are 
new developments in lighting technology there should be consideration given to the 
relative spectral distribution of the sources and thus the potential hazards presented to 
skin. 
Potential problems of UV exposure to photosensitized skin 
As well as potential hazards presented to normal skin from exposure to UVR whether 
recognised or inadvertent, there are additional hazards when skin has been 
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photosensitized. There are reports in the literature of severe phototoxic episodes 
resulting from excessive psoralen consumption. In one case a woman consumed 22.5 
mg of psoralen 36 when eating celery root and was subsequently hospitalized for 48 
hours following an half hour sunbed session 37. In another report, cosmetic tanners 
had misused psoralen in order to enhance their tan and sustained extensive skin 
injury38. These cases are rare and normal dietary consumption of psoralens present no 
39 
risk of photoxic injury 
UVR exposure limits 
In the UK there are no specific laws covering exposure to non ionizing-radiation in 
the workplace. Instead, control of exposure falls under the umbrella of the Health and 
Safety at Work Act etc 1974 and the Management of Health and Safety at Work 
Regulations 1999. If Health and Safety Executive Inspectors wish to assess 
compliance with the aforementioned directives then published guidelines are 
followed. Several bodies; the National Radiological Protection Board (NRPB), World 
Health Organisation (WHO), International Commission on Non-Ionising Radiation 
Protection (ICNIRP)`, United Nations Environment Programme (UNEP) and the 
American Conference of Government Industrial Hygienists (ACGIH), all of whom 
have been involved in the development of and subscribe to these guidelines. Limits 
were first published in 1985 41 and have been slightly modified and reaffirmed in 
29 several subsequent publications , 42,43 
An independent scientific organisation chartered in 1992 by the International Non-Ionising Radiation 
Committee of the International Radiation Protection Association (INIRC/IRPA) 40 
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All these UVR exposure recommendations utilize the S? weighting function 
(normalized to 270 nm), which is based upon the acute hazard to skin and eyes from 
exposure to UVR. The guidelines state that in an eight hour period unprotected skin 
and eyes should not be exposed to more than 30 Jm-2 Sk effective irradiance. This is 
thought to be ssubstantially below the levels that will produce clinically significant 
photokeratitis and also to provide only a third to a quarter of an MED 9. Thus, it can 
be said that any exposure resulting in these symptoms has provided much more than 
this dose. 
However, exposure limits do not consider abnormal skin and for individuals with 
specific photosensitivities, symptoms may occur below this threshold. Hence, if skin 
and eye problems do occur in a workplace it is necessary to consider the possibility of 
an aeroallergen, photoallergen or phototoxin in the environment. 
Skin and eve problems at work 
There are many reports in the literature of skin and eye problems in workplaces. 
Work related ocular damage is not uncommon 44. One survey of patients attending an 
eye casualty unit in Scotland found that 21.7% of the cases were work related 45 
Common eye injuries are due to chemical burns or foreign objects in the eye 46.46 
One survey of a workers compensation database found that cooks, housekeepers, and 
food service workers have a higher risk of atopic conjunctivitis (relative risk, 3.2 to 
7.3) compared with other workers, and also that the majority of the atopic 
conjunctivitis illnesses and burn injuries are associated with chemical exposures 46 
Although exposure of the eye may cause considerable pain, the human cornea appears 
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to be much less susceptible to the influence of phototoxic agents than the skin 47 so 
any agent that causes damage to the eye is likely to affect the skin as well. 
Occupational dermatitis is not uncommon. Gawkrodger et al (1986) 48 reported the 
common occurrence of hand dermatitis in cleaners and kitchen workers in hospitals. 
Lammintausta et al (1982) 49 found that 1% of hospital workers had hand dermatitis. 
This figure included, most commonly, cleaners, kitchen workers and nurses. 
`Wet' occupations can increase the risk factor for developing hand eczema 50 and 
many cleaning products contain irritants and contact allergens 51,52,52 Domestic and 
occupational products commonly contain fragrances, many of which are known to 
provoke contact allergy dermatitis 53. Rarely, foodstuffs can cause allergic contact 
dermatitis 54,55,55,56,56 but as in the cases of irritant or contact dermatitis due to cleaning 
products, it is the hands that are most commonly affected. 
Outbreak of skin and eye nlaints 
In August 2002, kitchen staff at a hotel in central Scotland experienced skin and eye 
problems believed to be related to their working environment. Symptoms included 
reddened, peeling skin on the face and hands and burning `gritty' eyes. This 
prompted the company's occupational health department to instigate an investigation 
into the cause of this outbreak. Occupational health contacted Dr Forsyth, Consultant 
Dermatologist at the Contact Dermatitis Unit at Glasgow Royal Infirmary and 
requested that the work place be examined. After her inspection, Dr Forsyth asked 
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the Photobiology Unit at Ninewells Hospital in Dundee to examine the kitchen with a 
view to making radiometric measurements. 
2. Patients and Methods 
Clinical Cases 
Out of 20 permanent kitchen staff, eight were reportedly affected. In April 2003, four 
of these were clinically evaluated at their place of work (patients 1-4). All presented 
with erythema (e. g. figure 6.1) and some peeling on their faces at the time of 
examination. The skin on photoexposed sites was clearly pigmented (figure 6.2). 
There was minimal involvement of the arms, hands and ears. Patients 1-3 also had 
active conjunctivitis at the time of examination. 
Figure 6.1: Affected members of staff. The ski goggles (left) were provided by 
the management. The erythema on exposed areas is clearly visible. 
/p, ol, 
.. 
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Figure 6.2: Patient shows pigmentation on photoexposed areas of skin 
Patients 1 and 4 described the skin sensation as being very like sunburn Patients 1,2 
and 3 complained of stinging, burning or `gritty' eyes. The staff reported that their 
skin became red and sore in the evening following a shift at work. Peeling developed 
1 day later. Symptoms always subsided within a day or two if they were not at work. 
The members of staff had all begun to suffer from October 2002 onwards. 
Patient 5 presented with no symptoms. He had suffered only one episode of skin and 
eye trouble the morning after he had painted the kitchen during one night in 
November 2003. All the lights were on in the kitchen and he had painted the ceiling 
using a long armed roller. Three hours after finishing the painting, he reported 
painful, swollen and weeping eyes, reddened and peeling skin. The symptoms cleared 
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over a five-day period off work. He has not had any recurrence of the symptoms 
since. 
The patients' symptoms are summarised in table 6.1. The skin type of the individual 
did not seem to affect the severity of their symptoms. There was no history of atopy, 
drug ingestion, family involvement or excessive consumption of psoralens in any of 
the patients examined. None had a past history of contact allergy and none were 
taking photoactive medication. 
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Clinical Impression 
The overall clinical impression was of conjunctivitis and sunburn-like erythema. The 
erythema could have various explanations. Flushing is a common cause for a 
transiently red face 57. Estimated figures suggest that as much as 10% of the general 
population suffer from rosacea, which causes a characteristically reddened face and 
can increase the frequency of flushing. Patients with rosacea have also reported 
affected eyes, including dryness and chronic conjunctivitis 58. The reddened face of 
seborrheic dermatitis may also involve secondary conjunctivitis but the estimated 
occurrence of this dermatosis in the general population is only 1-3% 59,59. Atopic 
dermatitis, thought to affect 20% of the population, can cause a red face and the hands 
are also generally involved 
60. The face is a common site for contact or photocontact 
dermatitis to manifest itself. Allergens may be airborne or in direct contact with 
patients skin and airborne allergens are known to cause conjunctivitis 61. 
It would be extremely unlikely for 24% of a workforce to have independently and 
simultaneously developed a dermatosis such as rosacea or seborrheic dermatitis. 
Eczema would not account for the ocular involvement. Given the prevalence of 
occupational skin disorders in kitchen staff, an irritant in the kitchen environment was 
suspected. 
Interestingly, kitchen staff working split shifts (10 am -2 pm and 5 pm to 10 pm) 
reported no symptoms or lesser effects than their colleagues working eight-hour 
stretches. This implied that the threshold dose for the irritant was only exceeded after 
four hours. 
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The involvement of the face, hands and eyes might have suggested an airborne irritant 
rather than one that required physical contact. Nevertheless, cleaning products were 
suspected, because irritants can be transferred from hands to face and eyes in affected 
individuals. Examination of the data sheets of all cleaning agents and sprays used 
within the kitchen pointed against an environmental phototoxin. 
Hotel management had provided the staff with ski goggles to wear in order to protect 
their eyes. Only patients I and 4 chose to wear the goggles. They found that their 
skin involvement continued, although the eyes and area protected by the goggles was 
no longer affected. This evidence, along with the marked cut off of erythema on 
photoprotected skin, suggested that there might be a UV source in the kitchen. Thus, 
the decision was made to examine the light sources in the kitchen for hazardous levels 
of UV. 
Kitchen Evaluation 
The hotel boasted several kitchens but the affected individuals all worked in one area. 
This area was inspected and hazard measurements were made using an International 
Light Sk weighted radiometer. Spectral measurements were also taken from several 
of the light sources in the kitchen using a Sola Scope 2000 meter with calibration 
traceable to NPL 62. 
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3. Results 
The on site survey using the Sola Scope 2000 meter revealed that incandescent lamps, 
positioned on the food counter in order to keep the food hot, were found to emit some 
UV (see figure 6.3) but the SX meter readings confirmed that this was not enough to 
be hazardous to health. Similarly, overhead fluorescent lights were found to emit 
minimal UV. There were also electric fly killers placed around the kitchen. Two of 
these units (Rentokil) contained clear fluorescent tubes with no phosphor in evidence. 
The Sola Scope 2000 meter proved to have too little sensitivity at low wavelengths to 
detect any hazardous W but the SA, radiometer readings at 20 cm from the unit 
suggested that there was a hazardous level of UV emitted from these tubes (1 Wm 2). 
Figure 6.3: Emission spectrum from lamps on food servery 
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There was a label on the units that stated that the tubes had been cleaned and replaced 
in July 2002. This date corresponds closely to the start of the skin and eye 
complaints. The tubes themselves were labelled 'UV-C' and `Dangerous for skin and 
eyes' on the outside of the glass envelope. UVC induced erythema and photokeratitis 
account for all the symptoms reported by the hotel staff 63,63 Patient 5 suffered the 
worst episode of photokeratitis because he was looking upwards in the direction of the 
UVC sources while he was painting the kitchen ceiling. 
One of the tubes was removed from one of the fly killers and taken to the UKAS 
accredited photo-laboratory at Ninewells Hospital, Dundee for accurate, 
spectroradiometric evaluation. Measurements were made at 30 cm from the Bentham 
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DM150 double grating spectroradiometer. This instrument has a cooled 
photomultiplier tube (-20°C +/- 1 °) and its calibration is traceable to NPL. The tubes 
were found to emit strongly in the UVC region (100 to 280 nm) (see figure 6.5). 
Total irradiance from the tubes (200 to 600 nm) was found to be 4.6 Wm'2. 
Application of the S7 weighting function revealed an effective irradiance of 2.2 Wm- 
2. Hence, the recommended upper level of 30 im -2 SX effective irradiance in eight 
hours on bare skin and eyes 
42 would be exceeded after only 14 seconds. 
The same weighting function can be used to calculate the time to the threshold dose 
for photokeratitis. This threshold is between 50 and 100 Jm 2 effective dose 64 . This 
dose would have been reached in 23-46 seconds. 
Figure 6.5: Emission spectrum from one of the UVC tubes in the flycatcher. 
This measurement was made using a double grating Bentham DM150 
spectroradiometer boasting a cooled (-20 +/-1 °C) photomultiplier. The 
irradiance scale is traceable to the National Physical Laboratory, Teddington, 
UK. The S), weighted irradiance is also shown. 
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Erythemal weighting of the WC tube spectra revealed that the erythemal effective 
irradiance was 4.5 Wm 2. A source of this intensity would deliver one SED (100 Jm" 
2) 65 in 22 seconds. For comparison- it would take >200 seconds to receive a similar 
dose at a distance of 30 cm from a TLO1 unit consisting of 8 tubes. 
The spectra obtained from the light sources in the kitchen are shown in figure 6.6. 
The relative intensity of the UVC tube is clear to see. This figure also shows the 
spectrum of the correct type of tube to fit in electric fly killers. 
Figure 6.6: Spectra of the light sources found in the kitchen. The intense UVC 
radiation from the UVC tube can clearly be seen. The series labelled `fly-lamp 2' 
represents the spectrum recorded from another flycatcher in the kitchen. This 
catcher had phosphor coated tubes fitted and represents no significant health 
hazard 
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4. Discussion 
Although cases of occupational UVC irradiation are rare, previous reports such as this 
15,21 indicate that confusion does arise with regard to the fitting of ultraviolet tubes to 
fly catchers. Of particular concern are the Rentokil electric fly killers that will fit 
either UVC or UVA tubes 
1,21. In order to avoid incidents such as this UVC tubes 
should be labelled more clearly and manufacturers should obtain more details as to the 
intended application before supplying tubes of this type. UVC tubes could also be 
manufactured with different fittings to other fluorescent tubes so that it would become 
impossible for end users to fit this type of tube in error. 
The irradiance levels reported in the current investigation represent a `worst case' 
scenario. Catering work involves moving about the workplace and generally looking 
down at food that is being prepared. An accurate measurement of the actual dose that 
the staff received could only have been achieved by attaching dosimeters to the staff 
uniform. Nevertheless, occupational exposure limits were obviously exceeded during 
a working day as the limits are set so as to avoid symptoms of exposure. These 
devices were mounted overhead and therefore the heads, faces and necks of the staff 
were receiving the majority of the radiation. This explains why there was minimal 
involvement of the arms and hands. Hats are also worn in the kitchen, which would 
explain why the ears were unaffected in most of the individuals. 
The UVC tubes were fitted in July 2002 but premises were not inspected and the 
problem identified until late April 2003. Staff had therefore been exposed to this 
radiation for some 9 months before the tubes were acknowledged as the cause of the 
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skin and eye problems. The effects of long term UVC exposure in humans is not 
known. UVC radiation is known to be mutagenic 66,67,67 and causes erythema in much 
the same manner as excessive UVB irradiation does 68. Whilst UVC photons are 
more energetic and therefore more damaging than longer wavelength UVB and UVA 
photons, they do not penetrate tissue as deeply. Therefore undesirable effects are 
confined to the outer tissue layers 69. However, there is very limited data on long- 
term effects of human exposure to UVC because there is no follow-up of patients after 
the acute effects have been dealt with. This group of workers may provide valuable 
evidence of the long-term effects of UVC exposure in the following years. Dr 
Forsyth intends to monitor their progress on a regular basis over the forthcoming 
years. 
Another issue highlighted by this incident is the lack of knowledge regarding UVR 
and its effects. The employees' symptoms went undiagnosed for some time despite 
visits to general practitioners. Although the tubes were labelled as being dangerous 
for skin and eyes, the kitchen staff described their symptoms as feeling like sunburn. 
However, no one in the company's occupational health department thought to check 
the UV sources in the kitchen possible due to the fact that few people are aware that 
artificial sources of UV can actually cause erythema. Ultraviolet from the sun, which 
is known to cause sunburn, is not thought of, by many members of the public, as 
being the same as artificial UV. This is a myth that has probably been perpetrated by 
the sunbed industry in promoting artificial UV as `safe'. 
There remains some debate over occupational exposure limits despite the fact that the 
relevant national and international bodies have been moving towards a consensus in 
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recent decades 43. One aspect that is under debate is the maximum dose integration 
time to take account of prolonged exposure beyond 8 hours. This case cannot answer 
that question but what is interesting to note is that where employees were working 
split shifts there were, except in the case of patient 3, no symptoms evident. Patient 3 
also only reported symptoms of the face. This employee had a 2.5-hour recovery 
period in the middle of an 8-hour exposure. This may mean that cellular repair 
processes had repaired the damage from the 4-hour exposure during this break, as is 
consistent with findings by Henriksen et al 70. However, without having data from 
personal dosemeters from the entire kitchen staff, both affected and unaffected, it is 
impossible to know for certain the doses received and thus, quantify the effects. 
Personal dose monitoring was not possible because the UVC `fly traps' were 
disconnected after the inspection visit to avoid any more harmful effects. 
None of the employees in this case had specific photosensitivities. The exposure 
guidelines were also far exceeded, thus, this case does not point to any problems with 
the published exposure limits. The very high level of UV exposure received from 
these sources, given their proximity to head height, could have induced a very serious 
reaction in individuals with photosensitive conditions or those taking photoactive 
medication. The lack of knowledge of the effects of artificial UV radiation is of 
concern, particularly amongst health professionals such as those working in 
occupational health departments and in primary care. 
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5. Conclusions 
" There should be greater safeguards in place to ensure that the correct UV tubes 
are fitted to flykillers. 
" Companies supplying UVC tubes should check the intended use more 
carefully. 
" The fittings on UVC tubes should be altered in order to prevent the tubes 
being fitted to a unit intended for UVA tubes. 
" Occupational health professionals are ignorant as to the potential effects of 
artificial UV and should be educated as to the potential problems that can 
occur if normal and photosensitive individuals are exposed. 
" These workers may provide useful evidence of the effects of long-term 
exposure to UVC. 
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Conclusions and further work 
The impacts on skin of light from some artificial sources in the environment 
have been considered in terms of hazards, measurement, regulation and 
protection. The hazards of such radiation depend on the nature of the skin. 
Normal and photosensitive skin have been considered in context. 
Pragmatic assessment of optical radiation hazards necessitates accurate spectral 
measurements. Diode array spectroradiometers may be useful for such 
measurements of UV sources. However, the Sola Scope (an instrument 
evaluated in chapter 2) should not be advocated for widespread medical use as 
the response of the instrument evaluated and the one purchased varied more than 
acceptable. Therefore a `one size fits all' calibration could not be used. The 
calibration method adopted for measurement of sunbeds (chapter 5) is similar to 
that used for filtered radiometers and limits the use of this instrument. Thus 
there are manufacturing issues to be resolved. 
The general assumption that action spectra can be used to predict responses to 
polychromatic radiation has been challenged for normal skinned individuals and 
those suffering with chronic actinic dermatitis (CAD). Solar urticaria was 
expected to not conform to a model of linear additivity and this was confirmed 
within the limits of the experimental methods employed. 
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Further research into the construction of action spectra in subjects with CAD is 
indicated. This could be achieved with narrower wavebands in phototesting and 
testing at more wavelengths. This would facilitate a more complex modelling of 
the response with potential fitting to another dose response function 1. 
Furthermore, a full consideration of the uncertainties of thermopiles and their 
comparability to spectral measurements should be undertaken. This would be a 
considerable undertaking as the thermopiles used in Dundee have a very small 
area whereas the bench-based spectroradiometer employs flat plate diffusers that 
collect radiation over wide angles. 
If these uncertainties were considered then the time to erythema from 
polychromatic sources may prove to be predictable using the erythemal action 
spectrum. The data presented in chapter 3 could be re-evaluated in terms of the 
discovered uncertainties. 
Cosmetic preparations have been shown to have potential for protecting 
photosensitive individuals from visible light. However, these should be tested 
for their photoallergic potential as some cosmetics contain sun protection factors 
and suncreams are significant photoallergens 2. 
Sunbeds available in commercial and council premises in Perthshire and Dundee 
are stronger than those previously measured 3. The doses that could be received 
from sessions on these beds were considered and the recommended exposure 
limit of 20 sessions per year 4 was found to be prudent. A repeat of this work in 
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a few years would be wise as it would allow the trends in the strength of sunbeds 
to be monitored. 
Most premises do not fulfil the criteria set out by the Health and Safety 
Executive in terms of recommended operator guidelines 5. Thus licensing is a 
sensible proposal as it would ensure that guidelines are followed. A feasibility 
and financial analysis study of licensing is indicated. 
The British Standard (BS) covering cosmetic tanning units was found to be 
outdated. Most of the sunbeds surveyed have spectral distributions and strengths 
such that they do not fit into any category in the existing standard. This should 
be revised and then premises could be forced to use units that comply with the 
BS under licensing regulations. 
Finally, the case of a UVC tube being used in a fly-killer in a hotel kitchen 
emphasises the fact that there should be greater safeguards in place to ensure that 
manufacturers supply the correct light sources for their intended use. The 
ignorance of occupational health professionals as to the effects and use of UV 
radiation was also highlighted by this case. Education of such professionals 
would help prevent such cases occurring again. Follow up of the employees 
affected in this case may provide useful evidence of the effects of long-term 
exposure to UVC. 
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Abstract 
An evaluation of two diode array radiometers, an UV spectroradiotneter, 
Type SC-MP-A, from 4D Controls (Redruth, UK) and an USB2000-UV- 
VIS spectrometer from Ocean Optics (Duiven, NL), was carried out at the 
Photobiology Unit, University of Dundee. Three parameters of the instruments' 
performance were investigated, having been identified as the most likely 
sources of error in phototherapy dosimetry: (1) calibration, (2) stray light 
rejection, (3) angular response. An assessment was then made of the reliability 
of this type of instrument for dosimetry in clinical practice by measurement 
of a selection of phototherapy sources, in direct comparison with calibrated 
radiometers. Both instruments were found to have significant stray light 
levels (SC: 13% and USB: 39%). The use of stray light compensation and 
a high output calibration source improves accuracy to within acceptable limits. 
Angular responses were satisfactory: f2 values (±60') of 5.9% and 7.8% 
for SC and USB, respectively. The SC spectroradiometer is supplied as a 
calibrated instrument. Using the supplied calibration resulted in errors in 
measuring phototherapy sources of up to 44% in UVA. Alternative calibration 
reduced the error in measuring UVA and UVB sources to within 12%. The 
USB spectrometer was found to have insufficient responsivity in both UVB and 
UVA to provide reproducible measurements of most phototherapy sources. 
1. Introduction 
Within photomedicine, the need for accurate dosimetry of therapeutic UV radiation has long 
been recognized (Diffey 1978, Green et al 1992). If treatment times are kept to a minimum and 
accurately monitored then the risk of carcinogenesis is minimized, treatments can be optimized 
and there is also the potential for patients to transfer treatment centres without jeopardizing 
the course of their therapy. Any instrument that is used for dosimetry should measure to 
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within 10% (Coleman et al 2000, Moseley 2001) because errors in dosimetry are clinically 
significant and may lead to painful erythematous reactions (Moseley et al 1993, Hansen et al 
1994). There are currently three different options for measuring UV radiation for health hazard 
or phototherapeutic assessment, namely spectroradiometers, personal dosemeters and filtered 
radiometers (Driscoll 1993). 
Spectroradiometry is beneficial because it allows the operator to resolve the spectrum 
of the lamp being measured. If spectral data are collected then there is the potential to 
apply different action spectra to the output of the lamp. Therefore, the risk of exposure 
can be assessed for patients with different skin conditions that exhibit different spectral 
sensitivities. This idea can also be extrapolated to other light sources in order to give advice to 
photodermatoses patients on exposure levels to all types of light. Absolute spectral irradiance 
measurements can be achieved at an uncertainty level of 4% in spectroradiometry (Kostkowski 
1997) but the technique involves expensive, bulky and complex equipment and can require a 
large period of time to take measurements. Within a busy treatment centre, transporting bulky 
equipment to measure outputs from phototherapy sources is impractical. 
Studies of personal phototherapy source dosimetry have been conducted, primarily using 
polysulphone film badges (Fanselow et al 1987, Jekler et al 1990, Knuschke and Barth 1996) 
since their introduction as personal dosemeters for UV radiation (Davis et al 1976). These 
badges can provide useful information regarding the distribution of phototherapy radiation 
over a patient's skin. Other commercial personal dosemeters incorporating UV sensitivity are 
available. These are generally based on solid state detector technology, e. g. the sp3 (Tunbridge 
Wells, Kent) 'Sunwatch'Th't which is based on a solid state gallium nitride detector. 
Output measurements from UV treatment cabinets and lamps have traditionally been 
carried out using filtered radiometers, calibrated against sources similar to those being 
measured. These broad or narrow band radiometers do have limited accuracy and cannot 
resolve the spectrum of the lamp of interest but by following guidelines for meter calibrations 
against a spectroradiometer (Norris et al 1994; Diffey and Hart 1997), doses can be measured 
to within 10% with relative ease. This type of meter is currently the preferred option for health 
hazard assessment (Driscoll 1993). 
The relatively new technology of the diode array spectroradiometer provides potentially 
the perfect answer to the trade off between spectral data collected with a cumbersome 
instrument and the ease and speed of the filtered radiometer: a portable instrument that 
will acquire spectral data (Ridyard 2000). An example of the optical layout of such a 
spectroradiometer is shown in figure 1. After incoming radiation has been split into its 
constituent wavelengths by a diffraction grating, a series of fixed, silicon photodetector pixels 
transduce the radiation into an electrical signal. As all the pixels have fixed positions, it is 
possible to predict the wavelengths that will fall on each pixel and a spectrum can therefore 
be determined using appropriate software. Before this type of instrument becomes widely 
used in the medical field, it is important to assess the limitations of their use and the reliability 
and accuracy of the data collected from them. If diode array instruments are to become the 
dosimetry instrument of choice in the future and filtered radiometers are to be usurped then 
the same requirements for accuracy should apply in both cases. 
During 2001 and 2002, two diode array instruments, from different manufacturers, were 
evaluated at the Photobiology Unit, University of Dundee. This is a well-equipped laboratory 
with ISO 9001 registration and standards traceable to the National Physical Laboratory (NPL) 
(Teddington, UK) spectral irradiance scale. A number of investigations were carried out to 
assess the performance parameters of these instruments. There are three areas of performance 
which were investigated as these were identified as, potentially, the largest sources of error in 
using the instruments-calibration, stray light rejection and angular response. 
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Figure 1. Diagram showing the optical layout of a diode array spectroradiometer. (Graphic 
courtesy of 4D Controls. ) 
(This figure is in colour only in the electronic version) 
The calibration of the instruments must be traceable to national standards and should 
agree with a calibrated, double grating, bench based spectroradiometer (Coleman et a! 2000). 
This ensures reliability of readings and facilitates transfer of doses between centres. 
In the case of diode array instruments, stray light is the radiation that is detected by 
the 'wrong' pixel for the wavelength of the radiation. This phenomenon is common to 
spectroradiometric systems although in the case of most bench based spectroradiometers, 
two successive gratings are used to improve the wavelength selection. These diode array 
instruments are single grating, portable instruments and as such would be expected to have 
poor stray light levels which will affect the overall calculated dose for any phototherapy 
instrument. 
As phototherapy sources are diffuse, wide angled and non-directional, it is important that 
any instrument for use in photomedicine will detect radiation at all the input angles from 
which radiation will be incident on the skin. Phototherapy cabinets are often 360" sources and 
the expectation of radiometers is that they have an error margin (f2 value) of 10% or better 
(Pye and Martin 2000, Moseley 2001). 
In order to give an assessment of the reliability of this type of instrument in clinical practice, 
the calibration of the instrument and the influence of its angular and spectral responses should 
be checked by measuring a number of phototherapy sources against calibrated radiometers or 
a spectroradiometer. 
An UV spectroradiometer, Type SC-MP-A. from 4D Controls (Redruth. UK) (hereafter 
referred to as Sola Scope) and an USB2000-UV-VIS spectrometer from Ocean Optics (Duiven, 
NL) (hereafter referred to as Ocean Optics) were both evaluated at the Photobiology Unit, 
University of Dundee. 
The Sola Scope is a self-contained spectroradiometric instrument which consists of a hand 
held 'sensor head' with a domed Teflon diffuser forming the input optics to the single grating 
and diode array, all contained in one compact box. The sensor head then connects to another 
hand held unit containing the software, control keypad and a display panel to enable spectra 
of measured lamps to be visualized. Data from the Sola Scope can be easily uploaded to a PC 
spreadsheet for analysis via the supplied (Sola-Term 2000) software. 
Diode 
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The Ocean Optics consists of a flat Teflon diffuser head attached to an optical fibre which 
forms the input optics to the spectrometer (single grating and diode array) which is a unit no 
bigger than a pack of cards. The spectrometer connects to a laptop PC via an USB port and 
the spectrometer can then be controlled using the supplied (OOIBase32) software. 
2. Methods and materials 
2.1. Calibration 
The instruments differed slightly in their mode of use. The Ocean Optics was designed for 
use as a comparative radiometer, or spectrometer. The idea is to use a standard reference 
lamp to record a spectrum in the software. The standard lamp's colour temperature can 
then be input into the software and during any subsequent measurement the software derives 
the measured lamp's spectrum from the colour temperature profile (based on a black body 
emission spectrum) of the standard reference lamp. The Sola Scope is sold as a calibrated 
instrument that will give readings in absolute units, traceable to NPL. 
To set the wavelength scale on the Ocean Optics instrument, a low-pressure mercury 
Pen-Ray lamp was used. The position of eight known spectral lines (between 253.65 nm and 
579.07 nm) and the pixel that detected these lines were analysed by linear regression and the 
regression coefficients were input into the software. The wavelength scale was then calculated 
by the software. For absolute unit calibration, the Ocean Optics instrument was calibrated 
by the investigator against a1 kW incandescent quartz halogen lamp (designated type FEL) 
calibrated at NPL. The lamp was allowed 30 min warm-up time and was run at a current of 
8.33 A. From the response of the Ocean Optics, a calibration template was derived at each 
wavelength such that 
SFa= 
where SF), is the sensitivity factor at a given wavelength, Ex is the lamp irradiance at the same 
wavelength and Ra is the instrument response at that wavelength. 
The Sola Scope's in-built calibration factor is derived by the manufacturer from a 
deuterium lamp. However, the software allows a custom calibration file to be created by 
recording a spectrum of a standard lamp, in the same way that the calibration template was 
created for the Ocean Optics. A calibration of this type was performed using the same 1 kW 
FEL lamp. The wavelength of the instrument was checked by sampling the spectrum of a 
low-pressure mercury lamp. 
2.2. Stray light 
Stray light levels were assessed in these instruments by the use of a xenon arc lamp, filtered 
for infrared radiation (IR) with a H2SO4 " CuSO4 solution and a cut on filter (WG305, Schott). 
The lamp was allowed at least 15 min to stabilize before the spectra were measured by the 
diode array instruments. The advantage of using a source with a broad spectral output is the 
fact that stray light contributions from longer wavelengths, which may be detected as short 
wavelengths, can be identified more easily than if a monochromatic source or a source with 
clear emission lines is used. As the filter has a well-known transmission profile, the stray 
light present in the recorded spectra can be expressed as a ratio of the signal level at a given 
wavelength (Kaye 1981). 
There is a method recommended to correct the stray light in the signal recorded from 
the Sola Scope. This method involves using an orange filter which only transmits radiation 
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above 355 nm. The filter is placed over the input optics of the Sola Scope and the resulting 
irradiance profile is then subtracted from subsequent scans. This procedure must be repeated 
before each lamp measurement because there will be a different stray light `profile' according 
to the spectral distribution of the lamp of interest. 
There is no method to remove stray light from the Ocean Optics instrument although the 
same procedure may be applicable. The calibration derived from the 1 kW FEL lamp should 
calibrate the stray light levels in the signal although this will be subject to some error due to 
the differing stray light `profiles' of the calibration source compared to what is measured. A 
recording of the dark spectrum was made before each measurement run and the dark current 
or noise is, therefore, subtracted from each spectrum. 
2.3. Angular response 
A measurement of the angular response of the instruments was made using a xenon arc lamp. 
The lamp (as used for assessing stray light) was allowed 15 min to stabilize after ignition. The 
instruments were positioned with the input optics at the centre of rotation of a turntable. The 
turntable is marked at 10 intervals. The turntable was moved manually and a spectrum was 
recorded at each 5' step over the interval ±60". 
The angular response of the Sofa Scope was measured in the planes parallel to the grating 
and perpendicular to the grating. The response of the Ocean Optics was considered in one 
orientation only as there is an optical fibre coupled to the diffuser so that all radiation is 
scrambled within the fibre. 
A value (f2) for the cosine response can be calculated as 
Rn I1 
- RocacH 
X f100 2= 
II 
where 0 is the angle of measurement, R0 is the response of the instrument at 0°, Ro is the 
response at the angle of measurement and it is the number of measurements. 
2.4. Measurement of plwtotherapy sources 
Any instrument intended for use in phototherapy dosimetry should be able to record an accurate 
dose (to within 10%), of any phototherapy lamp. A number of different sources in the unit 
were measured, ranging from whole body treatment cabinets to single fluorescent tubes. These 
measurements were made at a nominal distance of 30 cm from the source and at least 5 min 
was always allowed for the output from the lamps to stabilize. 
Measurements were made in direct comparison with either the unit's IL1400 radiometer 
(Able Instruments, Reading, UK), which has attachments for measuring both UVA and UVB; 
or a bench based double grating spectroradiometer (Bentham DM150). In accordance with 
guidelines, the radiometer was calibrated against sources with similar spectral outputs to those 
to be measured (CIE 1984), in direct comparison with the Bentham spectroradiometer. 
The calibration of the Bentham is traceable to NPL and has an estimated expanded 
uncertainty at the 95% confidence level, of 5.72% in UVB and 3.48% in UVA. These 
uncertainties have been calculated in accordance with NPL guidelines (Bell 2001) and 
include consideration of the uncertainty in the calibration sources used, alignment errors 
and uncertainty in the current from the cooled (-20 °C ±2 °C) photomultiplier tube. The 
transfer standard for UVA radiation measurements (315-400 nm) is a 100 W frosted glass 
tungsten lamp, and a 30 W deuterium discharge lamp is used as a transfer standard for UVB 
(280-315 nm). 
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Figure 2. Graph showing the relative spectral responsivities of both the Ocean Optics and the Sola 
Scope. 
Table 1. Wavelength error of Sola Scope. 
Spectral line (nm) Recorded position (nm) Error (nm) 
253.65 253.5 -0.15 
313.10 313.0 -0.10 
365.00 365.0 0.00 
404.70 404.5 -0.20 
435.80 436.0 0.20 
Table 2. Stray light ratios from the diode array instruments. The percentage value expressed is 
the ratio of the signal at 250 nm to that at 430 nm. 
Sola Scope 13% 2.0% 
Ocean Optics 39% 0.4% 
Bentham DM 150 <0.001% <0.0131 % 
Spectruradiometer 
Without compensation or With compensation or 
Instrument calibration calibration 
3.1. Calibration 
The calibrations of both instruments reveal significant differences in the relative responsivitics 
(see figure 2). Wavelength error for the Sola Scope is shown in table 1 and was satisfactorily 
small to be considered negligible. There was a significant amount of noise in the signals from 
both instruments. 
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Figure 3. Polar plot to represent spatially the cosine responses (as a percentage of the maximum) 
of the Ocean Optics and Sola Scope at incident radiation angles from 90 to -90'. 
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Figure 4. Graph to show the differences in measured inradiances when comparing manufacturer 
calibrated Sala Scope with IL14110 radiometer and, in the case of the UVAI lamp, the Bentham 
spectroradiometer. TLOI and TL12 values from the integrated irradiance 280-315 nm. PUVA 
and UVA I from integrated irradiance 315-400 nm. 
3.2. Stray light 
The stray light levels with both instruments were significant, as was expected. The method 
of correcting stray light with the orange filter reduced the stray light significantly. Table 2 
shows the stray light ratios if the signal at 250 nm (no irradiance, Schott 1993) is compared 
with that at 430 nm (maximum irradiance). The levels are significantly reduced when the Sola 
Scope's stray light compensation method is used and when the calibration is applied to the 
Ocean Optics' raw signal. 
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Figure 5. Graph to show the differences in measured irradiances when comparing custom calibrated 
Sola Scope with Bentham spectroradiometer and, in the case of the cabinets, an IL 14(10 radiometer. 
TLOI values from integrated irradiance 280-315 nm. PUVA and UVA I from integrated irradiance 
315-4(X) nm. 
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Figure 6. Measurement of a high dose UVAI source which illustrates the discrepancy that was 
seen to exist with the Sola Scope's supplied calibration. 
3.3. Angular response 
The f2 values for the instruments were both found to be within acceptable limits. For the 
Sola Scope the value was 5.1% in the plane parallel to its grating and 6.7% in the plane 
perpendicular to its grating (±60"). This provides an overall f2 value of 5.9% (±60"). For 
the Ocean Optics the value was 7.8% (±60°). The cosine responses can also be represented 
as a polar plot (figure 3). 
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Figure 7. Graph to show the differences in measured irradiances when comparing calibrated Ocean 
Optics with Bentham spectroradiometer and, in the case of the PUVA bank, an IL 14(X) radiometer. 
TLOI and TL12 values from the integrated irradiance 280-315 nm. PUVA from the integrated 
irradiance 315-400 nm. TLO3 from the integrated irradiance 4W-500 nm. 
3.4. Measurement of'phototherapy sources 
Results from using the Sola Scope revealed wide discrepancies in measured doses when using 
the supplied calibration (figure 4). The error was most pronounced as an overestimation of 
the irradiance at the UVA end of the spectrum (see figure 6). Use of the calibration created 
from measuring the 1 kW FEL lamp reduced these errors significantly (figures 5 and 6). 
Measurements of phototherapy sources using the Ocean Optics showed the instrument 
underestimated the irradiance in all but the cases of a blue light source (figure 7). The 
recorded spectra were very noisy at low wavelengths and this fact, combined with the low 
responsivity of the instrument at low wavelengths, produced errors of the magnitudes seen and 
illustrates that this instrument is not at present sensitive enough to be used for UV radiation 
dosimetry. 
4. Discussion and conclusion 
This type of spectroradiometer potentially represents a welcome addition to the instrumentation 
available to the medical physicist. The portability of the instruments is certainly a 
very attractive quality and the relative speed and ease of acquiring spectral data is also 
desirable. However, the potential for inaccuracies in dosimetry has been shown to be 
significant. 
One major issue encountered when calibrating both the instruments was the sensitivity 
of the detector arrays. Neither instrument proved to have sufficient sensitivity to detect the 
transfer standards usually employed in the department (see section 3.4). CIE guidelines (1984) 
recommend that detectors are calibrated against sources with a known spectral intensity and 
distribution that is similar to or the same as the source to be measured. Thus, the 1 kW FEL 
lamp employed was not ideal for UVB measurements but the instruments were not sufficiently 
sensitive to allow the use of a deuterium lamp. The deuterium discharge lamp is also a 
good approximation of a point source, and would normally be used for measuring the cosine 
response of any radiometer (Pye and Martin 2000). A xenon arc lamp was a second choice for 
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this measurement but did, however, demonstrate that the f2 values of both instruments were 
acceptable. 
The Sola Scope is supplied with a calibration derived from a deuterium source but we 
found that the instrument was not sensitive enough to detect the output from such a lamp. It 
transpires that the calibration is performed without the cosine diffuser attached to the sensor and 
a convolution of the transmittance of the diffuser and the responsivity of the detector array is 
then performed in order to give the final calibration (Ridyard 2002, personal communication). 
It is possible that uncertainties inherent in this calibration method lead to the error seen in 
the supplied calibration and subsequent errors when measuring phototherapy sources (see 
figures 5 and 7). Calibration or the intact instrument using the I kW FEL lamp was sufficient 
to reduce the error in the readings from the instrument to within 12% (figure 5). A calibration 
method such as this, keeping the instrument intact, would certainly be necessary for any 
clinical application. Errors of the magnitude that the supplied calibration was producing could 
certainly lead to patients receiving the wrong dose. 
The UV responsivity of the Ocean Optics meant that even using the 1 kW calibration 
source, recorded spectra were similar to the noise inherent in the instrument. This meant that 
all the phototherapy sources measured were too low in intensity to give a discernible spectral 
output and it was only with a largely visible source that the signal was discernible (TLO3). This 
occurred despite the instrument supposedly being optimized for UV and visible wavelengths. 
This instrument could have potential in the clinical environment if its quantum efficiency in 
the UV were increased substantially. The calibration method for this instrument should also be 
revised. Very few light sources, and certainly not phototherapy sources, match the black body 
emission spectral profile. Convolution of some calibration source to this emission spectrum, 
based on colour temperature immediately introduces error into the calibration. The method 
that was used with the 1 kW FEL lamp would certainly be more satisfactory if the sensitivity 
issue is addressed. 
The stray light levels in measurements from these instruments were high, as expected. It 
has been shown, however, that it is possible to compensate for the stray light by one of the 
two methods. An orange glass filter can be used to find the stray light profile for any source 
being measured and the `profile' then subtracted from any final spectrum. Alternatively 
the stray light can be calibrated by including stray light in any spectrum of a calibration source 
and, therefore, including stray light in the sensitivity factor (SFF). The first method is the most 
favourable because it takes into account different spectral profiles of any source, although it 
requires two scans of any source to be made which can have potential exposure risks when 
measuring phototherapy sources. 
The Sola Scope instrument currently shows significant potential for use in a clinical 
environment. The calibration supplied by the manufacturer was unsatisfactory but this could 
be improved using a high output source and stray light correction. With these modifications 
in place the errors in measuring phototherapy sources were calculated as being up to 12%, in 
line with errors inherent in filtered radiometer readings. 
The Ocean Optics device should have its sensitivity increased and its calibration protocol 
re-written before it should be considered for phototherapy dosimetry. 
Although there is potential benefit associated with this type of instrument, caution should 
be advised in its use within a clinical environment. Calibration issues surrounding this 
type of instrument have not yet been adequately addressed by manufacturers to advocate the 
replacement of the filtered radiometer in the photomedicine clinic with a device such as this. 
There would be particular concern over the use of a device such as this by non-specialist staff 
since errors can be considerable. An erroneous reading of the magnitudes reported in this 
paper could easily lead to a patient being burned. 
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CASE REPORT 
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Clustered outbreak of skin and eye complaints 
among catering staff 
Hannah Oliver' 2, Harry Moseley', James Ferguson' and Angela Forsyth3 
............................................................................................................................................................ Abstract In August 2002, kitchen staff at a hotel in Central Scotland experienced skin and eye problems believed 
to be related to their working environment. Of a total of 20 staff, eight cooks reported problems with a 
painful red skin affecting the face, eyelids, side and front of neck as well as burning, gritty eyes. Five of 
the affected individuals were clinically assessed in April 2003. The overall clinical impression was of 
conjunctivitis and sunburn-like erythema. Examination of the data sheets of all cleaning agents and 
sprays used within the kitchen pointed against an environmental phototoxin. The kitchen area was 
inspected and two electric fly killers positioned on the ceiling and sidewalls were found to be 
incorrectly fitted with UVC tubes. The output of these tubes was spectroradiometrically assessed. The 
recommended unprotected skin and eye exposure limit was reached in 14 s at a distance of 30 cm from 
the tubes. An exposure of about 60 s would be sufficient to induce minimal erythema in someone of 
skin type I/II. These results demonstrate the importance of exposure to ultraviolet radiation as a 
possible cause of facial erythema and conjunctivitis, no matter how unlikely this may seem. It is 
recommended that there should be increased awareness of the need to fit the correct type of lamps to 
electric fly killers and other devices that incorporate UV lamps. 
Key words Catering; electric fly killers; erythema; occupational; photokeratitis; sunburn; UVC. 
Introduction 
Work-related ocular damage is not uncommon [1]. One 
survey of patients attending an eye casualty unit 
in 
Scotland found that 21.7% of the cases were work-related 
[2]. Common eye injuries are due to chemical burns or 
foreign objects in the eye [3]. Two cases in the literature 
report eye problems 
due to incorrectly used UV sources 
in the workplace: a UVB source in one case [4] and a 
UVC source in another case [5]. UVC irradiation from 
welding equipment has caused or exacerbated skin 
conditions in three reported cases 
[6-8]. 
Occupational exposure to irritants can also cause skin 
disease. Gawkrodger et aL [9] reported the common 
occurrence of 
hand dermatitis in cleaners and kitchen 
workers in hospitals. Lammintausta et ad. 
[10] found that 
1 %/a of hospital workers had hand 
dermatitis. This figure 
included, most commonly, cleaners, kitchen workers 
and nurses. 
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`Wet' occupations can increase the risk factor for 
developing hand eczema [11] and many cleaning 
products contain irritants and contact allergens [12,13]. 
Domestic and occupational products commonly contain 
fragrances, many of which are known to provoke contact 
allergy dermatitis [14]. Rarely, foodstuffs can cause 
allergic contact dermatitis [15-17] but as in the cases 
of irritant or contact dermatitis due to cleaning products, 
it is the hands that are most commonly affected. 
A red face can have various explanations. Flushing is a 
common cause for a transiently red face [18]. Estimated 
figures suggest that as much as 10% of the general 
population suffer from rosacea that causes a character- 
istically reddened face and can increase the frequency of 
flushing. Patients with rosacea have also reported affected 
eyes, including dryness and chronic conjunctivitis [19]. 
The reddened face of seborrhoeic dermatitis may also 
involve secondary conjunctivitis, but the estimated 
occurrence of this dermatosis in the general population 
is only 1-3% [20]. Atopic dermatitis can be another 
cause of a red face, thought to affect 20% of the 
population, and the hands are commonly involved [211. 
The face is also a common site for contact or photo- 
contact dermatitis to manifest itself. Allergens may be 
airborne or in direct contact with patients' skin. Airborne 
allergens can also cause conjunctivitis [22]. 
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Table 1. Summary of presenting patients' symptoms 
Patient Age Sex Skin Shift Marked Sore Precautions Medical care Days of 
type worked tanning or eyes taken sought work lost 
erythema 
Face Hands 
1 29 M 3 8-9h Y Ski goggles GP None 
2 19 M 2 8h Y  None GP None 
3 34 M 4 8h shift split by 2.5 h loo None GP None 
4 34 F 1 8h shifts Y  Ski goggles Attended casualty None 
on one occasion 
5 44 M 3 7.5 h painting the kitchen ceiling on Y  None Optician 5 
one occasion 
In August 2002, kitchen staff at a hotel in central 
Scotland experienced skin and eye problems that they 
believed to be related to their working environment. 
Symptoms included reddened, peeling skin on the face 
and hands and burning `gritty' eyes. This prompted the 
company's occupational health department to instigate 
an investigation into the cause of this outbreak. Occu- 
pational health contacted the Dermatology department 
at the local hospital and requested that the workplace be 
examined. Following the inspection, a request was made 
to further examine the kitchen in order to make 
radiometric measurements. The results of the investi- 
gation are presented in the current paper. 
Patients and methods 
Clinical cases 
Out of 20 permanent kitchen staff, eight were reportedly 
affected. In April 2003, four of these were clinically 
evaluated at their workplace (patients 1-4). At the time 
of examination, all presented with erythema and some 
peeling on their faces. The skin on photoexposed sites 
was clearly pigmented. There was minimal involvement 
of the arms, hands and ears. Patients 1-3 also had 
conjunctivitis at the time of examination. 
Patients 1 and 4 described the skin sensation as being 
very like sunburn. All except patient 3 complained of 
stinging, burning or `gritty' eyes. The staff reported that 
their skin became red and sore in the evening following a 
shift at work. Peeling developed 1 day later. Symptoms 
always subsided within a day or two if they were not at 
work. The members of staff had all begun to suffer from 
October 2002 onwards. 
Patient 5 presented with no symptoms. He had 
suffered only one episode of skin and eye trouble the 
morning after he had painted the kitchen during one 
night in November 2003. All lights were on in the kitchen 
and he had painted the ceiling using a long armed roller. 
Three hours after finishing the painting, he reported 
painful, swollen and weeping eyes, reddened and peeling 
skin. The symptoms cleared over a 5-day period off work. 
He has not had any recurrence of the symptoms since. 
The patients' symptoms are summarized in Table 1. 
The skin type (Table 2) of the individual did not seem to 
affect the severity of their symptoms. There was no history 
of atopy, drug ingestion, family involvement or excessive 
consumption [231 of psoralens (e. g. celery or parsnips) in 
any of the patients examined. None had a past history of 
contact allergy or were taking photoactive medication. 
Table 2. Fitzpatrick skin types (39] 
Skin type Colour Reaction to sun 
Type I Very fair, blond or red hair, Always bums, never tans 
freckles, blue eyes 
Type II Fair skin, blond or red hair, Burns easily, tans with 
freckles, blue or green eyes difficulty 
Type III Fair to medium skin tone Burns moderately, tans 
gradually 
Type IV Medium skin tone Rarely burns, always 
tans well 
Type V Olive or dark skin tone Very rarely burns, tans 
very easily 
Type VI Deeply pigmented Never burns 
Clinical impression 
The overall clinical impression was conjunctivitis and 
sunburn-like erythema. It would be extremely unlikely 
that 24% of a workforce would have independently and 
simultaneously developed a dermatosis such as rosacea or 
seborrhoeic dermatitis. Eczema would not account for 
the ocular involvement. Given the prevalence of occu- 
pational skin disorders in kitchen staff, an irritant in the 
kitchen environment was suspected. 
Interestingly, kitchen staff working split shifts (10 am- 
2 pm and 5 pm-10 pm) reported no symptoms or lesser 
effects than their colleagues working 8-h stretches. This 
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implied that the threshold dose for the irritant was only 
exceeded after 4 h. 
The involvement of the face, hands and eyes might 
have suggested an airborne irritant rather than one that 
required physical contact. Nevertheless, cleaning prod- 
ucts were suspected, because irritants can be transferred 
from hands to face and eyes in affected individuals. 
However, examination of the data sheets of all cleaning 
agents and sprays used within the kitchen pointed against 
an environmental phototoxin. 
Hotel management had provided the staff with ski 
goggles to wear in order to protect their eyes. Only 
patients I and 4 chose to wear the goggles. They found 
that their skin involvement continued, although the eyes 
and area photoprotected by the goggles was no longer 
affected. This evidence, along with the marked cut off of 
erythema on photoprotected skin suggested that there 
might be a UV source in the kitchen. Thus, the decision 
was made to examine the light sources in the kitchen for 
hazardous levels of UV. 
Kitchen evaluation 
The hotel had several kitchens, but the affected individ- 
uals all worked in one area. This area was inspected and 
hazard measurements were made using an International 
Light SA weighted radiometer. This detector is a filtered 
photodiode and gives a weighted irradiance (W/m2) value 
indicating the hazard associated with the measured 
source. Spectral irradiance measurements were also 
taken from several light sources in the kitchen using a 
single grating, diode array Sola Scope 2000 meter with 
calibration traceable to the National Physical Laboratory 
(NPL, Teddington, UK) [24]. 
Results 
The on site survey using the Sola Scope 2000 meter 
revealed that incandescent lamps positioned on the food 
counter (to keep food hot) were found to emit some UV, 
but the Sk meter readings confirmed that this was not 
enough to be hazardous to health. Similarly, overhead 
fluorescent lights were found to emit minimal UV. There 
were also electric fly killers placed around the kitchen. 
Two of these units (Rentokil) contained clear fluorescent 
tubes with no phosphor coating in evidence. The Sola 
Scope 2000 meter proved to have too little sensitivity at 
low wavelengths to detect any hazardous UV, but the Sk 
radiometer readings at 20 cm from the unit suggested that 
there was a hazardous level of UV emitted from these 
tubes (1 W/m2). 
There was a label on the units that stated that the tubes 
had been cleaned and replaced in July 2002. This date 
corresponds closely to the start of the skin and eye 
complaints. The tubes themselves were labelled 'UVC' 
and `Dangerous for skin and eyes' on the outside of the 
glass envelope. UVC-induced erythema and photoker- 
atitis account for all the symptoms reported by the hotel 
staff [251. Patient 5 suffered the worst episode of 
photokeratitis because he was looking upwards in the 
direction of the UVC sources while he was painting the 
kitchen ceiling. 
One of the tubes was removed from one of the fly 
killers and taken to the United Kingdom Accreditation 
Service (who provide independent proficiency inspection 
and certification for calibration and testing laboratories) 
accredited photo laboratory at Ninewells Hospital, 
Dundee for accurate measurement of the spectral 
irradiance from the source. Measurements were made 
at a distance of 30 cm using a Bentham DM150 double 
grating spectroradiometer. This instrument has a cooled 
photomultiplier tube (- 20 °C ± 1°) and its calibration 
is traceable to NPL. The tubes were found to emit 
strongly in the UVC region (100-280nm) (Figure 1). 
Total irradiance from the tubes (200-600 nm) was found 
to be 4.6 W/m2. Guidance on maximum occupational 
exposure levels to unprotected skin and eyes has been 
published by the International Radiation Protection 
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Figure 1. Spectra of the light sources found in the kitchen. The intense UVC radiation from the UVC tube can clearly be seen. 
a. 
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Association [26] and is used by the Health & Safety 
Executive in the UK. Application of these guidelines to 
the spectral output from the lamp indicates that the 
recommended exposure limit would be exceeded only 
after 14s. This calculation involves the use of the so- 
called SX weighting function that gave an effective 
irradiance of 2.2 W/r2. The occupational exposure 
limit is an SA weighted effective dose of 30 J/m2. Since 
1W=I J/s, the time to reach the exposure limit is found 
by dividing the exposure limit by the effective irradiance 
from the lamp. The same weighting function can be used 
to calculate the time to the threshold dose for photo- 
keratitis. This threshold is between 50 and 100 J/m2 
effective dose [27]. This dose would have been reached in 
23-46 s. 
Erythemal weighting [28] of the UVC tube spectra 
revealed that the erythemal effective irradiance was 
4.5 W/m2. This weighting function takes account of the 
relative effectiveness of different wavelengths to induce 
erythema. Midday Southern European summer sun, by 
contrast, has an erythemally effective irradiance of 
0.27 W/m2 [29]. The UVC tube would thus deliver one 
standard erythema dose (100 j/m2) [30] in 22s. For 
comparison, it would take >200s to receive a similar 
dose at a distance of 30 cm from a narrow band UVB 
(TLOI) unit consisting of eight tubes, such as one might 
find in a phototherapy unit for treatment of psoriasis. 
The spectra obtained from the light sources in the 
kitchen are shown in Figure 1. The relative intensity of 
the UVC tube is clear to see. This figure also shows the 
spectrum of the correct type of tube to fit in electric fly 
killers. 
Given the results obtained, it was recommended that 
the UVC tubes were removed. This was done and the 
employees' problems resolved very soon afterwards. 
Discussion 
Although cases of occupational UVC irradiation are rare 
[6-8], episodes of accidental exposure have been 
reported before. In 1991, Forsyth et al. reported a similar 
incident where workers in a meat processing factory had 
been exposed to UVC radiation from similar Rentokil 
electric fly killers [5]. Electric fly killers are an effective 
tnethod of trapping insects. Standard fly catching tubes 
use UVA radiation from fluorescent tubes to attract 
insects onto an electrified mesh where they are killed and 
their bodies drop into a collecting tray [31]. This kind of 
trap removes the need for chemical deterrents or killers 
and thus also removes the possibility of cross-contami- 
nation of foodstuffs. Therefore, they are ideal for (and 
widely used in) kitchens. 
The irradiance levels reported in the current investi- 
gation represent a `worst case' scenario. Catering work 
involves moving about the workplace and generally 
looking down at food that is being prepared. An accurate 
measurement of the actual dose that the staff received 
could only have been achieved by attaching dosimeters to 
the staff uniform. Nevertheless, occupational exposure 
limits were obviously exceeded during a working day as 
the limits are set so as to avoid symptoms of exposure. 
These devices were mounted overhead and therefore the 
heads, faces and necks of the staff were receiving the 
majority of the radiation. This explains why there was 
minimal involvement of the arms and hands. Hats are 
also worn in the kitchen, which explains why the ears 
were unaffected in most of the individuals. 
The UVC tubes were fitted in July 2002 and the 
authors did not inspect the premises and identify the 
problem until late April 2003. Therefore, staff had been 
exposed to this radiation for about 9 months before the 
tubes were identified. The effects of long-term UVC 
exposure in humans are not known. LJVC radiation is 
known to be mutagenic [32,33] and causes erythema in 
much the same manner as excessive WB irradiation does 
[34]. While UVC photons are more energetic and 
therefore more damaging than longer wavelength UVB 
and UVA photons, they do not penetrate tissue as deeply 
so that undesirable effects are confined to the outer tissue 
layers [35]. For example, in the eye, UVC radiation is 
absorbed by the cornea and is not, therefore, transmitted 
to the retina [36]. 
This incident highlights the confusion that can occur 
resulting in incorrect tubes being fitted to electric 
flytraps. This type of tube is designed for air, water or 
surface sterilisation [37,38] and should not be used in fly 
killers. We suggest that the UVC tubes are labelled more 
clearly and that manufacturers obtain more details as to 
the intended application before supplying tubes of this 
type. We would also welcome a decision by manufac- 
turers to make UVC tube fittings differently from other 
fluorescent tubes so that it would become impossible for 
end-users to fit this type of tube in error. Potential users 
and health professionals should also be educated as to the 
potential adverse affects of this type of UV tube so that 
these symptoms would not go undiagnosed. 
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Presentations 
Diode array spectroradiometers: An Evaluation of Two Instruments in a 
Medical Context, UV Network meeting, Halkidiki, Greece, October 2002 
The Potentials and Pitfalls of Using Diode Array Devices to Measure Light 
Sources, Scottish Skin Biology Club, Edinburgh, November 2002 
Determining the reaction of photosensitive patients to polychromatic light 
sources, Medical Physics Journal Club, Ninewells Hospital, September 2003 
Too many cooks with red faces, Scottish Dermatological Society, Dundee, 
October 2003 
Predicting the reaction of photosensitive patients to polychromatic light 
sources: A mathematical method based on monochromator testing. 
European Societyfor Photobiology Conference, Vienna, September 2003 
Transmittance of sunscreen products from 600 to 800 nm. Poster 
presentation. European Societyfor Photobiology Conference, Vienna September 
2003 
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had either closed or dispensed with their sunbeds. Hence, 11 premises were visited 
for the first time, only 4 of which were known to the council and a further 7 that were 
identified by telephone enquiry. 
Dundee 
There are 23 premises in Dundee with 86 beds (43 beds and 43 booths). Three of 
these are local authority sports centres (gyms), one of which has 6 sunbeds and the 
others which offer just one. 
Spectral Measurements 
Calibration of the instrument 
Separate calibrations were made for fluorescent UVA tubes and for metal halide 
lamps, see figure 5.13. The mean calibration factor for UVA fluorescent tubes was 
1.11, indicating an underestimation of the irradiance from the instrument if its in built 
calibration were used. In particular, the peak at 312 nm had to be corrected by a 
factor of 3. 
Conversely, with the metal halide lamp, the average correction factor was 0.4 
indicating that the Sola Scope overestimated the irradiance from this lamp using its in 
built calibration factor. The relative differences in these calibration factors are likely 
to be due to the different spectral distributions of these lamps, creating different stray 
light profiles, which are then calibrated out. 
5.28 
